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ABSTRACT 
 
Background:  
An estimated two-thirds of global sales of antimicrobials occur over the counter without a 
prescription. Furthermore, antimicrobials are the most commonly sold medicines in developing 
countries. The overuse, misuse, or inappropriate use of antimicrobials are major contributing factors 
to the emergence of antimicrobial resistance. This does not only lead to failure of therapy, increased 
morbidity and mortality, and rise in healthcare costs, but it puts these countries on a fast track to 
the pre-antibiotic era. 
Thailand is experiencing soaring antimicrobial resistance. A few studies suggest that 
inadequate knowledge, incorrect attitudes and malpractices of healthcare professionals and 
patients regarding the use of antimicrobials and reducing the emergence of antimicrobial resistance 
may be fuelling this crisis. Pharmacists in particular, may have a key role in rationalising the use of 
antimicrobials in community and reducing the emergence of resistance.  
Aim 
This study aims to assess pharmacists’ knowledge, attitudes and practices regarding 
antimicrobials use over the counter and antimicrobial resistance.  
Methods  
A cross-sectional descriptive study was conducted using online self-administered 
questionnaire for pharmacists in Bangkok and Chonburi province in Thailand between May and 
July 2017. The self-administered questionnaire was developed following a review the literature 
relating to pharmacists and healthcare professionals using the Knowledge, Attitude and Practices 
(KAP) model regarding antimicrobial use and resistance.  The questionnaire was validated by an 
expert panel and its validity and reliability was tested in a pilot study. Statistic Package for the Social 
Science (SPSS) software version 24 was used for statistical analysis. The Cronbach’s alpha and 
Interclass correlation coefficients (ICC) were used to test of reliability. Kolmogorov-Smirnov Test 
was used for normal distribution testing. Descriptive data were examined by the median, 
interquartile range (IQR), Chi-squared test. Mann-Whitney U Test and Kruskal-Wallis test were 
used to describe associations between demographics with knowledge, attitude and practice of 
participants. Relationships between knowledge, attitude and practice dimensions were analysed by 
regression equations and Spearman’s correlation coefficient statistic. Qualitative data were coded 
and presented as percentages.  
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Results   
372 pharmacists completed the questionnaire obtaining a response rate of 71.4%. The 
community pharmacists age average was 32.02 (± 5.81) years. Most participants hold a bachelor 
degree in pharmacy (77.2%), and work at individual/ independent drug stores (62.6%). The average 
experience in community pharmacy is 5.46 (± 4.31) years. 69.4% of the participants work in 
Bangkok and 30.6% work in Chonburi. More than 90% of pharmacists have good knowledge, 
attitude and practice in antimicrobial use and resistance. However, there is only a slight correlation 
between attitude and practice score at rho = 0.149, p-value 0.004.  The most commonly 
encountered infections are respiratory infections and Aminopenicillin is the main drug provided in 
pharmacies. The main reported reason of pharmacists to provide antimicrobials without a 
prescription was their confidence in their competency.  
Conclusion  
Respiratory infections were the most commonly encountered infections in community in 
Thailand, with Aminopenicillin being the most commonly dispensed antibiotic. Community 
pharmacists in Thailand report competence as the main reason for them providing antimicrobials 
without a prescription. This study shows that over 90% of them have good knowledge, attitude, and 
practice regarding antimicrobial use and resistance. Pharmacists in Thailand could sustain their 
competence through continuing education, adherence to antimicrobials guidelines, collaboration 
with other healthcare providers, and raising public awareness regarding antimicrobial use and 
resistance.  Pharmacy associations could support pharmacists to improve pharmacy services 
through research, training, campaigning, professional standards and guidelines, and increasing 
inter-professional collaboration in fighting antimicrobial resistance. Further, government and policy 
makers could enhance pharmacists’ role in ensuring the appropriate use of antimicrobial and 
combatting antimicrobial resistance through the provision of national databases and surveillance 
programmes, research funding and healthcare regulations. 
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CHAPTER 1 
INTRODUCTION 
Antimicrobial resistance is becoming an imminent public health threat, fuelled by the 
increased consumption of antimicrobials worldwide, and the lack of development of new agents 
(WHO, 2016). Combatting antimicrobial resistance is now a main priority and is being promoted by 
healthcare professionals in all sectors including pharmacists. However, there is limited research on 
antimicrobial stewardship within community pharmacy in developing countries such as Thailand; 
especially that antibiotics can legally be obtained or dispended without a prescription. 
This chapter will first explain the problem and mechanisms of antimicrobial resistance, 
followed by a discussion of the various initiatives to combat resistance, including antimicrobial 
stewardship programmes. The chapter will then explain the rationale of this research and the thesis 
organisation. 
Principle of antimicrobial resistance 
The World Health Organisation (WHO) defines antimicrobial resistance as a biological 
phenomenon that develops when microorganisms (bacteria, fungal, virus or parasites) change 
when they are exposed to antimicrobials. This change renders the microorganism resistant and can 
survive the previous lethal antimicrobial. (WHO, 2015a; WHO, 2016). 
Antimicrobial resistance is a natural process and has existed for thousands of years (Hwang & 
Gums, 2016). It can be divided into two types: Intrinsic resistance and acquired resistance.  
Intrinsic resistance occurs when the drug cannot affect the microorganism because of the 
drug’s structure. Acquired resistance occurs when the microorganism acquires processes to 
decrease the effectiveness of drugs (Byarugaba, 2010). 
The emergence of antimicrobial resistance within microorganism can be explained by natural 
selection theory (Holmes et al., 2016). It is divided into four types 1) Inactivation of drugs via 
hydrolysis. 2) Alteration of drug targets within cells thus making them unrecognisable to the drug. 
3) Bypassing the drug target by changing permeability, preventing access of medication to the 
target, and 4) Increasing the export of the drug out of cells such as increasing efflux pumps 
(Penesyan et.al, 2015; Holmes et al., 2016). 
The mutation genes encoded in chromosomes can transfer to other microorganisms and hence 
transfer resistance. There are three mechanisms of transmission between microbes; 
Transformation, Transduction and Conjugation (Holmes et al., 2016; Hwang & Gums, 2016).  (See 
figure 1 for an illustration of the transfer of resistance) 
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Figure 1: Transmission mechanism of bacteria resistance DNA (Holmes et al., 2016) 
 
Causes of antimicrobial resistance  
 Antimicrobial resistance occurs as a result of various factors including: lack of effective 
antimicrobials to treat infectious diseases, inappropriate use of antimicrobials in humans and 
animals, and improper infections control. These causes are explained in the following paragraphs. 
Antimicrobials innovation and development 
Antimicrobial resistance continues to emerge while new class of antibiotics has not been 
developed since 1987 (Theuretzbacher, 2015). Only seven new antibiotic agents were launched 
between 2012 and 2016; most of them are gram-positive antibiotics (U.S.FDA, 2016). This 
highlights the difficulty to treat resistant gram-negative bacteria which is often implicated in severe 
and resistant infections (Marston et al., 2016). It is noteworthy that the last-resort antimicrobials are 
more expensive and could not be afforded in developing countries (Laxminarayan et al., 2015). This 
highlights the gap between the urgency to develop new antibiotics and the lack of this development. 
New antimicrobials development has been hindered by limited economic funding and 
stringent regulations (Ventora, 2015). Research funding from government and academic areas has 
been dramatically reduced following the economic crisis. In some pharmaceutical companies, 
research and development teams were reduced. Further, pharma has an inherent lack of interest 
in developing medicines for short/ minor illness if contrasted with highly ludicrous management of 
long-term conditions (Ventora, 2015; Marston et al 2016). Secondly, regulatory processes are an 
important factor for development; clinical trial studies and ethics require a high cost investment 
(Ventora, 2015). In February 2017, the WHO published the list of urgently need new antibacterial 
agents. The list aims to guide and promote research and development of new antimicrobials. The 
list, broken down into 3 groups includes: critical, high and medium priority (WHO, 2017). Gram-
negative bacteria were highlighted because of multi-resistance to antibiotics. 
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Collaboration between public and private sectors has proven to be useful for antimicrobials 
development such as the Innovative Medicines Initiative (IMI) between European Commission and 
pharmaceutical companies or the Generating Antibiotic Incentive Now (GAIN) in the US which 
launched new five antibiotics drugs since 2014 (Theuretzbacher, 2015).  
Antimicrobials use in animal and food industry  
Antimicrobial use in agriculture is a major cause of resistance development.  It is estimated 
that there is around 80 % of antibiotic use in agriculture. Antimicrobials are used in farm animals 
for growth-promotion (Laxminarayan et al., 2015; Hwang & Gums, 2016). The research of  
Van Boeckel and colleagues in 2015 demonstrate that 63,200 tons of antibiotics were used in 
livestock in 2010. The top five largest consumers of antibiotics in agriculture in 2010 are China 
(23%), the US (13%), Brazil (9%) India (3%) and Germany (3%). Moreover, the rate of antibiotic 
use in food animal products may rise to 105,600 tons in 2030. The top five countries which are 
predicted to have an increasing rate by 2030 are Myanmar (205%), Indonesia (202%), Nigeria 
(163%), Peru (160%) and Vietnam (157%).  
In Thailand, the database of this research of Centre for Disease Dynamics, Economic and 
Policy (CDDEP) shows that antibiotic use in animals was 82.4 mg per population correction unit 
(PCU) in 2010 and might increase to 24.8mg per PCU in 2030. (See Figure 2 for a comparison) 
The rate of consumption depends on the policy of each country. Restricting antibiotic use in food 
and animal industry can certainly lead to reduce consumption rate in the future (Van Boeckel et.al, 
2015; CDDEP, 2016). 
 
 
 
 
 
 
 
 
Figure 2: Comparisons of antibiotic use in animal between 2010 and 2030 (CDDEP, 2016). 
Antibiotic use in animals might have a positive correlation with resistance rate 
(Laxminarayan et al., 2015). Bacterial resistant strains such as extended spectrum β-lactamase 
(ESBL) have been found in poultry. Prevalence of extended spectrum β-lactamase (ESBL)-coding 
gene was detected in around 80% of chicken meat tested in the multi-centre study. The same 
strains were detected in human rectal and blood samples from hospitals within the same areas of 
the chicken meat. (Overdevest et al., 2011).  Resistant bacteria (as New Delhi metallo-β-lactamase 
 4 
 
(NDM-1) genes) have been found in cattle. Also, aquaculture animals, horses, donkey and mules 
have been found to contain resistant bacterial (CDDEP, 2015).  A research of ESBL producing  
E. coli prevalence indicates that the bacterial were prevalent in food product chain. There were 
highly positive E. coli tests around 77.3% of farm workers and 75.5% of food industry workers. Also, 
E. coli was found in livestock, commonly in pigs (76.7%) and broilers (40%). Moreover, the ESBL 
producing E. coli could be detected in fresh meat and vegetables in markets and environments 
particularly nearby animal farms (Boonyasiri et.al, 2014). This research highlights the ease of 
transfer of antibiotic resistant bacteria form animals, food products and the environment to humans. 
Legislation for the appropriate use of antimicrobials in agriculture can reduce the problem 
of antimicrobial resistance. Sweden has banned inappropriate antimicrobial use in animals since 
1986, followed by Denmark in 1994. The European Union has regulated antibiotic use in animals 
since 2006. This regulation has led to reduction in antibiotics consumption and a decrease is 
resistance in the region (Laxminarayan et al., 2015; CDDEP, 2015). To prevent and control 
antibiotic use in this sector, their use must be under veterinary supervision. Antibiotics should not 
be used for growth promotion and disease prevention in this sector. Also, good practice in hygiene 
and animal health in farming should be promoted (WHO, 2016). 
Inappropriate consumption of antimicrobials in healthcare 
Global antibiotic use in humans has seen a 36% increase between 2000 and 2010 (Van 
Boeckel et.al, 2014). Antibiotics are used in healthcare-settings between 20% and 80% in primary 
care with or without prescription worldwide (Kotwani & Holloway, 2011). Half of antibiotic provision 
in community is inappropriate and leads to antibiotic resistance (CDDEP, 2015).  
Inappropriate provision of antimicrobials fuels overconsumption. Antibiotics consumption 
rate between 2000 and 2010 rose by 36% globally (Van Boeckel et.al, 2014). The research shows 
that inappropriate treatment of acute diarrhoea and febrile illness in children increased 
cephalosporin and fluoroquinolone consumption particular in Bangladesh, Thailand, China and 
India.  India had the highest consumption rate in 2010 by 10.7 units per person, followed by China 
which consumed 7.5 units per person. In 2010, the top 3 mostly used antibiotics were board 
spectrum penicillin, cephalosporin and macrolides. However, carbapenems, polymyxin, 
glycopeptide and monobactam were increasingly being consumed in many countries. 
Cephalosporin and fluoroquinolone were highly being used in middle-income countries, India and 
China than others (Van Boeckal et al., 2014). 
Furthermore, inappropriate prescribing and dispensing can lead to misuse and overuse of 
antimicrobials.  For example, in the US, an antibiotic was prescribed in 221 prescriptions per 1000 
population for acute respiratory infection but only half of these prescriptions were appropriate 
treatment (Fleming-Duta et al., 2016). 
 
 
 5 
 
19,449 
12,273 
21,409 
9,894 
22,464 22,485 
19,551 
18,125 17,699 
 -
 5,000
 10,000
 15,000
 20,000
 25,000
Brazil Russia India Chaina Soulth
Africa
UK US Vietnam Thailand
st
a
n
d
a
rd
 u
n
it
s 
p
er
 1
0
0
0
 P
o
p
In England, antibiotic consumption has increased from 21.6 to 23.0 defined daily doses 
(DDD) per 1000 inhabitants per day between 2011 and 2014. The most commonly prescribed 
antibiotic is Co-Amoxiclav; 13.8% of it for treatment and 20.60% for surgical prophylaxis (Public 
and International Health, 2016).  
The CDDEP database shows that Thai people used 19,696 standard units per thousand 
population in 2007.This has decreased to 17,699 standard units per thousand population in 2014. 
The top three antibiotics used were penicillins included board and narrow spectrums, 
fluoroquinolones and cephalosporin (CDDEP, 2016). (See Figure 3 for a comparison of 
consumption rates) 
 
 
 
 
 
 
 
Figure 3: Comparisons of antibiotic use in 2014 (CDDEP, 2016 based on Van Boeckal et al., 2014). 
Infections prevention and control 
Infections prevention and control (ICP) practices can contribute to the development of 
resistance. Resistant microorganisms develop because of poor infection control, hygiene and 
sanitisation (WHO, 2016; O’neill, 2016). O’Neill (2016) highlights that poor infection prevention and 
control can increase incidence of infections and lead to increased antimicrobial use and resistance. 
It can also lead to increased morbidity, mortality and reduced quality of life.  
Poor sanitisation can lead to infectious diseases. O’Neill (2016) describes that around 60% 
of diarrhoea illnesses are a result of poor sanitisation and unsafe water. Though 70% of diarrhoea 
cases are viral infections, most patients receive antibiotics for its treatment.  Healthcare-associated 
infections (HAI) are a result of poor infections control in hospital.  7-10% of hospital infections in 
patients worldwide are healthcare acquired (O’Neill, 2016). Danchaivijitr et.al (2007) indicate that 
prevalence of HAI in Thai hospitals was 6.5%. Most infections sites were lower respiratory tract 
(36%) and urinary tract (26%). This has resulted in 12 days of increased hospital stay; increase of 
13% in mortality rate, and on average, Thailand spent $150 per case for HAI treatment.  
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Outcomes of antimicrobial resistance 
Antimicrobial resistance is a global threat that is causing increasing morbidity and mortality. 
The World Health Organisation (WHO) reports that 6.1million died from lower respiratory infections, 
HIV/AIDS and diarrhoeal diseases respectively in 2012. This increase in fatality has been attributed 
to antimicrobial resistance (WHO, 2014).  
According to the global action plan on antimicrobial resistance (WHO, 2015a), antimicrobial 
resistance has a direct and indirect effect. The direct effect involves increasing severity of infection 
leading to longer sickness, increased mortality, extended hospital staying time and decreased 
effectiveness of prevention in medical procedures such as operations and chemotherapy. The 
indirect effect relates to the increased health risks both in people and animals and increased 
economic burden through loss of productivity and higher costs of treatment and prevention. 
The European Centre for Disease Prevention and Control (ECDC) and the European 
Medicines Agency (EMA) estimate that infections caused by resistant bacteria cause 25,000 deaths 
in Europe annually and increase health costs and productivity loss costs to around 1.5 billion EU 
per year (ECDC/EMA, 2009). The picture in Thailand is similar; antimicrobial resistant infections 
add an additional 3.24 million hospitalisation days and 38,481 deaths by infections annually. 
Thailand spent $84.6- 202.8 million a year on antibiotics, and at least $1.3 billion of productivity loss 
costs through morbidity and mortality (Pumart et al., 2012). In the US, at least 2 million people had 
infections and 23,000 people died as result of antimicrobial resistance (Centre for Disease Control 
and Prevention (CDC), 2013). The direct healthcare cost from antibiotic resistance was $20 billion 
and a societal cost of approximately $35 billion a year (CDC, 2013). (See table 1 for a comparison 
of mortality and expenditure on antimicrobial resistance among countries) 
 Global 
(O’Neill, 2014) 
European 
(ECDC & EMA, 2009) 
USA 
(CDC, 2013). 
Thailand 
(Pumart et al., 2012). 
Death 
700,000 deaths/ yr. 
(10 million by 2050) 
25,000 deaths/yr. 
23,000  
deaths/yr. 
38,481deaths/yr. 
Economic  
burden 
60 to100 trillion 
USD/yr. 
1.5 billion EU/yr. 
antibiotics cost 
20 billion USD/yr. 
societal cost 
35 billion USD/ yr. 
antibiotics cost 
84.6- 202.8 million USD/yr. 
productivity loss 
1.3 billion USD USD/yr. 
Table 1: Burden of antimicrobial resistance in Global, European, USA and Thailand 
The disease burden of antimicrobial resistance and the damaging consequences on 
people’s health and economies warrant efforts to combat resistance at local, regional, national and 
international levels.   
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Strategies to combat antimicrobial resistance 
 Given the complexity and multi-factorial nature of antimicrobial resistance, interventions to 
tackle the issue have to be layered and multifaceted. Interventions to address this issue will be 
discussed in this section at four levels: international, national, organisation (community and 
hospital) and individual levels. There are 14 approaches to combat AMR issue (Uchil et.al, 2014). 
(See figure 4 for an illustration of the key interventions to tackle antimicrobial resistance)  
 
 
 
 
 
 
 
 
 
 
Figure 4: Approaches to combat antimicrobial resistance (Uchil et.al, 2014). 
 
 According to the fourteen approaches to combat antimicrobial resistance, it need to 
consider to individual country background. National policy and AMR committee seem to 
uncomplicated for generating by government, while some of actions have to more discussion with 
many stakeholders such as banning non-prescription antimicrobial.  
For example, in Thailand, the legal allows pharmacists to dispense non-prescription 
antimicrobials. It is a reason of healthcare system and affordable medication problem. Morgan and 
colleagues (2011) estimate that have no evidence to support prescription antimicrobials is better 
than non-prescription. Nevertheless, appropriate practice of healthcare profession could be more 
consider. It covers with other approaches in the model such as treatment guideline, rational drug 
use, infection control, hand hyenine, education and motivations. Similarly, the International 
Pharmaceutical Federation (FIP) (2015) suggests that community pharmacist has a role to triage 
patients and they could provide over-the-counter antimicrobials in minor infection diseases but 
referral to physician and specialist need to consider for serious health problem. So, appropriate 
practice in antimicrobial use is might better than legal force and healthcare profession have to 
collaborate each other to improve service and activities to combat the resistance problem.  
  
 
 
AMR committee 
Essential Drug List 
New AMR Programmes 
National Policy 
Increase Collaboration 
Rational Drug 
Use 
Infectious control & 
Prevention 
Antimicrobial 
Surveillance 
Ban on OTC Antibiotic 
Educate, Motivate 
R&D Drug /Vaccine 
Immunization coverage 
Hand Hygiene Std. Treatment 
Guideline 
Combat Antimicrobial 
Resistance 
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International level  
The World Health Organisation (WHO) has been considering this issue for decades. The 
global strategy for containment of antimicrobial resistance was published in 2001 to encourage 
member countries to act on this global health threat. In 2015, WHO launched a global action plan 
on antimicrobial resistance. It aims to ensure, for as long as possible, continuity of effective and 
safe medicines for the treatment and prevention of infectious disease. The member countries are 
expected to develop their nation action plan to combat antimicrobials resistance.  
However, an analysis of the response to WHO antimicrobial resistance plans by WHO 
(2015b) shows that the members are yet to act on WHO recommendations. Not all of the 6 key 
elements were addressed (National plan or strategy, Surveillance data, Access of quality and safety 
antimicrobials, Antimicrobial misuse control, Awareness and understanding of general public and 
Effective of infection prevention and control programme). The results show that an AMR strategy 
has not been developed in many countries (WHO, 2015b).   
National level 
  National level policy can reduce inappropriate use of antimicrobial medicine and resistance 
situation in the country (Uchil et.al, 2014). A “One- health’ approach is essential to ensure 
collaboration of all stakeholders; healthcare, farming, environment, and industry sectors.   
The UK formulated the UK five-year antimicrobial resistance strategy, 2013-2018 which 
uses an integrated approach to combat AMR. The primary goal of the strategy is to slow 
antimicrobial resistance developing and spreading (Davies & Gibbens, 2013). Consequently, the 
UK has the lowest level of resistance in EU/EEA (Public and International Health, 2016).   
In 2017, Ministry of Public Health Thailand (MOPH) and Ministry of Agriculture and Cooperatives 
Thailand (MOAC) launched a national strategic plan to combat antimicrobial resistance from 2017 
to 2021 using an integrated “one Health” approach (MOPH & MOAC, 2017). It aims to reduce AMR 
morbidity, decrease antimicrobial use in humans and animals, increase public knowledge and 
awareness and improve capacity of AMR management in the country.  
Organisation level 
Antimicrobial resistance has spread widely in community and hospital settings resulting in 
community acquired or hospital acquired resistant infections. Therefore, addressing AMR at an 
organisational level is urgent.  
In communities, public awareness of antimicrobial resistance is important to combating 
AMR. The common misuse is widely in community such as uncompleted antibiotic courses, 
ineffective dosing, unnecessary use and sharing medicines with other patients (Ocan et al., 2015). 
The work of Uchil and colleagues (2014) recommend that community level actions could increase 
rational use of antibiotics. These include regulating non-prescription antibiotic provision, antibiotic 
use guidelines in community and improving hygiene and sanitation. 
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In hospital settings, strict infection prevention and control can restrict the spread of 
resistance. Health providers have to preserve antimicrobial agents and improve their rational use. 
Also, they could encourage and educate their patients to understand antimicrobial resistance issues 
and how to use antimicrobials appropriately (WHO, 2015a). Hospital surveillance systems and 
microbiology to inform drug therapy are key to improving medical treatment and feeding into 
resistance database (Uchil et.al, 2014).  
Individual level 
Antimicrobial resistance awareness and adherence to appropriate antimicrobial use need 
to intensify in the public domain. A multi-country study on awareness of antibiotic use demonstrates 
that knowledge of people was inadequate, and they often misunderstood antibiotic use, 25% of 
participants shared antibiotics, 64% of them believed the medicine could cure a common cold and 
flu caused by viruses (WHO, 2015a). 
The key persons to motivate antimicrobial awareness and appropriate use of antimicrobials 
are healthcare providers. Healthcare professionals have the core responsibility of antimicrobial 
stewardship and promoting antimicrobial resistance awareness, good infection prevention and 
control including vaccination and screening programmes and educating the general public (Public 
Health England (PHE), 2015).   
Antimicrobial Stewardship 
Antimicrobial stewardship is an approach to promoting and monitoring antimicrobial use 
appropriately (National institute for health and clinical excellence (NICE), 2015). The main objective 
of antimicrobial stewardship is to achieve the most effective clinical outcome with less toxicity and 
adverse reactions. Also, it considers the effective antimicrobial dose, duration of action and route 
of administration (Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases 
Society of America (IDSA) & Paediatric Infectious Diseases Society (PIDS), 2012). In the UK, NICE 
launched the antimicrobial stewardship guideline. The guideline suggests that healthcare workers 
should follow, support and apply antimicrobial stewardship in their practices. Once the patient 
needs to use an antimicrobial, the prescriber would select the shortest treatment course, 
appropriate regimen and route of administration (NICE, 2015). Moreover, the antimicrobial 
stewardship teams should be multidisciplinary including physicians, pharmacists, nurses, 
microbiologists and others (SHEA, IDSA & PIDS, 2012; NICE, 2015). A randomised control trial in 
Australia found that the multidisciplinary antimicrobial stewardship team could improve therapy in 
terms of timeliness of treatment with blood culture infections (Cairns, et.al, 2016). Healthcare 
providers are important players in encouraging their patient and the public to be aware of AMR 
issues and antimicrobial stewardship programmes. Also, the general public needs to consider the 
problems and improve their knowledge and adherence with antimicrobial therapy.  
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Role of pharmacist in antimicrobial stewardship 
The role of pharmacists in antimicrobial use and resistance can be vital in hospital and 
community pharmacy because each setting contributes differently to antimicrobial resistance. It is 
widely agreed that hospital pharmacists can improve patients’ clinical outcomes through 
multidisciplinary practices while community pharmacists can reduce inappropriate antimicrobials 
use through improving public awareness and adherence.  
Hospital pharmacists can improve patients’ outcomes through inter-professional 
interactions (FIP, 2015). Hospital pharmacists in the UK have been key drivers of antimicrobial 
stewardship programme development in hospitals. They have improved prescribing standards and 
infection prevention and control practices (Howard et al., 2013).  Similarly, researchers in Thailand 
demonstrate that trained clinical pharmacists can increase appropriate use of antimicrobials in 
hospital settings (Apisarnthanarak et al., 2015). 
Community pharmacies are the first point of contract point to patients who have a minor 
illness. So, community pharmacists can encourage appropriate antimicrobial use and awareness 
of resistance directly (FIP, 2015). The campaign “Mirror, mirror on the wall, do I need antibiotics at 
all?” was developed by community pharmacy association of Thailand (CPA) to promote appropriate 
use of antibiotics in upper respiratory tract infections. Community pharmacists checked their 
patients’ throats to differentiate viral and bacterial infections and encouraged patients to self-care 
(CPA, 2012). In addition, Booth and colleagues (2013) indicate that good community pharmacy 
practice can reduce workload of general practice (GP) doctors. Community pharmacist could lead 
on health promotion, education regarding infection prevention, and provision of immunisation 
services. They could perform appropriate triage and refer patients as needed, and support 
optimising the use of antimicrobials in relation to adherence and safety (FIP, 2015). 
 It is clear that community pharmacists are essential in the overall strategy of combatting 
antimicrobial resistance. They need to perform their antimicrobial stewardship at all times, and they 
are expected to provide essential information to the public regarding antimicrobial use and 
resistance. This is particularly advocated since several studies in this area confirm that they have 
adequate knowledge, good attitude and proper practice in antimicrobials use and resistance. 
However, the varying legal and professional pharmacy context in each country, particularly in 
developing countries such as Thailand, may define different roles of pharmacists in relation to 
antimicrobial stewardship. This study explores community pharmacists’ knowledge, attitude, and 
practice of antimicrobials use and resistance in Thailand and draws on the wider literature to 
compare and benchmark Thai pharmacists, within the global picture of antimicrobial stewardship 
practices. 
 This research purposes to assess community pharmacists’ knowledge, attitudes, and 
practice in Thailand regarding non-prescriptions antimicrobials use and resistance. A self-
administrated questionnaire was developed from existing literature to measure community 
pharmacists’ knowledge and attitudes regarding antimicrobials use and resistance. The study was 
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conducted in two provinces of Thailand, Bangkok and Chonburi which cover more than 30% of 
pharmacies in the country.  
Results of this study provide insights into the current situation of antimicrobial use and 
resistance in community pharmacy practice. The use of the Knowledge, Attitude, and Practice 
(KAP) model is particularly advantageous here since previous studies have mainly used the Theory 
of Planned Behaviour (TPB) model to explore community pharmacists ‘behaviours in relation to 
antimicrobial provision; not covering pharmacists’ knowledge in relation to this aspect.  Moreover, 
the study is an initial assessment of community pharmacists regarding antimicrobial use following 
the introduction of the antimicrobial resistance national strategic in Thailand at the beginning of 
2017. This research can inform future interventions for community pharmacist such as continuing 
professional development (CPD) courses and antimicrobial stewardship training; these could be 
designed around the study findings on pharmacists’ current knowledge, attitude and practice.  
 This thesis examines antimicrobial stewardship practices of community pharmacists in 
Thailand through assessing their knowledge, attitude, and practice (KAP) using the KAP model. 
The healthcare context in Thailand will be presented in Chapter 2 including a background of the 
health system in Thailand and community pharmacy service in the country. A literature review 
(Chapter 3) will discuss existing research on community pharmacists’ antimicrobial stewardship and 
the KAP studies in the pharmacy profession regarding antimicrobials use and resistance. Then, 
chapter 4 will be discuss theoretical frameworks including a detailed description of the knowledge, 
attitude, and practice (KAP) framework and other relevant models. Methodology and statistical 
analysis will be described in chapter 5 followed by a presentation of the study findings in chapter 6. 
The results will then be discussed in chapter 7, followed by the conclusions of the study and 
suggested future research. Ethics approval letters, the research instrument, and supplementary 
data analysis tables will be included as appendices.  
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CHAPTER 2  
STUDY CONTEXT 
Although antimicrobial resistance is a threat to public health globally, strategies to 
overcome this issue have to be tailored to the individual country context. Thailand is a developing 
country with specific healthcare needs and a specific healthcare system. This chapter includes an 
overview of the health service system and pharmacy in Thailand, including pharmacy education. It 
then discusses the current antimicrobial stewardship activities to combat resistance particularly in 
community pharmacists.  
Health service in Thailand 
Health service administration 
The ministry of public health (MOPH) is a government department that is responsible for 
healthcare policy and system development, health administration and implementation on a national 
level. Legally, the ministry has the primary role of supporting health promotion, disease prevention 
and control, treatment and rehabilitation (MOPH, 2013).  
The ministry is divided into two levels, central level and provincial level. At a central level, 
there are four clusters that oversee eight departments.  At a regional level, there are 77 provincial 
health offices in Thailand, controlled by the Office of the Permanent Secretary from the central level 
(Tangcharoensathien, 2015). (See Figure 5 for a summary of the health service administration 
structure in Thailand)    
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 5: Ministry of Public Health Organisation  
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At a central level: The Office of the Permanent Secretary is an administration department. 
It also links with the provincial level administration.  The Cluster of Medical Services Development 
supports the medical department, traditional medicine and alternative medicine department and 
mental health department. The Cluster of Health Development is responsible for public health 
services including the disease prevention department. The Cluster of Public Health Service Support 
is responsible for drug and medical devices control. This cluster includes the department of health 
service support, department of medical sciences and the Food and Drug Administration 
(Tangcharoensathien, 2015). 
At a provincial level: 77 provincial health offices in Thailand are controlled by the Office 
of the Permanent Secretary at a central level. The health offices are grouped into 12 health areas 
by geographic region, health resources and service planning. Overall, each provincial health office 
is responsible for health administration and controlling public hospitals and health centres in their 
province (Tangcharoensathien, 2015). 
Access to medicines 
Thailand has a population of around 68 million people (World Bank, 2016). Thai people can 
access medicines through hospitals, private medical clinics and pharmacies. Medicines can also 
be purchased in retail shops (Apisonthanarak et.al, 2008; Saramunee et.al., 2011).  The National 
Statistics Office (NSO) in Thailand reports that households spent 0.9 % of their expense on 
purchasing self-medication in 2013 and this has increased to 1.4% in 2016. 
There are three types of health insurance systems that cover 99% of population. The 
Universal Coverage Scheme (UCS) covers 75% of people, the Civil Servant Medical Benefit 
Scheme (CSMBS) for government officers covers 8% of people and the Social Health Insurance 
(SHI) covers around 10% employees in the private sector (Tangcharoensathien, 2016).  The rest 
are uninsured. The health insurances schemes provide medical services and medications which 
are listed in the national list of essential medicines. The national list of essential medicines (NLEM) 
formulary is compiled based on an evidence–based selection system. The NLEM committees 
consider the health need, safety, efficacy, compliance, quality, treatment cost, cost-effectiveness, 
equity and national affordability. Thai NLEM is divided into five sub-lists including standard drugs, 
specialised drugs and high cost medicines (Yoongthong et.al, 2012).  
Medicines classification 
The current drug law in Thailand has been in place for around 50 years. It is the Drug Act 
of Thailand B.E. 2510 (The Royal Thai Government, 1967). The Drug Act of Thailand classifies 
medicines into four groups (Saramunee et. al, 2011): 
1. Home remedies: are general medicines for self-care and minor symptoms. These can be 
purchased in convenience stores and pharmacies without licence requirements for selling 
(approximately equivalent to UK General Sales List (GSL) medicines). 
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2. Ready-packed pharmaceuticals: are medications that can be sold without prescription but 
only through certain types of pharmacies (Type I and Type II pharmacies; this will be explained 
in the community pharmacy in Thailand section below)  
3. Dangerous drugs:  can be dispensed by pharmacists without medical prescription in Type I 
pharmacy. Most of oral medicines are classified in this category including oral antibiotics.  
4. Special control drugs: are medications that require a prescription to be dispensed. This 
category includes narcotic drugs and psychiatry medicines.   
Community pharmacy service in Thailand 
The main role of community pharmacy in Thailand is dispensing medications to patients 
with or without prescription. The Community Pharmacists Association (CPA) and National Health 
Security Office (NHSO) encourage the involvement of community pharmacy in health promotion 
and disease prevention projects (Chiyakunapruck et.al, 2016). However, providing vaccination 
service (such as flu vaccination) is not allowed in Thai community pharmacy. Furthermore, some 
community pharmacists develop their services in areas of home health care; these include 
medication use reviews (MURs), identifying drug-related problems (DRPs), patients’ education and 
developing treatment plans (Tunpichart et.al, 2012). This highlights the wide and active role of 
pharmacists in providing and ensuring appropriate access to medication, and emphasises the 
potential role of pharmacists in public health through ensuring appropriate use of antimicrobials and 
educating patients and the public on matters of antimicrobial resistance. 
Type of community pharmacy 
Legally, community pharmacies in Thailand can be classified as either Type I or Type II 
(The Royal Thai Government, 1967).  
Type I pharmacy is required to have a registered pharmacist working during service hours. 
The pharmacists provide medicines with and without prescription depending on the drug 
classification. There are around 15,000 type I pharmacies in the country (Bureau of drug control, 
2016). These pharmacies are reported to not always have a pharmacist working as per legal 
requirements. Some of these pharmacies do not have pharmacists present and they still provide 
medicines at all time (Saramunee et.al, 2011). 
Type II pharmacy does not legally require the presence of a registered pharmacist in order 
to provide medication as it can only provide home remedies and ready-packed pharmaceuticals.  
However, these pharmacies face challenges to control drugs provision because some sell 
medication without permission (Wuttipanich & Kitisopee, 2015).  
The drug law in Thailand has yet to allow online pharmacies to practice. So, medicines 
provision online and social media is currently illegal (The Royal Thai Government, 1967).  
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In terms of ownership, independent pharmacies in Thailand are still higher than chain 
pharmacies (comprising only 3% pf pharmacies in Thailand (Saramunee et al., 2011)). However, 
the trend of chain store pharmacies is increasing. It is important to consider this rising trend as the 
pressure of sales and performance in those chains may affect pharmacists’ decisions to provide 
medicines (including antibiotics) appropriately. 
Legislation relating to community pharmacy service 
The Good Pharmacy Practice (GPP) guidance argues that Thailand has strictly controlled 
community pharmacy practice since laws were updated in 2014. The regulation aims to improve 
community pharmacy service and reduce drug-related problems in primary care service 
(Wuttipanich & Kitisopee, 2015). Moreover, the pharmacy council of Thailand requires maintaining 
professional standards through continuing pharmacy education (CPE). This has only become 
compulsory recently (since 2016) and can lead to pharmacists losing their licence if they fail to 
comply (The Pharmacy Council of Thailand, 2015). This is anticipated to have a positive impact on 
patients’ quality of care as it ensures they receive appropriate medicines including antimicrobials. 
These new changes to legislation have to be taken into account when researching current 
knowledge, attitudes and practices in Thailand, since the existing body of evidence was established 
before the introduction of the CPE mandatory requirements and launch of new public health 
strategies.  
Pharmacy education in Thailand 
In addition to introducing new pharmacy laws and regulations, pharmacy education in 
Thailand has also dramatically changed in 2009 (Pongcharoensuk & Prakongpan, 2012).  
The newly qualified pharmacists are now expected to have more clinical skill and be able to run 
clinically focused services in their practice. The new generation community pharmacists now 
graduate with a Doctor of Pharmacy (PharmD) and theoretically have more clinical knowledge of 
pharmaceutical care than pharmacists who previously graduated with a Bachelor of pharmacy (BSc 
in Pharm or BPharm).   
Pharmacy education was a 5-year programme at a Bachelor level (BPharm or BSc in Pharm). 
In 1999, Nareasuan University started the first 6-year Doctor of pharmacy (PharmD) programme. It 
aims to enhance patient-facing roles and move away from more product-based pharmacy 
education. This change has been inspired by the American pharmacy education system. As a result 
of this change, in the period of 1999-2013, there were two degrees of pharmacy in Thailand. This 
is a further motive to investigate pharmacists’ knowledge, attitudes and practices as a result of 
those education and training changes. It is anticipated that the new graduates would have better 
knowledge and understanding of the current issues such as antimicrobial resistance and how to 
tackle them. The following section will discuss the current strategies proposed to tackle the issue 
of antimicrobial resistance in Thailand. 
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Antimicrobial resistance combating programme in Thailand 
In Thailand, there are some actions to support AMR containment such as the Thailand 
AMR Containment and Prevention (AMRCP) Programme (Thamlikitkul et.al, 2015). The 
programme estimates the national burden of antibiotic resistance, antibiotic resistance chain in the 
country, and devises and promotes strategies for appropriate use of antimicrobials and improved 
infection prevention and control systems.  
Antibiotic Smart Use is a model of practice in hospital and community levels. Sumpradit 
and colleagues (2012) suggest that the project was introduced as a model to promote rational use 
of antibiotics. The first phase was a behaviour change intervention in prescribing antibiotics in three 
conditions that do not require antibiotics: diarrhoea, flu, wounds. The second phase was a scale up 
attempt to other areas. Both phases changed antibiotic prescription behaviours in hospitals. 
National strategic to combat AMR in Thailand 
In 2017, Thailand has launched a national strategy in AMR from 2017 to 2021 using an 
integrated “one Health” approach (MOPH & MOAC, 2017). It aims to reduce AMR morbidity, 
decrease antimicrobial use in humans and animals, increase public knowledge and awareness and 
improve capacity of AMR management in the country. There are 6 strategies to achieve these goals: 
(MOPH & MOAC, 2017) 
1. Use one health approach in surveillance system 
2. Regulation of antimicrobial distribution 
3. Infection prevention and control and antimicrobial stewardship in humans 
4. AMR prevention and control and antimicrobial stewardship in agriculture and companion 
animals 
5. Public knowledge on AMR and awareness of appropriate use of antimicrobials and  
6. Governance mechanisms to develop and sustain AMR-related actions  
However, the strategy does not encourage the need for research and development funding of new 
antimicrobials given the economic capacity, skills and human resources of the country.  
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Community pharmacist competency to provide antimicrobial in Thailand 
Although Thailand does not yet have guidelines for antimicrobial stewardship in community 
pharmacy, there is a requirement for of pharmacists to have “competency regarding antimicrobials 
use” by the pharmacy council of Thailand (The Pharmacy council of Thailand, 2012). Pharmacists 
must have knowledge in pharmaceutical products in relation to acquisition, preparation and storage. 
They also need to follow good dispensing practice and rational use of drugs in common diseases. 
The common diseases that related to infections are HIV infection without opportunistic infection, 
parasitic infections, sexually transmitted diseases and vaginitis, tuberculosis, upper respiratory 
infections (common cold, pharyngitis, purulent rhinitis, otitis media and sinusitis), urinary tract 
infections (cystitis) and immunisation. All pharmacists in Thailand should evaluate medication 
related problems, analyse prescription and follow good dispensing practice for their patients.  
Moreover, the pharmacists need to have an underpinning understanding of the health and public 
health systems in the country (The Pharmacy council of Thailand, 2012). (See figure 6 for a 
summary of Thai pharmacists’ competencies) 
 
 
 
 
 
 
 
 
 
Figure 6: Core competency of Thai pharmacists regarding infection diseases.   
Thai pharmacists do not have a specific competency relating to antimicrobial use and 
resistance. They are expected to follow standards of core competency by Thai pharmacy council. 
As part of the growing rates of resistance, and the transforming pharmacists’ education, it may be 
prudent to ensure pharmacists competence in relation to antimicrobials. The pharmacy council and 
related associations could formulate standards on roles of community pharmacists to combat 
antimicrobial resistance and increase professional values for patients and general public.    
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In summary, Thailand is a specific context in relation to antimicrobials use. At a national 
level, healthcare system is controlled by the ministry of public health.  Pharmacies are under 
supervision of the MOPH legally via public health office in each province, and they vary in type and 
level of service delivery. Although a legal classification of medicines exists, most antimicrobials are 
classified as dangerous but can still be dispensed without prescription. Community pharmacists 
practicing in Thailand may have either a Bachelor or a PharmD degree. In both cases, they are 
allowed to dispense antimicrobials legally with or without prescription. The pharmacy council of 
Thailand which regulates pharmacists in the country has launched a core competency framework 
for pharmacists and good pharmacy practice guidance in community pharmacy to ensure that the 
pharmacist provide medicines such antimicrobials appropriately.  However, antimicrobial 
stewardship guidelines are yet to be issued despite the introduction of several campaigns to 
improve antimicrobials use in healthcare settings such as antibiotic smart use programme.  
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CHAPTER 3 
LITERATURE REVIEW 
Various factors can lead to the inappropriate use of antimicrobials in community pharmacy. 
Lack of knowledge, patients demand and financial benefits from pharmaceutical companies have 
often been reported by healthcare professionals as reasons for the inappropriate provision of 
antimicrobials (Apisanthanarak et.al 2008; Saengcharoen & Lerkiatbundit, 2010; Puspitasari et.al, 
2011). This chapter aims to present relevant evidence of community pharmacists’ knowledge, 
attitudes and practice in relation to antimicrobial use and resistance. Further, antimicrobial 
stewardship studies in community pharmacy will be discussed, highlighting the current research 
gaps that will be explored through the proposed study. 
The association between pharmacists’ knowledge and inappropriate practice 
Knowledge of pharmacists can influence their practice in antimicrobials provision. Many 
researchers argue that inadequate knowledge is associated with inappropriate use of 
antimicrobials. A study was conducted in Pratumthani province north of Bangkok shows that 
antibiotic prescribing in pharmacies remains inappropriate. The researchers recommend that 
pharmacists could be educated on antimicrobial stewardship and resistance problems 
(Apisarnthanarak et.al, 2008). The same research team found that there are 4 reasons to 
dispensing inappropriate antibiotics; worrying about complications if they don’t treat, lack of 
knowledge, limited supply of medication and patient’s pressure (Apisarnthanarak et.al, 2009).  Both 
studies did not specify if the provision of antibiotics was through pharmacists or technicians. Many 
studies show that the inappropriate use of antimicrobials in community pharmacy is a result of 
inadequate knowledge of providers.  
Moreover, educational interventions targeting community pharmacists can improve their 
practice. A randomised control trial (RCT) study to investigate antibiotic dispensing behaviour in 
Vietnam and Thailand shows that an educational intervention to improve pharmacists’ knowledge 
was effective in reducing low-dose antibiotic dispensing behaviour (Chalker et.al, 2005). 
It appears that knowledge of pharmacist would be an influencing factor towards behaviour 
to dispense antimicrobials. Inadequate knowledge can lead to misuse or overuse of antimicrobials. 
If pharmacists improve their knowledge of antimicrobial stewardship, they could enhance their 
practice.  
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The association between pharmacists’ attitudes and their practice 
Several studies show that pharmacists attitude towards antimicrobials use and resistance 
is associated with their practice. A study on the factors influencing dispensing antimicrobial agents 
in Thai community pharmacists was published in 2008. The researchers used the theory of planned 
behaviour (TPB) as a framework to investigate the behavior of community pharmacists who provide 
antibiotics for the treatment of upper respiratory infections (URIs). The research indicates that 
attitude is the strongest influence on dispensing behavior followed by subject norms and perceived 
behavior control (Saengcharoen et.al, 2008). Moreover, a study on attitudes and behavior of 
pharmacy workers who treat childhood diarrohea indicates that lack of history taking, inadequate 
knowledge and patient satisfaction are factors leading to inappropriate dispensing (Saengcharoen 
& Lerkiatbundit, 2010).  
Similarly, a study in Portugal used a questionnaire to evaluate attitudes of community 
pharmacists towards antimicrobial use and resistance confirms that attitude can influence 
pharmacists’ tendency to dispense non-prescription antibiotics (Roque et al., 2015).   
The evidence seems to support that attitudes are associated with pharmacy practice in 
community pharmacy. Poor attitude of pharmacists leads to inappropriate dispensing of 
antimicrobials. 
Community pharmacy practice in in relation to antimicrobial provision and 
stewardship.  
A study in Indonesia used simulated patients and scenarios to request antibiotics such as 
Ciprofloxacin, Tetracycline, Amoxicillin from pharmacies. Results show that antibiotics can be 
obtained from the pharmacy without an initial assessment and the obtained antibiotics were mostly 
inappropriate for the condition (Puspitasari et.al, 2011).   
A study in Jordan revealed that pharmacies facilitated the inappropriate use antimicrobials 
even though pharmacists were present at 90% of the participating pharmacies. Antibiotics were 
provided inappropriately for sore throat, acute sinusitis, otitis media, diarrhoea, and uncomplicated 
urinary tract infections (UTIs) (Almaaytah et.al, 2015).  
However, these is not a strong evidence base to argue that antimicrobial provision through 
prescription is always better than its provision without a prescription (Morgan et.al, 2011). In a 
comparative study between General medical practitioners (GPs) and community pharmacists in 
Malaysia, both parties show poor adherence to appropriate use guidelines. Community pharmacists 
were worse at diagnosis than GPs, but the GPs prescribed far more unnecessary medicines and 
antibiotics than pharmacists (Alabid, Ibrahim, & Hassali, 2014) 
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Antimicrobial stewardship in community pharmacy can be of benefit to healthcare system. 
Booth and colleagues (2013) conducted their research in community pharmacies in Scotland. The 
community pharmacists provided pharmacy services and prescribed antibiotic for uncomplicated 
urinary tract infections (UTIs) following clinical guidelines. The results show that through involving 
community pharmacists, patients could easily access treatment without increasing appointment 
time on GP practices (Both et al., 2013). 
However, the existing evidence shows that community pharmacists have to improve their 
stewardship practices particularly in collaboration with other healthcare providers. Khan and 
colleague (2016) conducted a cross-sectional study in Malaysia to examine perception and practice 
of community pharmacists.  The results show that pharmacists have positive perception of 
antimicrobial stewardship by improving patient care. However, the results indicate that community 
pharmacist in Malaysia need to improve their stewardship practice through integration of 
antimicrobial stewardship programmes in pharmacies and collaboration with other healthcare 
providers such as physician.  
The existing literature suggests links between pharmacists’ knowledge, attitudes and their 
practice. However, the nature of these relationships needs to be further explored. Further, in 
Thailand, there is no current information on pharmacists’ knowledge, attitudes, and practice in 
relation to antimicrobials use and resistance.  
Further, the variety of background/ context of each country might affect research results. 
The KAP study in community pharmacy about antibiotic dispensing in Saudi Arabia was conducted 
in 2016. The research indicates that most pharmacists were not aware that dispensing non-
prescription antibiotics was illegal and their practice was not appropriate (Hadi et al., 2016). This 
context is different to Thailand where provision of antibiotics without prescription is legal.  
This research is an assessment community pharmacists’ knowledge, attitude and their 
practice in Thailand regarding antimicrobial use and resistance. The relationship between these 
three factors will be examined, and the findings can potentially enhance our understanding of 
antimicrobial stewardship practices in community pharmacy in Thailand, and highlight areas of 
improvement.  
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Theoretical framework 
 There are several health behaviour models that describe the factors affecting behaviour. 
Researchers use various models to describe individual behaviours of both healthcare professionals 
and the general public. These include the health belief model (HBM), the theory of planned 
behaviour (TPB) model and the Knowledge-Attitude-Practice (KAP) model. These models will be 
discussed in the following paragraphs. 
Health Belief Model (HBM) 
 Health belief model explains health decision making and health behaviour. It was 
developed by the U.S Public health service in 1950s (LaMorte, 2016). The model aims to 
understand people’s failure in disease prevention. It predicts a person’s likelihood of changing their 
health behaviour based on the person’s belief in individual threat and illness and effectiveness of 
health behaviour or action. There are six constructs in the model (WHO, 2012; LaMorte, 2016).  
(See figure 7 for an illustration of the model)  
 
 
  
 
 
 
 
 
 
a = definition of constructions by WHO, 2012 
 
Figure 7: The Health Belief Model  
(adapted from Fayanju et.al, 2014 and Sharafkhani et.al, 2016) 
 
 For example, Heid et.al (2016) uses the health belief model in their study about the 
perception of patients of antimicrobial stewardship in out-patient setting in Wisconsin, U.S. The 
researchers conducted 30 semi-structure interviews with patients who received antimicrobials in 
hospital. The results show that patients were aware of antibiotic resistance but perceived 
themselves as being at low susceptibility risk. The patients therefore did not engage well with 
antimicrobial stewardship initiatives.  
The health belief model has limitations in that it cannot provide information on participants ‘attitude 
and beliefs that affect their behaviour. The model assumes that participants have equal information 
on illness and disease which is not accurate in real life (LaMorte, 2016).  
Perceived threat 
Perceived barriers  
Beliefs about the material and 
psychological costs of taking action.a   
Perceived benefits  
Beliefs about the effectiveness of 
taking action to reduce risk or 
seriousness. a  
Perceived 
susceptibility 
Beliefs about the 
chances of getting a 
condition. a  
Likelihood of 
taking preventive 
action 
Self-efficacy  
Confidence in one’s ability 
to take action. a   
Perceived 
severity  
Beliefs about the 
seriousness of a 
condition and its 
consequences. a  
Cue to action  
Factors that activate readiness to 
change” – a trigger mechanism. a 
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The Theory of Planned Behaviour (TPB) 
The TPB model is useful to describe factors that influence behaviours (See figure 8 for an 
illustration of the model components). The model does not only show the attitude toward a 
behaviour but also the social-norms and the perceived degree of control over that behaviour. 
 
 
 
  
 
 
 
  
 
 
Figure 8: The Theory of Planned Behaviour (TPB) model 
 
 
Sangchareon and colleague (2008) conducted their research using the theory of planned 
behaviour framework to examine factors in the model that influence community pharmacists to 
dispense antibiotics in South of Thailand. The research shows that attitude can strongly influence 
intention and behaviour to dispense antibiotics while subject norm and perceive behaviour control 
can mildly affect pharmacists’ behaviour to dispense antibiotics. Although the researchers 
discussed that inadequate knowledge is a factor affecting appropriate use of antibiotics, this is not 
apparent using the TPB model.  
LaMorte (2016) suggests that TPB fails to describe other factors in the model such as fear, 
threat, mood or previous experience. Also, it cannot explain environmental and economic factors 
which might influence intention in the model. In addition, according to previous research of 
Sangchareon and colleagues (2008), it can be assumed that the model cannot show how 
knowledge of participant relates to attitude and behaviour.  
  
Attitude 
Social norm  Intention Behaviour 
Perceived  
Behaviour Control 
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Practice Knowledge 
Attitude 
Knowledge, Attitude and practice (KAP) model 
The knowledge, Attitude and practice (KAP) model was developed as a tool to investigate 
what is known, believed and done by participants in a specific topic. The KAP survey was developed 
for family planning and population studies in 1950s. It is widely used in cross-sectional surveys 
(Launiala, 2009; Vandamme, 2009). Usually, the KAP model is used to structure interviews and 
questionnaire. In pharmacy practice research, this survey is a tool to investigate experience, opinion 
and behaviour. KAP model has been used in research for decades and is a common tool to collect 
patients’ and practitioners’ information (Kishore, 2016).  Correlation among Knowledge-Attitude- 
Practice was developed based on cognitive, affective and behaviour theory by Schwartz to study 
relation of knowledge, attitude and practice of diet (Bano et al., 2013). (See Figure 9) 
 
 
 
 
 
 
 
 
 
Figure 9: The Knowledge-Attitude-Practice Model (Bano et al., 2013) 
Advantage of KAP model 
The KAP survey method is easy to conduct. The results of this method are relatively easy 
to interpret and have a concise presentation (Launiala, 2009). KAP model is a rational model in 
health education. It is based on the notion that increasing personal knowledge will influence 
behaviour change (WHO, 2012). 
The KAP model can be used to achieve the following objectives: describing current 
population’s knowledge, attitude and practice, problem identification and intervention planning, and 
assessing outcomes when designing a pre-test and post-test study (Vanndamme, 2009). 
Limitations of KAP model 
There are limitations to the KAP model. In terms of knowledge, it tends to assess 
community knowledge of public health concept. Launiala, (2009) argues that KAP model cannot 
investigate knowledge in anthropology terms such as culture-specific knowledge of illness or 
knowledge about health system for example referral and quality. The term of knowledge includes 
local knowledge, belief and biomedical knowledge. Moreover, attitude analysis in the KAP model 
does not link them to other factors such as belief, emotion and they are positive and negative. 
Furthermore, the KAP model does not always explain why and how to practice (Launiala, 2009).  
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In KAP surveys there are three important domains of identification; Knowledge, Attitude 
and Practice.  
Knowledge refers to participant understanding of any given topic (Kaliyaperumal, 2004). 
Knowledge is ability to receive, retain and use information that is mixed with experience and skills. 
It can be different to education which is a prerequisite of knowledge. It is an increase of acquired 
intellectual competency and skill, developed ethical quality and manner (Badran, 1995).  
Attitude refers to participants’ feelings about the topic (Kaliyaperumal, 2004). Attitude is a 
propensity to react in a definite way to a certain situation (Badran, 1995).  
Practice refers to the way that participants demonstrate their knowledge and attitude 
(Kaliyaperumal, 2004). In other words, it means the application of rule and knowledge regarding 
action (Badran, 1995).  
According to the previous definition, this research can define meaning of Knowledge, 
Attitude and practice as follow; 
Knowledge is a personal understanding of antimicrobial resistance and antimicrobial use.     
Attitude is participants’ feelings about positive or negative statements in relation to antimicrobial 
use and resistance.  
Practice is an action of participant towards antimicrobial provision.  
In this study, the KAP model will be useful to understand pharmacists’ behaviour in general. 
It can describe current knowledge, attitude, and practice of community pharmacists and determine 
the relationship of each factor with antimicrobials use and resistance. As a feature of the model, it 
is useful for the identification of problems in order to create effective interventions. Moreover, the 
KAP model is useful to determine knowledge; which has previously been ignored by other models 
that were used in previous studies. The KAP model can address this gap to clearly understand how 
knowledge relates to attitude, and practice towards antimicrobial use and resistance among 
community pharmacists. It also allows this study to be conducted within the limited financial and 
time frames. 
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CHATER 4 
RESEARCH METHODOLOGY 
 Firstly, this chapter will provide details of aim, objectives, and research questions of study. 
After that research methodology will be described including the study design, sample size 
calculation, and sampling method. Also, details of the questionnaire development will be, and the 
validity and reliability of the study will be discussed. Data collection, ethical consideration, and data 
analysis method will then be addressed. 
Aim, objectives and research questions 
This study aims to evaluate community pharmacists’ knowledge, attitude and practices 
regarding non-prescription antimicrobials use and antimicrobial resistance. The research uses self-
administered questionnaire for assessment in each dimension. Also, it analyses correlation of 
factors in KAP model to examine their relationships. This research has four objectives:  
1. To describe current situation of community pharmacy practice in antimicrobials provision.  
The questionnaire includes questions about common infections encountered in community 
pharmacy, most frequently dispensed antimicrobial and reasons for provision of 
antimicrobials without prescription. The objective can explore by a research question RQ1,  
RQ1: What is current on the status of antimicrobials provision in community 
pharmacy? 
The participants will answer questions about antimicrobials provision in community 
pharmacy in terms of encountered infectious diseases, commonly dispensed antimicrobials, and 
reason to dispense non-prescription antimicrobials. The answers will be coded, descried and 
presented as percentages. 
2. To assess knowledge, attitude, and practice of community pharmacists on antimicrobial 
use and resistance. This objective can explore by a research question RQ2  
RQ2: What is community pharmacists’ knowledge, attitude and practice in 
antimicrobials use and resistance? 
Participants will answer to questions about knowledge, attitude, and practice regarding 
antimicrobials use and resistance. Score of each dimension will be calculated and analysed 
normal distribution through Kolmogorov-Smirnov Test. Descriptive statistic such as mean, 
standard deviation, median, interquartile range, percentage will also be used.  
Also, relationship of knowledge, attitude and practice scores will be analysed correlation by 
Spearman’s rho correlation coefficient.  There are three hypotheses to explore the relationships 
can be seen in figure 10: 
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Practice Knowledge 
Attitude 
 
 
 
 
 
 
 
 
Figure 10: Relationship of knowledge, attitude, and practice framework  
H1: Knowledge of antimicrobial use and resistance correlates with attitude  
H2: Attitude towards antimicrobial use and resistance correlates with pharmacists’ practices 
of antimicrobials provision.  
H3: Practice of antimicrobials provision correlate with Knowledge of antimicrobial use and 
resistance 
3. To determine characterise of community pharmacists related with knowledge, attitude, and 
practice in antimicrobials use and resistance. The objective can describe by a research 
question RQ3. 
RQ3: What are the characteristics of community pharmacists associated to 
knowledge, attitude and practice in antimicrobials use and resistance? 
Participants give their characteristics in age, gender, educations, professional experience, 
working location and type of their pharmacy by. Mann-Whitney U Test and Kruskal-Wallis H 
test and Chi-square test will be employed for describing between various of demographics and 
knowledge, attitude, and practice factors.  
  
 H1 
H3 
H2 
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Methodology 
Study design 
A questionnaire is easy to conduct and can involve a large number of participants (Bresee, 
2014). It can be designed specifically to address the aim of the research and can be adapted from 
previous research. (Boynton& Greenhalgh, 2004; Bresee, 2014). However, a questionnaire needs 
to be valid and reliable before being used (Smith, 1997; Boynton& Greenhalgh, 2004; Draugalis, 
et.al, 2008; Bresee, 2014).  
This research is a cross-sectional descriptive study using a self-administered 
questionnaire. This method was used because it is relatively easy to conduct in the limited time 
period and less costly compared to other approaches. Face- to face interviews for example can 
increase traveling cost, it is difficult to invite people and remunerate them to participate in the 
research. Online questionnaire was used in this study because it is easy to distribute to potential 
participants and is convenient to access anytime, anywhere.  
Population 
Population in this study is community pharmacists working in Bangkok and Chonburi 
province, Thailand. The area has 5082 Type I pharmacies which covers 33% of pharmacies in 
Thailand. It is expected to have at least one pharmacist during opening hours.   
Sample size  
The minimal sample size is 358 participants that calculate by equation   
n = Z2 x P (1 - P)/e2     
However, this research has small population it could be adjusted by   
n(adjusted) =n / 1+(n/N) 
So, the final equation is                                                 
 
(Sergeant, 2017). 
 
Where,  Z= Z value 
  P = percentage picking a choice 
 e = margin error 
 N= population  
This research uses 95% Confidence interval, so Z value is 1.96. Proportion expected to 
respond is 50% or 0.5, margin error use 5% or 0.05 and population is 5082. Consequently, the 
minimal sample size is 358 participants.  
 
 
 
 
n   =     (Z2 x P(1 - P))/e2   
        1+(Z2 x P(1 - P))/e2 N          
 29 
 
Sampling  
Pharmacies name lists were collected from a database on the Thai FDA and Community 
Pharmacy Association of Thailand (CPA) websites. Also, researcher invited pharmacists through 
social media, LINE application groups in Chonburi drugstore network and Group of community 
pharmacy service. Pharmacists on social media groups were invited to participate in the study. 
Simple random sampling was used to select participants from the pharmacy lists. 
Inclusion criteria 
1. Participant must be a pharmacist who graduated in pharmacy degree on 
undergraduate level (BSc in Pharm, BPharm or PharmD). 
2. Participant must practice as full-time or part-time community pharmacist in Bangkok 
and Chonburi provinces.  
Exclusion criteria  
1. Other pharmacy workers such as assistant pharmacist, pharmacy technician or 
owners who have not graduated with a pharmacy degree.  
2. Participants in the pilot study were excluded from the main study.  
Questionnaire Development  
A questionnaire was developed from previous literature, and has been validated by experts 
in antimicrobial stewardship. Also, the questionnaire construction followed the Knowledge, Attitude 
and Practice study guidelines (Kaliyaperumal, 2004; Vandamme, 2009; Macías & Glasauer, 2014) 
and recommendations in survey research (Smith, 1997; Boynton & Greenhalgh, 2004; Draugalis, 
et.al, 2008; Bresee, 2014). 
In terms of instrument validity and reliability, researcher invited three experts in 
antimicrobial stewardship and community pharmacy service to validate questionnaire’s content. 
Reliability was measured by pilot study including 15 pharmacists regarding consistency and 
reproducibility of the questionnaire. The questionnaire was adjusted based on validation or reliability 
results before being used in the main study.  
Questionnaire design 
The first draft of the questionnaire contains thirty- eighth questions. It was divided into four 
sections to assess the pharmacists ‘knowledge, attitude and practice regarding non-prescription 
antimicrobial use and resistance. 
Demographics section 
 This section was developed to describe characteristics of community pharmacists and 
confirm inclusion criteria of sampling. Five main questions about personal background, educations, 
professional experiences, workplace location and type of pharmacy. 
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• Personal background (age, gender); to describe general characteristic of participants 
and confirm inclusion criteria (age over than 18 years) 
• Education profiles (Pharmacy degree, highest education): to examine various types of 
pharmacy degree in Thailand and confirm that the participants have graduated with a 
pharmacy degree as per inclusion criteria. 
• Professional Experiences: to examine experiences of community pharmacists that might 
be influence their knowledge, attitude and practice.   
• Workplace location to confirm that the participant is working in Bangkok and/ or Chonburi 
province and can examine the proportion of participants in each province. 
• Type of pharmacy to examine proportion of pharmacists who work in individual drug store 
and chain stores in the study areas, Bangkok and Chonburi province.   
Knowledge section 
According to the survey in public awareness about antibiotic resistance of WHO (2015), 
knowledge of participants was measured in two topics: knowledge of resistance and knowledge of 
antimicrobials use. Furthermore, Chuenchom et.al (2016) assessed knowledge of final year medical 
students in Thailand through clinical scenarios which aim to assess the participant knowledge of 
antimicrobial use following local guidelines.  
This study will assess pharmacists’ knowledge in two topics, knowledge of antimicrobial 
resistance and antimicrobial use. Also, it uses clinical scenarios to measure knowledge in 
antimicrobial use based on antibiotic smart use guidelines in Thailand (Chongtrakul, 2011). 
Five questions assess knowledge of antimicrobial resistance; these relate to the principles 
of resistance, and antimicrobial stewardship.  Five other questions measure knowledge of 
antimicrobial use relating to pharmacology and rational use of antibiotics through clinical scenario. 
The scenarios were selected from the antibiotic smart use guideline in Thailand and previous 
research (Apisarnthanarak et.al, 2008; Chongtrakul, 2011; Chuenchom et.al, 2016). 
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Question items in knowledge section 
Antimicrobial resistance 
k1 “Superbugs” are microorganisms which generate antimicrobial resistance that include 
bacteria, fungal, virus or parasites.   
k2 Resistance DNA in bacteria can transfer each other by virus.   
k3 Antibiotic consumptions in human are provided in healthcare-setting more than community 
setting. 
k4 The main objective of antimicrobial stewardship is the most effective clinical outcome with 
less toxicity and adverse reactions. 
k5 Antimicrobial stewardship is a role of hospital pharmacist 
Antimicrobial Use 
k6 Penicillin, cephalosporin, and fluoroquinolone are Beta-lactam (β-lactam antibiotic. It need to 
consider Beta-lactamase producing bacterial. 
k7 Patients who allergic Amoxicillin could avoid using Cephalexin.   
k8 Is it appropriate? When, pharmacist dispense amoxicillin 1,500 mg a day, 7 days for a 26-
year-old male with allergic rhinitis, had high-grade fever rhinorrhoea, and sore throat? 
(Chongtrakul, 2011; Chuenchom et.al, 2016) 
k9 Is it appropriate? When, pharmacist dispense only mineral powder in case a 2-year-old boy 
with watery diarrhoea, no mucous, no bloody stool, no fever, no vomiting? (Chongtrakul, 
2011; Chuenchom et.al, 2016) 
k10 Is it appropriate? When, pharmacist dispense Dicloxacillin 250 mg four time a day for 5 days 
to prevent infection in case a 24-year old male has had skin abrasion wound on his right arm 
without exudates for 2 days, limited to subcutaneous layer, mild tenderness, no swelling, no 
active bleeding, no fever, and not allergic to any antibiotic? (Apisanthanarak, et.al, 2008; 
Chongtrakul, 2011) 
Attitude section 
Attitudes section examines community pharmacists’ agreement with antimicrobial use and 
resistance statements. Ten statements were adapted and adopted from existing qualitative and 
quantitative research to develop attitude statements on antibiotics dispensing of community 
pharmacists in Portugal (Roque et.al, 2013; Roque et.al, 2014). 
According to Roque et.al (2013), attitude of community pharmacists to provide antimicrobials 
can be examined through attitudes towards the problem of resistance and attitudes towards 
antibiotic use. The previous research was used to develop 16 statements to evaluate participants’ 
attitudes. However, this research uses 10 statements from the previous research to accommodate 
the Thai context and shorten the length of the questionnaire. The selected statements have high to 
excellent reliability and an intraclass correlation coefficients (ICC) of more than 0.6 (Roque et.al, 
2014). Further, the statements have been divided into two group, attitude towards antimicrobial 
resistance and attitudes towards antimicrobials use. 
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* = negative statement  
Practice section 
Practice section aims to investigate pharmacists' current actions of antimicrobials dispensing 
in pharmacy according to their knowledge and attitudes. This section was split into two parts; 
multiple choices questions and open-ended questions.  
Multiple choices questions 
Ten statements relating to provision of antimicrobials were selected from existing literature 
on perceptions and practices of community pharmacists toward antimicrobial stewardship (Khan 
et.al, 2016). The questionnaire was validated by experts. However, it was adjusted to be 
appropriate for Thai community pharmacists because the law allows the pharmacists to dispense 
antimicrobials without a prescription. Further, statements from a WHO survey on the roles of 
pharmacists in antimicrobial use (2015) were used to develop the research instrument. Ten action 
statements were included in this questionnaire as follows. 
 
 
 
 
 
Antimicrobial resistance 
a1 Antimicrobial resistance is an important public health problem of ours.  
a2 The fact of a patient taking an antibiotic increases the risk of developing resistance. 
a3 An important cause of appearance of antibiotic resistance is long-term prescription of new 
molecular entities. 
a4 I am convinced that new antimicrobials will be developed to solve the problem of 
resistance. 
a5 The use of antibiotics in animals for human consumption is an important cause of 
appearance of new resistance to pathogenic agents in humans. 
Antimicrobials use 
a6 In all cases where antimicrobials are dispensed, it is essential that patients be advised 
about complying with the treatment. 
a7* Antimicrobials are sometimes dispensed without medical prescription because the patient 
is known to have difficulty in obtaining a medical consultation.  
a8 If a patient feels that he/she needs antibiotics, and these are not dispensed, he/she will 
easily manage to obtain them at another pharmacy. 
a9* Antimicrobials are sometimes prescribed without medical prescription because the patient 
is known to have neither the time nor the money to see a physician 
a10 Dispensing antimicrobials without prescription should be more closely controlled 
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p1 I ask patient’s history symptom of their infections before deciding to dispense antimicrobials. 
p2 I sought additional clinical information (e.g. drug interaction, ADRs, allergy, etc.) 
before deciding to dispense the antimicrobials 
p3 I screen the antimicrobials in accordance with local guidelines before dispensing 
p4 I dispense antimicrobial with complete clinical information 
p5 I educate patients on the use of antimicrobials and resistance-related issues 
p6* I dispense antimicrobials without a prescription.  
p7 I take part in antimicrobial awareness campaigns to promote the optimal use of 
Antimicrobials 
p8* I lack continuing education in antimicrobial use and resistance topics.  
p9 I make efforts to prevent or reduce the transmission of infections within the 
Community 
p10 I collaborate with other health professionals for infection control and antimicrobial 
stewardship 
*= negative statement 
 
Open–ended questions   
 From reviewing the literature, it was found that most community infections are respiratory 
infections (Apisarnthanarak et.al, 2008, Saengcharoen et.al, 2008) and the top three groups of 
antibiotics used in Thailand were Penicillin, Fluoroquiniolone and Cehalosporin (CDDEP,2016). 
Three open-end questionnaires were developed to ask pharmacists about commonly encountered 
infectious diseases, antimicrobials used and the reason for dispensing non-prescription 
antimicrobials for patients. These questions aim to explore the current situation of antimicrobials 
provision in community pharmacy in Thailand. The finding here will not be used to calculate 
relationships with other factors. 
Question items 
• What are the top three most common infections encountered in community pharmacy?  
• What are the top three antimicrobials most commonly be dispensed in community 
pharmacy? 
• What is the main reason for dispensing antimicrobials without a prescription? 
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Questionnaire validation and reliability test 
 Although this questionnaire was developed based on previous research instruments that 
were validated by experts, the new questionnaire would still need to be validated because of the 
different setting and type of participants. Smith (1997) suggests that questionnaire which was 
developed by previous research should be valid and reliable. The new setting, different population 
and modifications do not guarantee that the questionnaire retains its validity and reliability. Similarly, 
the new questionnaire that uses only selected items from existing questionnaires should provide 
evidence of its validity and reliability (Draugalis et.al, 2008).   
Questionnaire validation  
Method of validation 
The questionnaire was validated by an expert panel. Researcher invited three experts in 
antimicrobial stewardship and community pharmacy service to review the questionnaire. The expert 
must be a pharmacist with a minimum of an MSc in the relevant field. They must have experience 
of dealing with antimicrobial resistance and delivering community pharmacy services.  Validation 
form was sent to the panel by e-mail. The result of ratings was calculated using an item-objective 
congruence (IOC) score for each item. The experts gave scores for each question to -1 (clearly not 
measure), 0 (the content is unclear) and 1 (clearly to measure). The average IOC score > 0.5 
indicates good content validity (Turner & Carlson, 2003).  Moreover, the experts were invited to 
give comments on the questions for improvement. The results of the review were used to finalise 
the questionnaire before using it in the pilot study. 
The panel of expert 
Dr. Somying Pumthong (Expert 1) is an assistant professor in the faculty of pharmacy, 
Srinakharinwirot University in Thailand. She graduated with a doctoral degree in social-pharmacy 
from University of Nottingham, UK and has research experience in antimicrobial use and resistance 
in Thailand both in community and hospital setting.  
Mrs. Suneerat Kittikun (Expert 2) is a community pharmacist in Chonburi province. She has 
a professional experience in a drugstore exceeding ten years. She graduated with an MSc degree 
and her work was on decision-making of consumers in pharmacies. She also received the 
Certificate of Pharmaceutical Care in Community Pharmacies (Health Promotion and Disease 
Prevention). She is a teacher practitioner, and she collaborates with the National Health Security 
project to provide community pharmacy services in primary care.  
Dr. Suphannika Prateepjarassaeng (Expert 3) is a clinical pharmacist and teacher 
practitioner in the department of clinical pharmacy, Burapha University. She graduated with a 
Doctorate of Pharmacy and Specialised Fellowship in Internal Medicine Pharmacotherapy. Her 
experience of antimicrobial stewardship includes participation and leadership on integrating the role 
of pharmacists in antimicrobials use at the internal medicine department. She develops medication 
profiles for patients’ treatment, and infections prevention and control practices training to physicians 
and nurses.  
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Reliability test  
The validated questionnaire was sent online to fifteen community pharmacists 
(Surveymonkey®). Cronbach’s alpha was used for internal consistency reliability test to confirm that 
the questionnaire can measure what it intends to measure (Rodrigues et.al, 2016). The acceptable 
alpha value is more than 0.7 and low value of alpha indicates that the questionnaire should be 
revised.  (Tavakol & Dennick, 2011; Rodrigues et.al, 2016).  
Interclass Correlation Coefficients (ICC) was employed for measuring reproducibility 
reliability (test-retest). The pharmacists responded to the same questionnaire on two separate 
occasions, one week apart. Statistic two-way mixed ICC analysed repeatability for each question 
(Koo & Li, 2016). ICC value lower than 0.4 indicates low reproducibility, acceptable rate is 0.4-0.75 
meaning fair to good and over 0.75 means high reproducibility (Rodrigues et.al,2016). 
However, Cohen’s kappa was used for test-retest analysis in the knowledge section 
because it is recorded as binary data, correct and incorrect (McHugh, 2012; Tan et.al, 2015). The 
kappa value of more than 0.75 is excellent, 0.40 to 0.75 is moderate to good, and less than 0.4 is 
poor agreement (Kirkwood & Sterne, 2010).  
 Pilot sampling 
 Researcher invited fifteen (n=15) community pharmacists in Thailand to take part in this 
pilot test; this has been excluded from the main study. The pharmacists responded to the adjusted 
questionnaire twice online, initially and after one week, between 17 and 26 April 2017.  
 The results of validation and reliability test was used for improving the questionnaire (See 
Chapter 5, Results of questionnaire validation and reliability test). The final questionnaire contains 
35 questions and divided into 4 section, Demographics, Knowledge, Attitude, and Practice which 
included three opened-end questions about current status of antimicrobials provision in community 
pharmacy (See table 2).  
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Items Questions References 
K1 
“Superbugs” are microorganisms which generate antimicrobial resistance. They 
include bacteria, fungal, virus or parasites. 
 
K2 Resistance DNA in bacteria can transfer to other bacteria by virus.  
K3 Antimicrobial resistance in hospital setting is higher than community setting.  
K4 
The main objective of antimicrobial stewardship is to achieve the most effective 
clinical outcome with less toxicity and adverse reactions to antimicrobials. 
 
K5 
Penicillin, cephalosporin, and fluoroquinolone are β -lactam antibiotics. It need to 
consider Beta-lactamase producing bacterial. 
 
K6 
Patients who are allergic to Amoxicillin (Anaphylaxis type) should not use 
Cephalexin. 
 
K7 
Is it appropriate?  When a pharmacist dispenses amoxicillin 1,500 mg a day, 7 
days for a 26-year-old male with allergic rhinitis, high-grade fever rhinorrhoea, 
and sore throat, and no known drug allergy. 
Chuenchom et.al, 
2016 
K8 
Is it appropriate?  When a pharmacist dispenses only mineral powder for a 2-
year-old boy with watery diarrhoea, no mucous/bloody stool, no fever, no 
vomiting. 
Chuenchom et.al, 
2016 
K9 
Is it appropriate?  When a pharmacist dispenses dicloxacillin 250 mg four time a 
day for 5 days to prevent an infection in case of a 24-year old male who has had 
a skin abrasion wound on his right arm without exudates for 2 days, limited to 
subcutaneous layer, mild tenderness, no swelling, no active bleeding, no fever, 
and no known drug allergy. 
Apisarnthanarak 
et.al, 2008. 
 
A1 Antimicrobial resistance is an important public health problem of ours. Roque et.al, 2014 
A2 
The fact that a patient is taking an antibiotic increases the risk of developing 
resistance 
Roque et.al, 2014 
A3 New antimicrobials development can solve antimicrobial resistance problem. Roque et.al, 2014 
A4 
The use of antimicrobials in livestock animals is an important cause of 
appearance of new resistance to pathogenic agents in humans. 
Roque et.al, 2014 
A5 
In all cases where antimicrobials are dispensed, it is essential that patients be 
advised about complying with the treatment 
Roque et.al, 2014 
A6 
Antimicrobials are sometimes dispensed without medical prescription because 
the patient is known to have difficulty in obtaining a medical consultation. 
Roque et.al, 2014 
A7 
Antimicrobials are sometimes prescribed without medical prescription because 
the patient is known to have neither the time nor the money to see a physician. 
Roque et.al, 2014 
A8 Dispensing antimicrobials without prescription is serious issue. Roque et.al, 2014 
P1 I educate patients on the use of antimicrobials and resistance-related issues. Khan et.al, 2016 
P2 
I take part in antimicrobial awareness campaigns to promote the optimal use of 
antimicrobials 
Khan et.al, 2016 
P3 I lack continuing education in antimicrobial use and resistance topics. Khan et.al, 2016 
P4 
I make efforts to prevent or reduce the transmission of infections within the 
community. 
Khan et.al, 2016 
P5 
I collaborate with other health professionals for infection control and antimicrobial 
stewardship 
Khan et.al, 2016 
P6 
I ask patient’s history and symptom of their infections before deciding to dispense 
antimicrobials. 
Khan et.al, 2016 
P7 
I sought additional clinical information (e.g. drug interaction, ADRs, allergy, etc.) 
before deciding to dispense the antimicrobials 
Khan et.al, 2016 
P8 I screen the antimicrobials in accordance with local guidelines before dispensing Khan et.al, 2016 
P9 
I dispense antimicrobial with complete clinical information (e.g. drug interaction, 
ADRs, allergy, etc.) 
Khan et.al, 2016 
P10 I dispense antimicrobials without a prescription. Khan et.al, 2016 
P11 
What are top three most commonly encountered infections in your community 
pharmacy? 
 
P12 
What are the top three most commonly dispensed antimicrobials in your 
community pharmacy? 
 
P13 What is a main reason for dispensing antimicrobials without a prescription?  
 
Table 2: Lists of Knowledge, Attitude, and Practice items in the final questionnaire. 
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Data collection 
The questionnaire link on Surveymonkey®   was published on social media and e-mailed to 
participants. Five-hundred and twenty-one (521) pharmacists were invited to access an online 
questionnaire by e-mail list (n=213), LINE application group Chonburi drugstore network (n=195), 
and Group of community pharmacy service (n=113).  
The participants could answer the questionnaire from 9 June 2017 to 7 July 2017, sixty 
days. Reminder massages were sent to participants every two week.    
Ethical consideration 
This research follows the University of Hertfordshire Policies and Regulations (UPRs) of 
Studies Involving the Use of Human Participants. It was granted ethical approval under protocol 
number: LMS/PGR/UH/02811 
Data analysis 
 Variables in the study are demographics, knowledge, attitude and practice of the 
participants. They can be collected using different scales as shown in table 3.  
Variables Type of scale 
Age Ratio scale; 18-100  
Gender Nominal scale; 0= male, 1= female  
Education 
Nominal scale; 0= BSc/BPharm (5-year programme),  
1 = PharmD (6-year programme) 
Experience Interval scale; 0-60 year(s) 
Workplace location Nominal scale; 0= Bangkok, 1= Chonburi 
Type of pharmacy Nominal scale; 0= Individual, 1= chain-store 
Knowledge Interval scale; 0 – 10 point(s) 
Attitude 
Ordinal scale; 1=Strongly Disagree, 2=Disagree, 3=Neither agree nor 
disagree, 4=Agree and 5=Strongly Agree. 
Practice 
Ordinal scale; 1= Never, 2=Rarely, 3= Sometimes, 4=Often and 
5=Always 
Table 3: Variables and collecting scale in study 
Though age and gender have been collected as ratio scale, they have been classified into 
3 groups of each factor which are ordinal scale Age split into lower than 30 yrs., 30-40 yrs., and 
over group than 40 yrs. gr Experience divided into lower than 5 yrs., 5-10 yrs., and over than 10 
yrs. cluster.  
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Scoring  
 Knowledge section: The participant gets 1 point for the correct answer to each question. 
If they choose “Uncertain” this indicates that they do not know a correct answer. As there are nine 
items in this section, the total knowledge sore can be between zero to nine points.  The participants 
who score lower and equal to 50% are defined to have poor knowledge (Khan et.al, 2014).  
 Attitude section: The participant provides their agreement with each agreement on a  
5-point Likert scales as; 1= Strongly Disagree, 2= Disagree, 3= Neither agree nor disagree, 
4=Agree and 5=Strongly Agree, the midpoint is 3.  Also, reverse coding was used for negative 
statements.  Total attitude score from eight items was calculated ranging from 8 to 40. The total 
midpoint is 24 showing a natural attitude. So, the participants who get a total attitude score of less 
than the total midpoint (24) mean they disagree with attitudes (Peterson‐Clark et.al, 2010). They 
are classified as having a poor attitude in antimicrobials use and resistance.  
 Practice section: The participant evaluates their actions in 10 statements on a 5-point 
frequency Likert scales as; 1= Never, 2= Rarely, 3= Sometimes, 4=Often and 5=Always, the 
midpoint is 3.  Also, reverse coding was used for negative statements.  Total practice score from 
10 items ranges from 10 to 50. The total midpoint is 30 showing a total natural practice. The 
participants who get total practice scores less than the total midpoint (30) have a poor practice in 
antimicrobials use and resistance. 
The Statistic Package for the Social Science (SPSS) software version 24 was used for analysis.  
1. Reliability test in pilot study (see detail in reliability test in questionnaire development 
section) 
o Internal consistency use Cronbach’s alpha analysis 
o Reproducibility reliability measured by Interclass correlation coefficients (ICC).  
2. Descriptive analysis 
Descriptive statistical analysis such as mean, standard division (SD), Chi-square test, Mann-
Whitney U Test and Kruskal-Wallis test were used to describe demographics in relation to 
knowledge, attitude and practice of participants (Khan et.al, 2016). 
3. Correlation analysis 
Spearman’s correlation coefficient statistic was used to determine relationships of knowledge-
attitude, attitude -practice and practice-knowledge (Huang et.al, 2013). 
4. Qualitative data 
The results of open-end questions were coding using coding technique to interpret respondents’ 
answers and present them as percentages.  
 .  
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CHAPTER 5 
STUDY RESULTS 
Results of questionnaire validations and reliability test  
Questionnaire validation 
 The average IOC score of each item were calculated by experts rating (See Table 4). 
The questions that have an average IOC score less than 0.5 will be excluded from the questionnaire 
because they content is not a proper measure (Turner & Carlson, 2003).   
Overall, the experts suggested that we provide more information on some questions to 
enhance clarity. For example, researcher provided further details of amoxicillin allergy as 
anaphylaxis, gave information about drug allergy profile of patients in clinical scenarios. Also, the 
practice section was reorganised according to their suggestions regarding definition and context of 
the research.  
 In the knowledge section, question k5 “Antimicrobial stewardship is a role of hospital 
pharmacists” was rejected. The panel suggested that the question might indicate an attitude of 
participants rather than knowledge.  In the attitudes section, item a3 “An important cause of 
appearance of antimicrobial resistance is long course prescription of new antimicrobials” was 
rejected because it does not represent Thai pharmacists attitude, and might be misunderstand 
especially if there is a language barrier. The question A8 “If a patient feels that he/she needs 
antibiotics, and these are not dispensed, he/she will easily manage to obtain them at another 
pharmacy” was eliminated because Thailand allows pharmacies to dispense antimicrobial for 
patients; this means that antimicrobials can easily be purchased in any store depending on the 
discretion and/or ethic of the provider. Also, the question does not indicate feelings of the participant 
towards the topic.  
According to the experts’ comments, the practice section was reorganised and divided into 
two groups similar to the knowledge and attitude sections. Questions p5, p7, p8, p9, and p10 were 
grouped as practice regarding antimicrobial resistance while p1, p2, p3, p4, p6 were defined as 
practice statements on antimicrobial use. The experts accepted all questions in this section in 
relation to content, and no questions were rejected here.  
After validation, the final questionnaire consisted of thirty-five questions. This was then 
used in the pilot test involving fifteen pharmacists for reliability measuring. 
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Table 4: The results of Item-Objective Congruence (IOC) scores from experts 
Items 
 
Question/Statement 
 
Item-Objective Congruence (IOC) 
score 
 
 
Result 
Developed question/ statement after validation 
Expert 
1 
Expert 
2 
Expert 
3 
Total 
score 
Average 
score 
  
Knowledge Section 
Knowledge in antimicrobial resistance 
k1 “Superbugs” are microorganisms which generate 
antimicrobial resistance. They include bacteria, fungal, virus 
or parasites. 
1 1 1 3 1.00 Accept K1: “Superbugs” are microorganisms which generate 
antimicrobial resistance. They include bacteria, fungal, 
virus or parasites. 
k2 Resistance DNA in bacteria can transfer to other bacteria by 
virus. 
1 1 1 3 1.00 Accept K2:  Resistance DNA in bacteria can transfer to other 
bacteria by virus. 
k3  Antibiotic consumptions in humans is higher in hospital 
setting compared to community setting. 
0 1 1 2 0.67 Accept K3:  Antimicrobial resistance in hospital setting is 
higher than community setting. 
k4 The main objective of antimicrobial stewardship is to achieve 
the most effective clinical outcome with less toxicity and 
adverse reactions to antimicrobials. 
0 1 1 2 0.67 Accept K4: The main objective of antimicrobial stewardship is 
to achieve the most effective clinical outcome with less 
toxicity and adverse reactions to antimicrobials. 
k5 Antimicrobial stewardship is a role of hospital pharmacists. 0 0 1 1 0.33 Reject  
Knowledge in antimicrobial use 
k6 Penicillin, cephalosporin, and fluoroquinolone are  
β -lactam antibiotics. It need to consider Beta-lactamase 
producing bacterial. 
1 0 1 2 0.67 Accept K5:  Penicillin, cephalosporin, and fluoroquinolone are 
β -lactam antibiotics. It need to consider Beta-
lactamase producing bacterial. 
k7  Patients who are allergic to Amoxicillin should not use 
Cephalexin.   
1 1 0 2 0.67 Accept K6: Patients who are allergic to Amoxicillin 
(Anaphylaxis type) should not use Cephalexin.   
k8  Is it appropriate?  
When a pharmacist dispenses amoxicillin 1,500 mg a day, 7 
days for a 26-year-old male with allergic rhinitis, high-grade 
fever rhinorrhoea, and sore throat. 
1 1 0 2 0.67 Accept K7: Is it appropriate?  
When a pharmacist dispenses amoxicillin 1,500 mg a 
day, 7 days for a 26-year-old male with allergic rhinitis, 
high-grade fever rhinorrhoea, and sore throat, and no 
known drug allergy. 
k9 Is it appropriate?  
When a pharmacist dispenses only mineral powder for a 2-
year-old boy with watery diarrhoea, no mucous/bloody stool, 
no fever, no vomiting. 
1 1 1 3 1.00 Accept K8: Is it appropriate?  
When a pharmacist dispenses only mineral powder for 
a 2-year-old boy with watery diarrhoea, no 
mucous/bloody stool, no fever, no vomiting. 
k10 Is it appropriate?  
When a pharmacist dispenses dicloxacillin 250 mg four time 
a day for 5 days to prevent an infection in case of a 24-year 
old male who has had a skin abrasion wound on his right 
arm without exudates for 2 days, limited to subcutaneous 
layer, mild tenderness, no swelling, no active bleeding, no 
fever, and no known drug allergy.  
1 1 1 3 1.00 Accept K9: Is it appropriate?  
When a pharmacist dispenses dicloxacillin 250 mg four 
time a day for 5 days to prevent an infection in case of 
a 24-year old male who has had a skin abrasion wound 
on his right arm without exudates for 2 days, limited to 
subcutaneous layer, mild tenderness, no swelling, no 
active bleeding, no fever, and no known drug allergy. 
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Items 
 
Question/Statement 
 Item-Objective Congruence (IOC) 
score 
Result Developed question/ statement after validation 
Expert 
1 
Expert 
2 
Expert 
3 
Total 
score 
Average 
score 
  
Attitude Section 
Attitude in antimicrobial resistance 
a1 Antimicrobial resistance is an important public health 
problem of ours. 
1 1 1 3 1.00 Accept A1: Antimicrobial resistance is an important public 
health problem of ours. 
a2 The fact that a patient is taking an antibiotic increases 
the risk of developing resistance  
1 1 1 3 1.00 Accept A2: The fact that a patient is taking an antibiotic 
increases the risk of developing resistance 
a3 An important cause of appearance of antimicrobial 
resistance is long course prescription of new 
antimicrobials 
0 0 0 0 0 Reject  
a4 I am convinced that new antimicrobials will be developed 
to solve the problem of resistance. 
1 1 1 3 1.00 Accept A3: New antimicrobials development can solve 
antimicrobial resistance problem. - shorter 
a5 The use of antibiotics in animals for human consumption 
is an important cause of appearance of new resistance 
to pathogenic agents in humans. 
1 1 1 3 1.00 Accept A4: The use of antimicrobials in livestock animals is 
an important cause of appearance of new resistance 
to pathogenic agents in humans. 
Attitude in antimicrobial use 
a6 In all cases where antimicrobials are dispensed, it is 
essential that patients be advised about complying with 
the treatment 
1 1 1 3 1.00 Accept A5: In all cases where antimicrobials are dispensed, 
it is essential that patients be advised about 
complying with the treatment 
a7 Antimicrobials are sometimes dispensed without medical 
prescription because the patient is known to have 
difficulty in obtaining a medical consultation. 
1 1 1 3 1.00 Accept A6: Antimicrobials are sometimes dispensed without 
medical prescription because the patient is known to 
have difficulty in obtaining a medical consultation. 
a8 If a patient feels that he/she needs antibiotics, and these 
are not dispensed, he/she will easily manage to obtain 
them at another pharmacy. 
0 0 1 1 0.33 Reject  
a9 Antimicrobials are sometimes prescribed without medical 
prescription because the patient is known to have neither 
the time nor the money to see a physician. 
0 1 1 2 0.67 Accept A7: Antimicrobials are sometimes prescribed without 
medical prescription because the patient is known to 
have neither the time nor the money to see a 
physician. 
a10 Dispensing antimicrobials without prescription should be 
more closely controlled 
1 1 1 3 1.00 Accept A8: Dispensing antimicrobials without prescription is 
serious issue. 
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Items 
 
Question/Statement 
 
 Item-Objective Congruence (IOC) 
score 
Result Developed question/ statement after validation 
Expert 
1 
Expert 
2 
Expert 
3 
Total 
score 
Average 
score 
  
Practice Section (reorganised) 
Practice in antimicrobial resistance 
p5 I educate patients on the use of antimicrobials and 
resistance-related issues. 
1 1 1 3 1.00 Accept P1: I educate patients on the use of antimicrobials 
and resistance-related issues. 
p7 I take part in antimicrobial awareness campaigns to 
promote the optimal use of antimicrobials. 
1 1 1 3 1.00 Accept P2: I take part in antimicrobial awareness campaigns 
to promote the optimal use of antimicrobials 
p8 I lack continuing education in antimicrobial use and 
resistance topics.  
1 1 1 3 1.00 Accept P3: I lack continuing education in antimicrobial use 
and resistance topics. 
p9 I make efforts to prevent or reduce the transmission of 
infections within the community. 
1 1 1 3 1.00 Accept P4: I make efforts to prevent or reduce the 
transmission of infections within the community. 
p10 I collaborate with other health professionals for infection 
control and antimicrobial stewardship. 
1 1 1 3 1.00 Accept P5: I collaborate with other health professionals for 
infection control and antimicrobial stewardship 
Practice in antimicrobial use 
p1 I ask patient’s history and symptom of their infections 
before deciding to dispense antimicrobials. 
1 1 1 3 1.00 Accept P6: I ask patient’s history and symptom of their 
infections before deciding to dispense antimicrobials. 
p2 I sought additional clinical information (e.g. drug 
interaction, ADRs, allergy, etc.) before deciding to 
dispense the antimicrobials 
1 1 1 3 1.00 Accept P7: I sought additional clinical information (e.g. drug 
interaction, ADRs, allergy, etc.) before deciding to 
dispense the antimicrobials 
p3 I screen the antimicrobials in accordance with local 
guidelines before dispensing 
1 1 1 3 1.00 Accept P8: I screen the antimicrobials in accordance with 
local guidelines before dispensing 
p4 I dispense antimicrobial with complete clinical 
information 
1 1 0 2 0.67 Accept P9: I dispense antimicrobial with complete clinical 
information (e.g. drug interaction, ADRs, allergy, 
etc.) 
p6 I dispense antimicrobials without a prescription. 1 1 1 3 1.00 Accept P10: I dispense antimicrobials without a prescription. 
Current situation in practice (open-end questions) 
 p11  What are top three most commonly encountered 
infections in community pharmacy? 
1 1 1 3 1.00 Accept P11: What are top three most commonly encountered 
infections in your community pharmacy? 
 p12   What are the top three most commonly dispensed 
antimicrobials in community pharmacy? 
1 1 1 3 1.00 Accept P12: What are the top three most commonly 
dispensed antimicrobials in your community 
pharmacy? 
 p13  What is a main reason for dispensing antimicrobials 
without a prescription? 
1 1 1 3 1.00 Accept P13: What is a main reason for dispensing 
antimicrobials without a prescription? 
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Questionnaire reliability testing 
A pilot test was conducted to test if the questionnaire can measure community pharmacists’ 
knowledge, attitude, and practice in the topic with reliability and reproducibility. The participants in 
the test are Thai community pharmacist with varying types of pharmacy degree, location, and type 
of drugstore. They could represent opinions of pharmacists who will participate in the main study in 
the same way. However, age and years of experience may not be representative as it a small 
number of participants.  
Test-retest reliability was applied test reliability and reproducibility of the questionnaire.  
Researchers designed two occasions in one-week period based on a learning recall effect that 
could disturb findings in a re-test. The period should be short enough to not change participants’ 
behaviour and long enough to avoid remembering the questions (Rodrigues et.al, 2016).  
A total of fifteen (n=15) community pharmacists in the pilot test responded to the validated 
online questionnaire. The majority of pharmacists were female, 66.7% (n=10) with an average age 
of 28.98 years. 53.3% (n=8) of participants graduated through the five-year pharmacy programme, 
and 33.3% (n=5) of the pharmacists held a postgraduate degree at Master level. The participants 
have practiced in community pharmacy for a mean 3.53 years.  40% (n=6) worked in Bangkok, 20% 
(n=3) in Chonburi, and others 40% (n=6).  Most of pharmacy type was individual pharmacy (66.7%, 
n=10). (Table 5) 
 
 
 
 
 
 
 
 
 
Table 5:  Demographic profile of participants in pilot test 
 
 
 
 
Demographic data 
Age (mean ± SD) 28.98 ± 1.82 
Experience (mean ± SD) 3.53 ± 2.56 
Gender, n (%) 
Female   
Male 
 
10 (66.7) 
5 (33.3) 
Pharmacy Degree, n (%) 
BPharm/BSc in Pharm 
PharmD 
 
8 (53.3) 
7 (46.7) 
Postgraduate Degree, n (%) 
None 
Master degree 
 
10 (66.7) 
5 (33.3) 
Location, n (%) 
Bangkok 
Chonburi 
Others 
 
6 (40.0) 
3 (20.0) 
6 (40.0) 
Type of Pharmacy, n (%) 
Individual store 
Chain store 
 
10 (66.7) 
5 (33.3) 
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Internal consistency reliability test 
Cronbach’s alpha was applied for analysis of internal consistency reliability test. The alpha 
values were 0.769, 0.783, and 0.742 in knowledge-, attitude- and practice section, respectively in 
early test. Moreover, alpha values in re-test were calculated and present at 0.731, 0.718, and 0.723 
as show in Table 6.  The results of alpha values show that questions can measure each variable 
factor because the values are acceptable, more than 0.7 (Tavakol & Dennick, 2011; Rodrigues 
et.al, 2016). 
Section Number of Items 
Cronbach's Alpha 
Pre-test 
Cronbach's Alpha 
Retest 
Knowledge 9 0.769 0.731 
Attitude 8 0.783 0.718 
Practice 10 0.742 0.723 
Table 6: Cronbach’s alpha value in each section in reliability test. 
Reproducibility test 
Test-retest reliability can examine that a measurement is reproducible over time.  
Regarding reproducibility test, Cohen’s kappa (k). Kappa values range from -1 to +1 to 
indicate agreement between test and retest (McHugh, 2012, Tan et.al, 2015). The kappa value of 
more than 0.75 is excellent, 0.40 to 0.75 is moderate to good, and less than 0.4 is poor agreement 
(Kirkwood & Sterne, 2010; McHugh, 2012).  The results in Table 7 show that the lowest value is 
question K7 (k=0.444) indicating a fair agreement between two occasions test and the highest value 
was in question K2 and K8 (k=0.762) showing an excellent agreement in the test. The questions in 
the knowledge section are acceptable based on the kappa values and this means that these are 
reproducible.  
Table 7: The kappa coefficient value in knowledge section 
Items 
Kappa p-value 
Knowledge Section 
K1: “Superbugs” are microorganisms which generate antimicrobial resistance. They 
include bacteria, fungal, virus or parasites. 
0.615 0.01 
K2:  Resistance DNA in bacteria can transfer to other bacteria by virus. 0.762 0.002 
K3:  Antimicrobial resistance in hospital setting is higher than community setting. 0.634 0.008 
K4: The main objective of antimicrobial stewardship is to achieve the most effective 
clinical outcome with less toxicity and adverse reactions to antimicrobials. 
0.634 0.008 
K5:  Penicillin, cephalosporin, and fluoroquinolone are beta -lactam antibiotics. It 
need to consider Beta-lactamase producing bacterial 
0.634 0.008 
K6: Patients who are allergic to Amoxicillin (Anaphylaxis type) should not use 
Cephalexin. 
0.634 0.008 
K7: Is it appropriate?  When a pharmacist dispenses amoxicillin 1,500 mg a day, 7 
days for a 26-year-old male with allergic rhinitis, high-grade fever rhinorrhoea, and 
sore throat, and no known drug allergy. 
0.444 0.038 
K8: Is it appropriate?  When a pharmacist dispenses only mineral powder for a 2-
year-old boy with watery diarrhoea, no mucous/bloody stool, no fever, no vomiting. 
0.762 0.002 
K9: Is it appropriate?  When a pharmacist dispenses dicloxacillin 250 mg four time a 
day for 5 days to prevent an infection in case of a 24-year old male who has had a 
skin abrasion wound on his right arm without exudates for 2 days, limited to 
subcutaneous. 
0.650 0.003 
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Intraclass correlation coefficient (ICC) analysis was used; this is generally used in test-
retest (Koo & Li, 2016). According to Koo and Li guideline in 2016, the researcher employed two-
way mixed model to calculate ICC value in test because it used selected participants of interest; 
fifteen pharmacists took part, a measurement at two different times, and there was no random 
sampling. The ICC value indicates reproducibility that <0 . 4  is low, acceptable rate of 0 . 4-0 . 75  
means fair to good and >0.75 means high reproducibility (Rodrigues et.al, 2016). 
 Overall, statements in attitude and practice sections show that there is an acceptable rate 
agreement between test and retest (Table 8). Attitude section showed the lowest ICC values in 
statement A1 (0.471) with acceptable reproducibility through to excellent reproducibility in A7 
(0.840). Practice section presented lowest agreement but acceptable in P10 (0.448) up to P10 
(0.921) as excellent agreement. It means that statements in the questionnaire in attitude and 
practice sections are reproducible on different occasions.  
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Items ICC 95% CI p-value 
Knowledge Section 
K1: “Superbugs” are microorganisms which generate antimicrobial resistance. 
They include bacteria, fungal, virus or parasites. 
0.667 0.253-0.874 
0.002 
 
K2:  Resistance DNA in bacteria can transfer to other bacteria by virus. 0.774 0.450-0.918 <0.001 
K3:  Antimicrobial resistance in hospital setting is higher than community setting. 0.650 0.226-0.867 0.003 
K4: The main objective of antimicrobial stewardship is to achieve the most 
effective clinical outcome with less toxicity and adverse reactions to antimicrobials. 
0.650 0.226-0.867 0.003 
K5:  Penicillin, cephalosporin, and fluoroquinolone are beta -lactam antibiotics. It 
need to consider Beta-lactamase producing bacterial 
0.650 0.226-0.867 0.003 
K6: Patients who are allergic to Amoxicillin (Anaphylaxis type) should not use 
Cephalexin. 
0.650 0.226-0.867 0.003 
K7: Is it appropriate?  When a pharmacist dispenses amoxicillin 1,500 mg a day, 7 
days for a 26-year-old male with allergic rhinitis, high-grade fever rhinorrhoea, and 
sore throat, and no known drug allergy. 
0.480 -0.023-0.789 0.003 
K8: Is it appropriate?  When a pharmacist dispenses only mineral powder for a 2-
year-old boy with watery diarrhoea, no mucous, no bloody stool, no fever, no 
vomiting. 
0.774 0.450-0.918 <0.001 
K9: Is it appropriate?  When a pharmacist dispenses dicloxacillin 250 mg four time 
a day for 5 days to prevent an infection in case of a 24-year old male who has had 
a skin abrasion wound on his right arm without exudates for 2 days, limited to 
subcutaneous. 
0.650 0.226-0.867 0.003 
Attitude section 
A1: Antimicrobial resistance is an important public health problem of ours. 0.471 -0.035-0.784 0.033 
A2: The fact that a patient is taking an antimicrobial increases the risk of 
developing resistance. 
0.619 0.176-0.854 0.005 
A3: New antimicrobials development can solve antimicrobial resistance issue. 0.655 0.234-0.869 0.003 
A4: The use of antimicrobials in livestock animals is an important cause of 
appearance of new resistance to pathogenic agents in humans. 
0.526 0.039-0.811 0.018 
A5: In all cases where antimicrobials are dispensed, it is essential that patients be 
advised about complying with the treatment. 
0.636 0.203-0.861 0.004 
A6: Antimicrobials are sometimes dispensed without medical prescription because 
the patient is known to have difficulty in obtaining a medical consultation. 
0.485 -0.016-0.791 0.028 
A7: Antimicrobials are sometimes prescribed without medical prescription because 
the patient is known to have neither the time nor the money to see a physician. 
0.840 0.589-0.943 <0.001 
A8: Dispensing antimicrobials without prescription should be more closely 
controlled. 
0.770 0.443-0.917 <0.001 
Practice section 
P1: I educate patients on the use of antimicrobials and resistance-related issues 0.577 0.112-0.835 0.010 
P2: I take part in antimicrobial awareness campaigns to promote the optimal use 
of antimicrobials 
0.921 0.782-0.973 <0.001 
P3: I lack continuing education in antimicrobial use and resistance topics. 0.520 0.031-0.808 0.019 
P4: I make efforts to prevent or reduce the transmission of infections within the 
community 
0.710 0.328-0.892 0.001 
P5: I collaborate with other health professionals for infection control and 
antimicrobial stewardship 
0.556 0.082-0.825 0.013 
P6: I ask patient’s history and symptom of their infections before deciding to 
dispense antimicrobials. 
0.583 0.121-0.838 0.009 
P7: I sought additional clinical information (e.g. drug interaction, ADRs, allergy, 
etc.) before deciding to dispense the antimicrobials 
0.735 0.374-0.902 0.001 
P8: I screen the antimicrobials in accordance with local guidelines before 
dispensing 
0.509 0.16-0.803 0.022 
P9: I dispense antimicrobial with complete clinical information (e.g. patient's 
history, drug interaction, ADRs, allergy, etc.) 
0.491 -0.008-0.794 0.027 
P10: I dispense antimicrobials without a prescription. 0.448 -0.064-0.773 0.041 
*p <0.05    ** p<0.01 *** p <0.001 
Table 8: The results of Interclass Correlation Coefficients (ICC) in each question. 
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521 persons were invited to participate a questionnaire. 
 
 
 
 
 
378 persons completed answers in the questionnaire 
  
6 participants were excluded   
• 2 persons do not graduate in pharmacy 
degree 
• 4 persons cannot identify location of 
workplace 
  
  
  
  
372 persons were collected data for analysis. 
  
Invitation E-mail  
- 213 persons listed by 
online databases. 
  
 
  
  
  
  
Social media groups 
- 195 persons in Chonburi 
drugstores network group. 
- 113 persons in 
Community pharmacy 
service group. 
. 
  
 
  
  
  
  
Results of data collection 
Community pharmacists in Bangkok and Chonburi province in Thailand were invited to 
participate an online questionnaire totally 521 persons. Invitation massages was posted in social 
media groups of LINE® application which famous social media in Thai pharmacists. There are 195 
members in Chonburi Drugstores Network groups, and 113 members in Community Pharmacy 
Service in Bangkok group. Direct e-mail was sent to invite 213 community pharmacists who were 
random selected from database websites of Thai FDA, and Community Pharmacy Association of 
Thailand.  378 persons participated the questionnaire, however, there are 6 participants were 
rejected because they cannot justify inclusion criteria. Finally, 372 community pharmacists who met 
requirements were collected data and gain 71.4% of respond rate.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Flow chart of participants who included in study. 
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Results of current situation in community pharmacy practice in antimicrobials 
provision 
Open-end questions were included in the questionnaire to explore the current antimicrobial 
provision in community pharmacy in Thailand. The participants confirmed the most commonly 
encountered infections in their pharmacy, frequently used antimicrobials and reasons for providing 
antimicrobials without a prescription.  
Encountered infections 
 There were 717 responses from the pharmacists. These were grouped as shown in figure 
12. Respiratory infections were the most common (36.8%), followed by Skin and soft tissue 
infections (SSTIs) including wounds (22.9%). The results show that urinary tract infections (UTIs) 
and gastric infections including diarrhoea have a similar frequency of16.6% and 16.7% respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: The commonly encountered infections in community pharmacy. 
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Respiratory Infections term included lower respiratory infections, upper respiratory infections, 
bronchitis, nasopharyngitis, otitis media, pharyngitis, rhinitis, sinusitis, sore throat, and tonsillitis.  
SSTIs and wound term included abscess, acne, bacterial skin infection, cellulitis, conjunctivitis, 
hordeolum, herpes simplex, impetigo, and tinea. 
UTIs included term included cystitis. 
GI infections term included diarrhoea. 
STDs term included candidiasis, chlamydia, vaginitis, and gonorrhoea. 
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Dispensed antimicrobials  
 We collected 742 responses of the most commonly dispensed antimicrobials in community 
pharmacy. The answers were coded and classified by medicine classification as demonstrated in 
figure 13. Antibacterial agents were most commonly dispensed, while antifungals (1.3%) and 
antiviral agents (0.1%) were rarely provided. Aminopenicillin group is the most common class of 
antibiotics provided in community pharmacy (39.8%) followed by Fluoroquinolone (25.1%) and 
Penicillinase-resistance penicillin (17.4%).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: The commonly dispensed antimicrobials in community pharmacy. 
 
 
 
 
 
Aminopenicillin; Amoxicillin (n=242), Amoxicillin/Clavulanic acid (n=52), and Ampicillin (n=1) 
Fluoroquinolone; Norfloxacin (n=146), Ciprofloxacin (n=28), Ofloxacin (n=12) 
Penicillinase-resistant-penicillin; Dicloxacillin (n=122), Cloxacillin (n=7) 
Macrolide; Roxithromycin (n=61), Azithromycin (n=20), Erythromycin (n=1) 
Tetracycline; Doxycycline (n=9), Tetracycline (n=3) 
Cephalosporin; Cephalexin (3), Cefuroxime (n=1), Cephalosporin (n=1) 
Other Antibiotics; Clindamycin (n=11), Co-trimoxazole (n=1), Metronidazole (n=1) 
Antifungal; Clotrimazole (n=4), Ketoconazole (n=3), Fluconazole (n=2), antifungal cream (n=1) 
Antiviral; Acyclovir (n=1) 
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Reasons for dispensing non-prescription antimicrobials. 
 The community pharmacists gave the following reasons for dispensing antimicrobials 
without a prescription: they have the ability to treat common infections in their store (19.4%), and 
drug store is convenient to access medicine (18.7%), patients have neither time nor money to meet 
a physician (15.5%) and the patients present symptom that need to be treat by antimicrobials 
(12.7%). In terms of the system, the law allows pharmacist to provide antimicrobials 11.6%). Results 
are shown in figure 14.  
 
 
Figure 14: The reasons for dispensing antimicrobials without a prescription. 
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Results of community pharmacists’ Knowledge, attitude and practice in 
antimicrobial resistance and use 
Knowledge in antimicrobial use and resistance 
Knowledge of community pharmacists in antimicrobial resistance and use were evaluated 
in the knowledge section of the questionnaire. Table 9 shows percentages of correct, incorrect, and 
uncertain answer in each item.  
Items 
Correct Incorrect Uncertain 
n % n % n % 
K1: “Superbugs” are microorganisms which generate 
antimicrobial resistance. They include bacteria, fungal, 
virus or parasites. 
176 47.3 98 26.3 98 26.3 
K2:  Resistance DNA in bacteria can transfer to other 
bacteria by virus. 
207 55.6 113 30.4 52 14.0 
K3:  Antimicrobial resistance in hospital setting is higher 
than community setting. 
278 74.7 50 13.4 44 11.8 
K4: The main objective of antimicrobial stewardship is to 
achieve the most effective clinical outcome with less 
toxicity and adverse reactions to antimicrobials. 
283 76.1 80 21.5 9 2.4 
K5:  Penicillin, cephalosporin, and fluoroquinolone are β -
lactam antibiotics. It need to consider Beta-lactamase 
producing bacterial. 
262 70.4 107 28.8 3 0.8 
K6: Patients who are allergic to Amoxicillin (Anaphylaxis 
type) should not use Cephalexin.   
332 89.2 30 8.1 10 2.7 
K7: Is it appropriate?  
When a pharmacist dispenses amoxicillin 1,500 mg a day, 
7 days for a 26-year-old male with allergic rhinitis, high-
grade fever rhinorrhoea, and sore throat, and no known 
drug allergy. 
297 79.8 61 16.4 14 3.8 
K8: Is it appropriate?  
When a pharmacist dispenses only mineral powder for a 2-
year-old boy with watery diarrhoea, no mucous/bloody 
stool, no fever, no vomiting. and no known drug allergy. 
330 88.7 35 9.4 7 1.9 
K9: Is it appropriate?  
When a pharmacist dispenses dicloxacillin 250 mg four 
time a day for 5 days to prevent an infection in case of a 
24-year old male who has had a skin abrasion wound on 
his right arm without exudates for 2 days, limited to 
subcutaneous layer, mild tenderness, no swelling, no 
active bleeding, no fever, and no known drug allergy. 
256 68.8 81 21.8 35 9.4 
Table 9: Frequency of correct, incorrect, and uncertain answer in knowledge section. 
Overall, the majority of participants gave correct answers to the knowledge questions and 
obtained percentages of correct ranging from 47.4% (K1) to 89.2% (K6). The question K1 has the 
lowest percentage of correct responses. It can indicate that most participants were unsure of the 
term of “superbugs” because 26.3% of participants selected and uncertain choice. Also, they were 
unsure about resistance mechanism in question K2 which has only 55.6% as correct and 14% gave 
uncertain answer. Otherwise, results show that the pharmacists have a good understanding of the 
prevalence of antimicrobial resistance in health and community setting (K3) with 70.4% as correct, 
and aim of antimicrobial stewardship (K4) which achieved 76.1%.   
In terms of antimicrobial use, the participants show that they can identify the appropriate 
use of antimicrobials through clinical scenario questions. The pharmacists selected correct answer 
at 88.7% in the diarrhoea case (K6), 79.8% in the respiratory case (K7), and 68.8% in the wound 
scenario (K9).   
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Knowledge score in antimicrobial use and resistance 
Table 10 shows descriptive statistic of total knowledge score. The total knowledge score of 
the participants ranged from 3 points to 9 points, with an average score of 6.48 (±1.258), and a 
median score is 7.00 (±1).  
 
Knowledge total score (K1-K9) 
Minimum 3 
Maximum 9 
Mean 6.48 
Std. Deviation 1.258 
Median 7.00 
Interquartile Range 1 
Table 10: Knowledge score of participants in antimicrobial use and resistance 
  
According to one-sample Kolmogorov-Smirnov test, it has a hypothesis that distribution of data 
is normal. The results can be interpreted that total knowledge score of participants in this study do 
now have a normal distribution at p-value < 0.001 (Table 11). So, non-parametric statistic is suitable 
for analysis in this study.  
 
Kolmogorov-Smirnov 
Statistic df Sig. 
Knowledge total score (K1-K9) .165 372 .000 
Table 11: Kolmogorov-Smirnov Test of total knowledge score normal distribution 
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Attitude regarding antimicrobial use and resistance 
Community pharmacists generally agreed with positive attitude statements in relation to 
appropriate use of antimicrobials and resistance issue but most of them agreed with negative 
statements on antimicrobial use as well. Table 12 shows results of agreement of participants with 
each attitude statement. 
Table 12: Results of participants’ agreeing in each attitude statement. 
 
 
 
Items 
Strongly 
disagree 
n (%) 
Disagree 
 
n (%) 
Neither 
agree or 
disagree 
n (%) 
Agree 
 
n (%) 
Strongly 
Agree 
n (%) 
Median 
 
(IQR) 
A1: Antimicrobial resistance 
is an important public health 
problem of ours. 
1 (0.3) 1 (0.3) 2 (0.5) 107 (28.8) 261 (70.2) 5 (1) 
A2: The fact that a patient is 
taking an antibiotic 
increases the risk of 
developing resistance 
5 (1.3) 26 (7.0) 38 (10.2) 200 (53.8) 103 (27.7) 4 (1) 
A3: New antimicrobials 
development can solve 
antimicrobial resistance 
problem.  
37 (9.9) 96 (25.8) 83 (22.3) 111 (29.8) 45 (12.1) 3 (2) 
A4: The use of 
antimicrobials in livestock 
animals is an important 
cause of appearance of new 
resistance to pathogenic 
agents in humans. 
5 (1.3) 20 (5.4) 68 (18.3) 177 (47.6) 102 (27.4) 4 (2) 
A5: In all cases where 
antimicrobials are 
dispensed, it is essential 
that patients be advised 
about complying with the 
treatment 
1 (0.3) 3 (0.8) 12 (3.2) 96 (25.8) 260 (69.9) 5 (1) 
A6: Antimicrobials are 
sometimes dispensed 
without medical prescription 
because the patient is 
known to have difficulty in 
obtaining a medical 
consultation. 
12 (3.2) 40 (10.8) 91 (24.5) 179 (48.1) 50 (13.4) 4 (1) 
A7: Antimicrobials are 
sometimes prescribed 
without medical prescription 
because the patient is 
known to have neither the 
time nor the money to see a 
physician. 
14 (3.8) 51 (13.7) 97 (26.1) 171 (46.0) 39 (10.5) 4 (1) 
A8: Dispensing 
antimicrobials without 
prescription is serious issue. 
31 (8.3) 85 (22.8) 88 (23.7) 113 (30.4) 55 (14.8) 4 (1) 
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In terms of positive statements, the participants strongly agreed (median=5) that 
antimicrobial resistance is an important public health issue (A1). They agreed that taking of 
antibiotics in human (A2) and animals (A4) can increase the risk of resistance (median=4). 
However, the pharmacists were neutral regarding new antimicrobials solving the resistance 
problem (A3) which a median of 3. More than 69% of participants (median=5) strongly agreed that 
patients who take antimicrobials need to be advised (A5). Also, they agreed with A8 statement that 
non-prescription dispensing of antimicrobials is serious (median=4) but results of “agree” and 
“strongly agree” account for only 30.4% and 14.8%.  
 Apart from negative statements (A6, A7), the participants should disagree, but they mostly 
agreed with the items. They agreed that antimicrobials can be dispensed without prescription 
because patient may find it difficult to afford medical service (agree 48.2%, strongly agree13.4%, 
median=4), and have no time and no budget to meet a physician (agree 46.0%, strongly 
agree10.5%, median=4). This point is interesting and will be considered later in the discussion 
chapter.  
Attitude score in antimicrobial use and resistance 
Table 13 shows descriptive statistics of the total attitude score. The total attitude score of 
the participants were between 19 and 37 points, average score is 28.52 (±3.450), and median score 
is 28.00 (±5).  
Attitude total score (A1-A8) 
Minimum 19 
Maximum 37 
Mean 28.52 
Std. Deviation 3.450 
Median 28.00 
Interquartile Range 5 
Table 13: Attitude score of participants in antimicrobial use and resistance 
To confirm that the attitude score needs to be analysed by non-parametric statistics, one-
sample Kolmogorov-Smirnov test was used for analysing the hypothesis that attitude score has a 
normal distribution (Table 14). Results of the test show that p-value of the test < 0.001, which is a 
significant difference for the hypothesis. So, it can be interpreted that total attitude score does not 
have a normal distribution. It confirms the need to use non-parametric statistical analysis for 
comparing factors as well as the total knowledge score. 
 
 
 
 
 
Table 14: Kolmogorov-Smirnov Test of total attitude score normal distribution 
 
Kolmogorov-Smirnova 
Statistic df Sig. 
Total attitude score (A1-A8) .078 372 .000 
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Practice in antimicrobial use and resistance 
Community pharmacists mostly demonstrate good practice in antimicrobials resistance and 
use, but they routinely dispense antimicrobials without a prescription. Table 15 shows the frequency 
of practice of participants in relation to reducing antimicrobial resistance and prudent use of 
antimicrobial agents. 
Table 15: Results of participants’ frequency actions in each practice statement. 
The community pharmacists are likely to educate their patients on antimicrobial resistance 
awareness (P1) (usually= 41.1%, always=41.4%). Also, more than 60% (of the pharmacists 
(usually=39.5%, always=22.3%) participate in combatting antimicrobial resistance campaigns (P2) 
and attempt to prevent and reduce resistance in community (P4), (usually=49.5%, always=20.4%). 
However, the pharmacists responded that they have no chance to collaborate with other health 
Items 
Never 
n (%) 
Several 
n (%) 
Fairly  
often 
n (%) 
Usually 
n (%) 
Always 
n (%) 
Median 
(IQR) 
P1: I educate patients on 
the use of antimicrobials and 
resistance-related issues. 
- 14 (3.8) 51 (13.7) 153 (41.1) 154 (41.4) 4 (1) 
P2: I take part in 
antimicrobial awareness 
campaigns to promote the 
optimal use of antimicrobials 
2 (0.5) 38 (10.2) 102 (27.4) 147 (39.5) 83 (22.3) 4(1) 
P3: I lack continuing 
education in antimicrobial 
use and resistance topics. 
79 (21.2) 196 (52.7) 75 (20.2) 18 (4.8) 4 (1.1) 2(1) 
P4: I make efforts to prevent 
or reduce the transmission 
of infections within the 
community. 
2 (0.5) 20 (5.4) 90 (24.2) 184 (49.5) 76 (20.4) 4(1) 
P5: I collaborate with other 
health professionals for 
infection control and 
antimicrobial stewardship 
81 (21.8) 104 (28.0) 67 (18.0) 85 (22.8) 35 (9.4) 3 (2) 
P6: I ask patient’s history 
and symptom of their 
infections before deciding to 
dispense antimicrobials. 
- 3 (0.8) 7 (1.9) 111 (29.8) 251 (67.5) 5 (1) 
P7: I sought additional 
clinical information (e.g. 
drug interaction, ADRs, 
allergy, etc.) before deciding 
to dispense the 
antimicrobials 
1 (0.3) 56 (15.1) 59 (15.9) 157 (42.2) 99 (26.6) 4 (2) 
P8: I screen the 
antimicrobials in accordance 
with local guidelines before 
dispensing 
- 5 (1.3) 57 (15.3) 186 (50.0) 124 (33.3) 4(1) 
P9: I dispense antimicrobial 
with complete clinical 
information (e.g. drug 
interaction, ADRs, allergy, 
etc.) 
1 (0.3) 20 (5.4) 75 (20.2) 176 (47.3) 100 (26.9) 4 (2) 
P10: I dispense 
antimicrobials without a 
prescription. 
1 (0.3) 18 (4.8) 69 (18.5) 124 (33.3) 160 (43.0) 4(1) 
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professionals (P5) such as physicians for infections control and antimicrobial stewardship 
(never=21.8%, several=28.0%).  
 In terms of antimicrobials provision, over 97% (usually=29.8%, always=67.5%) of the 
pharmacists practice history taking regarding infections with their patients (P6). Also, most 
participants (usually=42.2%, always=26.6%) seek clinical information such as drug interaction, 
allergic profile (P7), usually=42.2%, always=26.6%) and dispensing antimicrobials following 
evidence (P9), usually=47.3%, always=26.9%). Furthermore, over 83% (usually=50.0%, 
always=33.3%) of the pharmacists confirmed that they dispense antimicrobials following local 
guidelines (P8).  
In relation to negative practices, around 6% (usually=4.8 %, always=1.1%) of the 
participants reported lack of continuing education on antimicrobials use and resistance topics. The 
question relating to dispensing antimicrobials without prescription (P10) generated responses of 
usually 33.3%, and always 43.0%.  
Practice score in antimicrobial use and resistance 
Table 16 shows descriptive statistic of total practice score. The total pratice score of the 
participants were between 21 and 49 points, average score is 36.76 (±4.993), and median score is 
37.00 (±5).  
Practice total score (P1-P10) 
Minimum 21 
Maximum 49 
Mean 36.76 
Std. Deviation 4.993 
Median 37.00 
Interquartile Range 6 
Table 16: Practice score of participants in antimicrobial use and resistance 
To confirm that the practice score needs to be analysed using non-parametric statistics, 
one-sample Kolmogorov-Smirnov test was used for the hypothesis that the practice score is of 
normal distribution (See table 17). Results of the test show that p-value of the test < 0.001, so, it 
can be interpreted that total practice score is not of normal distribution. It confirms the need to use 
non-parametric statistical analysis to compare factors. 
 
 
 
 
Table 17: Kolmogorov-Smirnov Test of total practice score normal distribution 
  
 
Kolmogorov-Smirnov 
Statistic df Sig. 
Practice total score (P1-P10X .068 372 .000 
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Relationship between knowledge, attitude, and practice score  
 Consistent with the knowledge, attitude, and practice or KAP model, it is expected that each 
of the dimensions could be related. Spearman's rho correlation was used to show the relationship 
between knowledge, attitude, and practice scores. Table 18 shows results of correlation by 
Spearman's rho test.  
 
 Spearman's rho p-value 
Knowledge - Attitude 0.100 0.053 
Attitude - Practice 0.149 0.004** 
Knowledge - Practice 0.071 0.174 
**=significant at p value < 0.01 level 
Table 18: Correlation of Knowledge-, Attitude-, and Practice score 
 The results indicate that there is no relationship between knowledge and attitude and 
knowledge and practice; correlation coefficient of attitude and practice is 0.149 and p-value is 0.004 
at 0.01 level or 99% confident interval. It can be assumed that there is a weak correlation between 
attitude and practice dimensions.  
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Results of community pharmacists’ characteristics associated to knowledge, 
attitude and practice in antimicrobials use and resistance. 
Characteristic of community pharmacists 
The average age of participants was 32.02 (± 5.81) years and most of them were grouped 
into a range between 30 and 40 years (n=185, 49.7%). The majority of participants were female 
(n=260, 69.9%), graduated with Bachelor of pharmacy 5-years programme (n-=287, 77.2%), and 
worked in individual drugstore (n=233, 62.6%). An average of experience in community pharmacy 
was 5.46 (± 4.31) years. The participants who work in Bangkok account for 69.4% (n=258,), and 
for 34.6% in Chonburi (n=114). The demographic data of participants is presented in Table 19.   
  
Demographic data 
Age (mean ± SD)  32.02 ± 5.81 
Lower than 30 yrs., n (%) 
30-40 yrs. 
Over than 40 yrs. 
145 (39.0) 
185 (49.7) 
42 (11.3) 
Experience (mean ± SD)  5.46 ± 4.31 
Lower than 5 yrs., n (%) 
5-10 yrs. 
Over than 10 yrs. 
180 (48.4) 
152 (40.9) 
40 (10.8) 
Gender, n (%) 
Male 
Female 
 
112 (30.1) 
260 (69.9) 
Pharmacy Degree, n (%) 
BPharm/BSc in Pharm 
PharmD 
 
287 (77.2) 
85 (22.8) 
Postgraduate Degree, n (%) 
None 
Master degree 
Doctoral degree 
 
276 (74.2) 
91 (24.5) 
5 (1.3) 
Location, n (%) 
Bangkok 
Chonburi 
 
258 (69.4) 
114 (30.6) 
Type of Pharmacy, n (%) 
Individual store 
Chain store 
 
233 (62.6) 
139 (37.4) 
 
Table 19: Demographic data of participants 
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Relationship between characteristics 
Age: Senior pharmacists tend to have extensive experience and hold postgraduate 
qualifications. While young pharmacists were PharmD graduates, and were more likely to work in 
chain pharmacies. The results of p-value in Chi-square test show in Table 20.  
 
***=significant at p-value <0.01 
Table 20: Relationship of age among other demographics 
Postgraduate degree: Pharmacists over 40 years of age are more likely to have a postgraduate 
qualification (20 pharmacists or 45.45% of the group). This is followed by pharmacists between 30 
and 40 years of age (29.19%), and pharmacists younger than 30 years of age (15.17% of 
participants in this group). 
Pharmacy degree: The young pharmacists are more likely to hold a Doctor of Pharmacy (PharmD).  
There are 64 PharmD pharmacists, or 44.14% in the lower age range, followed by 21 PharmD, or 
11.35% of pharmacists aged between 30 to 40 years, and no PharmD graduates older than 40 
years of age since it is a relatively new programme.  
Pharmacy type: Individual pharmacy (in the UK this is known as independent pharmacies) is the 
most common type of workplace (n=233). The young pharmacists are more likely to work in chain 
pharmacies (51.72% of them n=75), while the other two age groups are more likely to work in 
independent pharmacies (68.11% of 30-40 years and 88.10% for over 40 years).  
Experience: 115 pharmacists (79.31%) who aged lower than 30 years are experience less than 5 
years in community pharmacy.  Similarly, in middle age range, 111 people or 60% of them are 
experience between 5 and 10 years, and 69% of the senior pharmacists (n=29), are extensive 
experience (over than 10 years) in community pharmacy setting. 
  
 
 
 
 
  
Demographics 
Age 
p-value < 30 yrs. 
(n =145) 
30-40 yrs. 
(n=185) 
> 40 yrs. 
(n=42) 
Gender Male (n=112) 43 54 15 
0.730 
Female (n=260) 102 131 27 
Postgraduate 
degree 
None (n=276) 123 131 22 
0.000*** 
Postgraduate (n=96) 22 54 20 
Pharmacy 
Degree 
BPharm (n=287) 81 164 42 
0.000*** 
PharmD (n=85) 64 21 0 
Locations Bangkok (n=258) 107 124 27 
0.308 
Chonburi (n=114) 38 61 15 
Pharmacy 
type 
Chain (n=139) 75 59 5 
0.000*** 
Individual (n=233) 70 126 37 
Experience < 5 yrs. (n=180) 115 63 2 
0.000*** 5 to 10 yrs. (n=152) 30 111 11 
> 10 yrs. (n=40) 0 11 29 
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Experience 
Participants who have extensive experience are more likely to hold a postgraduate 
qualification. Most Bangkok participants had a lower experience while most of participants in 
Chonburi had 5-10 years’ experience. The results of p-value Chi-square test are shown in Table 
21.  
Demographics 
Experience 
p-value < 5 yrs. 
(n=180) 
5 to 10 yrs. 
(n=152) 
> 10 yrs. 
(n=40) 
Gender 
Male (n=112) 53 46 13 
0.947 
Female (n=260) 127 106 27 
Postgraduate 
degree 
None (n=276) 145 111 20 
0.000*** Postgraduate 
(n=96) 
35 41 20 
Pharmacy 
Degree 
BPharm (n=287) 109 138 40 
0.000*** 
PharmD (n=85) 71 14 0 
Locations 
Bangkok (n=258) 132 96 30 
0.097* 
Chonburi (n=114) 48 56 10 
Pharmacy 
type 
Chain (n=139) 80 53 6 
0.002*** 
Individual (n=233) 100 99 34 
*=significant at p-value <0.1, ***=significant at p-value <0.01 
Table 21: Relationship of experience among other demographics 
Postgraduate degree: 50% of the participants who have extensive experience (more than 10 
years) hold a postgraduate degree, followed by 26.97% of pharmacists with 5 to 10 years in and 
19.44% of pharmacists with less than 5 years’ experience.  
Pharmacy degree: 39.44% of participants hold a PharmD; these also tend to be the least 
experienced pharmacists. 
Pharmacy type: 44.44% of pharmacists with less than 5 years’ experience work in a chain 
pharmacy, followed by 34.87% of pharmacists with 5-10 years’ experience, and only 15% of 
experienced pharmacists.  
Location: 65.35% of all participants work in Bangkok. Most of Bangkok pharmacists have low 
experience in community pharmacy (51.16%) followed by 37.21% of pharmacists with 5-10 years’ 
experience and 11.63% with extensive experience. 30.65% of pharmacists work in Chonburi 
province. Most of them have 5-10 years’ experience (49.12%), followed by 42.10% of pharmacists 
with less than 5 years’ experience and 8.77% with more than 10 years’ experience.  
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Pharmacists’ qualifications 
The information in table 22 shows that PharmD graduates prefer to work in Bangkok and 
in chain stores.  
 
Demographics 
Pharmacy Degree Postgraduate Degree 
BPharm 
(n=287) 
PharmD 
(n=85) 
p-value 
None 
(n=276) 
Postgraduate 
degree 
(n=96) 
p-value 
Gender 
Male 
(n=112) 
79 33 
0.059* 
82 30 
0.797 
Female 
(n=260) 
208 52 194 66 
Locations 
Bangkok 
(n=258) 
190 68 
0.016** 
191 67 
1.000 
Chonburi 
(n=114) 
97 17 85 29 
Pharmacy 
type 
Chain 
(n=139) 
94 45 
0.001*** 
111 28 
0.066* 
Individual 
(n=233) 
193 40 165 68 
Postgraduate 
degree 
None 
(n=276) 
196 80 
0.000*** 
PG 
(n=96) 
91 5 
*=significant at p-value <0.1, **=significant at p-value <0.05, ***=significant at p-value <0.01 
Table 22: Relationship of pharmacy qualification among other demographics 
Gender: The participants who graduate with BPharm are typically female (n=208, 55.9%). Male 
pharmacists represent 38% (n=33) of the PharmD pharmacists.  
Location: The proportion of PharmD pharmacists who work in Bangkok is higher than those who 
work in Chonburi. There are 68 pharmacists who work in Bangkok holding a PharmD degree (26.36 
%) whereas Chonburi has only 17 PharmD pharmacists, or 14.91% of participating pharmacists 
from the province.  
Pharmacy type: PharmD pharmacists are likely to work in chain store pharmacies. 32.75% of 
BPham pharmacists (n=94) work in chain stores but more than 52% of PharmD pharmacist work in 
this pharmacy type. As a result of postgraduate degree, 29.18% (n=68) of pharmacists who work 
in stand-alone pharmacies hold postgraduate degree, this higher than pharmacists who work in 
chain pharmacies (20.14%, n=28).   
Postgraduate degree: Pharmacists who graduate with a BPharm are more likely to pursue a 
postgraduate qualification compared to PharmD pharmacists. There are 91 BPharm pharmacists 
(31.7%) with a postgraduate qualification but only 5 PharmD pharmacists (5.89%) have a 
postgraduate degree.  However, as results of statistical analysis, gender, location and pharmacy 
type are not statistically different in relation to postgraduate qualifications.  
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Pharmacy type and location 
 The results show that Bangkok has more chain store pharmacies than Chonburi province.  
Gender representation does not vary with pharmacy type and the location. Results are shown in 
table 23.   
Demographics 
Pharmacy Type Location 
Chain 
(n=139) 
Individual 
(n=233) 
p-value 
Bangkok 
(n=258) 
Chonburi 
(n=114) 
p-value 
Gender 
Male 
(n=112) 
41 71 
0.907 
79 33 
0.807 
Female 
(n=260) 
98 162 179 81 
Locations 
Bangkok 
(n=258) 
111 147 
0.001*** 
  
 
Chonburi 
(n=114) 
28 86 
  
***=significant at p-value <0.01 
Table 23: Relationship of pharmacy type and location among other demographics 
Location: Though pharmacists typically work at individual pharmacies in the both cities, the 
reported proportion of chain stores in each city is different. Bangkok respondents show 111 
pharmacists working in chain stores (that is 43% of Bangkok pharmacists) while, in Chonburi, only 
24.56% of respondents (n=28) work in work in chain stores.  However, location of pharmacy has 
no statistical different in comparison to gender. 
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Characteristics and knowledge score   
Results show that PharmD degree and chain store pharmacist have better knowledge than 
another compared group. Knowledge score and demographic data were compared to examine 
demographic factors that would influence knowledge of pharmacists in antimicrobial use and 
resistance. Results of each demographic and knowledge score are shown in table 24.  
Demographics 
Knowledge score 
Median (IQR) mean rank p-value 
Gender a 
Male (n=112) 
Female (n=260) 
7 (2) 
6 (1) 
197.49 
181.77 
0.183 
Age b 
lower than 30 yrs. (n=145) 
30-40 yrs.  (n=185) 
over than 40 yrs. (n=42) 
7 (2) 
6 (1) 
7 (1) 
196.18 
179.96 
181.90 
0.358 
Age a 
lower than 30 yrs. (n=145) 
30-40 yrs.  (n=185) 
7 (2) 
6 (1) 
173.51 
159.22 
0.165 
lower than 30 yrs. (n=145) 
over than 40 yrs. (n=42) 
7 (2) 
7 (1) 
95.67 
88.25 
0.421 
30-40 yrs.  (n=185) 
over than 40 yrs. (n=42) 
6 (1) 
7 (1) 
113.74 
115.15 
0.896 
Degree a 
B Pharm (n=287) 6 (1) 180.96 0.060* 
PharmD (n=85) 7 (2) 205.22  
Postgrad a 
None (n=276) 
PG degree (n=96) 
7 (1) 
6 (1) 
190.06 
176.26 
0.265 
Experience b 
less than 5 yrs. (n=180) 
5-10 yrs. (n=152) 
more than 10yrs. (n=40) 
6.5 (2) 
6 (1) 
6.5 (1) 
183.24 
189.92 
188.24 
0.840 
Experience a 
less than 5 yrs. (n=180) 
5-10 yrs. (n=152) 
6.5 (2) 
6 (1) 
163.69 
169.82 
0.551 
less than 5 yrs. (n=180) 
more than 10yrs. (n=40) 
6.5 (2) 
6.5 (1) 
110.05 
112.54 
0.818 
5-10 yrs. (n=152) 
more than 10yrs. (n=40) 
6 (1) 
6.5 (1) 
96.600 
96.11 
0.959 
Location a 
BKK (n=258) 
CHON (n=114) 
7 (1) 
6 (1) 
189.10 
180.61 
0.470 
Type a 
Chain (n=139) 
Individual (n=233) 
7 (2) 
6 (1) 
199.18 
178.94 
0.071* 
a = Mann- Whitney U test, b= Kruskal Wallis H test, *=significant at p-value < 0.1 
Table 24: Relationship of knowledge score and demographic data.  
Pharmacy degree: PharmD degree graduates demonstrate a higher knowledge score 
(meanrank=205.22) compared to BPharm degree graduation (mean rank=180.96).  It is a statistically 
significant difference at p-value=0.060.  
Type of pharmacy:  Chain store pharmacists (mean rank=199.18) have better knowledge 
compared to individual store pharmacists (mean rank=178.94). It is a statistically significant 
difference at p-value=0.071. 
 67 
 
Characteristics and knowledge type 
350 of participant were judged as having a good knowledge in antimicrobial resistance and 
use (94% of participants). The results indicate that pharmacists’ characteristics (demographics) do 
not affect participants’ knowledge. The total knowledge score of each participant was classified 
into two types, poor- and good knowledge in antimicrobial resistance. Chi- square test was 
employed for analysis with 95% Confidence Interval. The results are shown in table 25.  
Demographics 
Knowledge type 
Poor (n) Good (n) 
p-value 
22 350 
Gender 
Male (n=112) 
Female (n=260) 
6 
16 
106 
244 
0.817 
Age 
lower than 30 yrs. (n=145) 
30-40 yrs.  (n=185) 
over than 40 yrs. (n=42) 
12 
7 
3 
133 
178 
39 
0.238 
Pharmacy Degree 
B Pharm (n=287) 
PharmD (n=85) 
16 
6 
271 
79 
0.794 
Postgraduate degree 
None (n=276) 
PG degree (n=96) 
18 
258 
4 
92 
0.464 
Experience 
less than 5 yrs. (n=180) 
5-10 yrs. (n=152) 
more than 10yrs. (n=40) 
13 
6 
3 
167 
146 
37 
0.412 
Location 
BKK (n=258) 
CHON (n=114) 
17 
5 
241 
109 
0.482 
Type 
Chain (n=139) 
Individual (n=233) 
6 
16 
133 
217 
0.370 
Table 25: Relationship of knowledge types and demographic data. 
 
  
 68 
 
Characteristics and attitude score   
Results demonstrate that type of pharmacy degree, pharmacy ownership, and experience 
seem to affect the attitude score. PharmD graduates, chain store pharmacists and experienced 
pharmacists have a better attitude. 
Demographic data and attitude score were analysed by Mann-Whitney U test and Kruskal-
Wallis H test for comparing a various group of demographics. It can examine how various 
demographic data relate to the attitude score (Table 26).   
Demographics Attitude score 
Median (IQR) mean rank p-value 
Gender a 
Male (n=112) 
Female (n=260) 
29 (5) 
28 (5) 
185.50 
186.93 
0.905 
Age b 
lower than 30 yrs. (n=145) 
30-40 yrs.  (n=185) 
over than 40 yrs. (n=42) 
29 (4) 
28 (5) 
29 (6) 
196.18 
178.63 
199.12 
0.350 
Age a 
lower than 30 yrs. (n=145) 
30-40 yrs.  (n=185) 
29 (4) 
28 (5) 
172.89 
159.71 
0.211 
lower than 30 yrs. (n=145) 
over than 40 yrs. (n=42) 
29 (4) 
29 (6) 
93.00 
97.45 
0.637 
30-40 yrs.  (n=185) 
over than 40 yrs. (n=42) 
28 (5) 
29 (6) 
111.92 
123.17 
0.314 
Degree a 
B Pharm (n=287) 
PharmD (n=85) 
28 (4) 
30 (2) 
177.77 
215.99 
0.004*** 
Postgrad a 
None (n=276) 
PG degree (n=96) 
29 (5) 
28 (5) 
187.12 
184.71 
0.849 
Experience b 
less than 5 yrs. (n=180) 
5-10 yrs. (n=152) 
more than 10yrs. (n=40) 
28 (4) 
28 (5) 
31 (5) 
182.90 
178.96 
231.34 
0.019** 
Experience a 
less than 5 yrs. (n=180) 
5-10 yrs. (n=152) 
28 (4) 
28 (5) 
168.38 
164.28 
0.697 
less than 5 yrs. (n=180) 
more than 10yrs. (n=40) 
28 (4) 
31 (5) 
105.02 
135.14 
0.007*** 
5-10 yrs. (n=152) 
more than 10yrs. (n=40) 
28 (5) 
31 (5) 
91.18 
116.70 
0.01** 
Location a 
BKK (n=258) 
CHON (n=114) 
28 (5) 
29 (5) 
188.84 
181.21 
0.528 
Type a 
Chain (n=139) 
Individual (n=233) 
29 (4) 
28 (5) 
206.16 
174.77 
0.006*** 
a = Mann- Whitney U test, b= Kruskal Wallis H test 
**=significant at p-value <0.05, ***=significant at p-value <0.01 
Table 26: Relationship of attitude score and demographic data.  
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Results of a median score in each various group show that most participants in each group 
have a total attitude score over the midpoint (24). Most participants have a good attitude in 
antimicrobial resistance and use. Moreover, there are significant differences in relation to pharmacy 
degree types, experience range, and type of pharmacies.   
Pharmacy degree: There is a significant statistical difference in attitude score between participants 
with BPharm and PharmD (p-value 0.004).  The results show that mean rank of PharmD group is 
215.99, which is higher than BPharm group (mean rank=177.77). As well as the median score, 
BPharm participants have a median score of 28 while PharmD graduates obtained a score of 30. It 
can be seen that the pharmacists who graduated with PharmD degree had a better attitude 
compared to pharmacists with BPharm.  
Experience: Experience affects the attitude score of participants. The H test shows that there is a 
difference in the attitude score of all experience ranges by p=value =0.019. When the data were 
analysed by the U test in each two groups, it shows that people with extensive experience differ 
from others. The long experience group (mean rank=135.14) has a better attitude compared to least 
experienced group (mean rank=105.02) by p-value= 0.007. Also, the long experience group (mean 
rank=116.70) has a better attitude score when compared with pharmacists with 5-10 years’ 
experience (mean rank=91.18) by p-value = 0.01.  
Pharmacy type: The pharmacists who work in different type of pharmacies are significantly 
different in their total attitude score. People who work in individual pharmacy (mean rank=174.77) 
have a lower attitude score than chain store workers (mean rank=206.16) by p-value= 0.006.   
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Characteristics and attitude type  
93.28% (n=347) of participants were classified as having a good/ positive attitude in 
antimicrobial use and resistance. Age, pharmacy degree, location and pharmacy type affect the 
attitude score of participants in antimicrobials use and resistance. The young pharmacists, PharmD 
graduates, working in Bangkok and chain store have a good/ positive attitude compared to others.   
To clearly describe the relationship between attitude and demographics, Chi-square test 
was used to analyse the attitude towards antimicrobials use and resistance in relation to diverse 
demographic data. The results are presented in table 27. 
Demographics 
Attitude type 
Poor (n) Good (n) 
p-value 
25 347 
Gender 
Male (n=112) 
Female (n=260) 
9 
16 
103 
244 
0.653 
Age 
lower than 30 yrs. (n=145) 
30-40 yrs.  (n=185) 
over than 40 yrs. (n=42) 
5 
13 
7 
140 
172 
35 
0.011** 
Pharmacy Degree 
B Pharm (n=287) 
PharmD (n=85) 
24 
1 
263 
84 
0.023** 
Postgraduate degree 
None (n=276) 
PG degree (n=96) 
15 
10 
261 
86 
0.101 
Experience 
less than 5 yrs. (n=180) 
5-10 yrs. (n=152) 
more than 10yrs. (n=40) 
9 
12 
4 
171 
140 
36 
0.413 
Location 
Bangkok (n=258) 
Chonburi (n=114) 
13 
12 
245 
102 
0.070* 
Type    
Chain (n=139) 
Individual (n=233) 
5 
20 
134 
213 
0.085* 
*=significant at p-value <0.1, **=significant at p-value <0.05 
Table 27: Relationship of attitude types and demographic data.  
Age: Age groups significantly differ in their attitude score with p-value = 0.11. It appears that the 
younger the pharmacist, the better their attitude score.  
Pharmacy degree:  Pharmacists graduating with PharmD are more likely to have a better attitude 
towards antimicrobial use and resistance compared to BPharm graduates. 
Location: Pharmacists working in Bangkok have a significantly different (and better) attitude 
compared to their colleagues in Chonburi with a p value of p-value 0.070.   
Type of pharmacy: 96.4% (n=134) of chain store pharmacists were have a good attitude towards 
antimicrobial use and resistance compared to pharmacists working in individual/ independent 
pharmacies.  
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Characteristics and practice score    
Male gender and PharmD qualification are characteristics that relate to a higher practice 
score, while experience between 5 to 10 years relates to a lower practice score. Results of median 
score and p-value of Mann-Whitney U test and Kruskal- Wallis H test to compare practice score in 
each group of demographics are shown in table 28.   
Demographics 
Practice score 
Median (IQR) mean rank p-value 
Gender a 
Male (n=112) 
Female (n=260) 
38 (7) 
36 (6) 
204.97 
173.54 
0.029** 
Age b 
lower than 30 yrs. (n=145) 
30-40 yrs.  (n=185) 
over than 40 yrs. (n=42) 
36 (6) 
37 (6) 
36 (8) 
189.59 
188.66 
166.29 
0.430 
Age a 
lower than 30 yrs. (n=145) 
30-40 yrs.  (n=185) 
36 (6) 
37 (6) 
165.97 
165.14 
0.937 
lower than 30 yrs. (n=145) 
over than 40 yrs. (n=42) 
36 (6) 
36 (8) 
96.63 
84.93 
0.216 
30-40 yrs.  (n=185) 
over than 40 yrs. (n=42) 
37 (6) 
36 (8) 
116.53 
102.86 
0.222 
Degree a 
B Pharm (n=287) 
PharmD (n=85) 
37 (7) 180.86 
205.55 
0.062* 
37 (6) 
Postgrad a 
None (n=276) 
PG degree (n=96) 
37 (6) 
36 (7) 
188.41 
181.01 
0.560 
Experience b 
less than 5 yrs. (n=180) 
5-10 yrs. (n=152) 
more than 10yrs. (n=40) 
37 (7) 
36 (6) 
36 (7) 
198.93 
178.96 
231.34 
0.091* 
Experience a 
less than 5 yrs. (n=180) 
5-10 yrs. (n=152) 
37 (7) 
36 (6) 
175.85 
155.43 
0.053* 
less than 5 yrs. (n=180) 
more than 10yrs. (n=40) 
37 (7) 
36 (7) 
113.58 
96.64 
0.127 
5-10 yrs. (n=152) 
more than 10yrs. (n=40) 
36 (6) 
36 (7) 
97.25 
93.64 
0.714 
Location a 
Bangkok (n=258) 
Chonburi (n=114) 
37 (6) 
37 (7) 
189.04 
180.75 
0.492 
Type a 
Chain (n=139) 
Individual (n=233) 
36 (5) 
37 (7) 
180.36 
190.16 
0.394 
a = Mann- Whitney U test, b= Kruskal Wallis H test 
*=significant at p-value <0.05 
Table 28: Relationship of practice score and demographic data.  
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Gender: Male pharmacists obtained a higher practice score (mean rank= 204.97) compared to 
female pharmacists (mean rank =173.54) at a statistically significant p-value of 0.029. 
Pharmacy degree: PharmD degree group (mean rank= 205.55) has a higher practice score than 
the BPharm group (mean rank= 180.86) with statistically significant difference at p-value of 0.062.  
Experience: The Kruskal- Wallis H test shows that there is at least one group with a statistically 
significant difference among the three groups at p-value= 0.091. It demonstrates that the group of 
5 to 10 years’ experience has the lowest mean rank = 178.96. The Mann-Whiteney U test was 
employed to explore the relationship between the groups. The results show that there is significant 
difference between the least experienced group (mean rank= 175.85) and the 5-10 years’ 
experience group (mean rank= 155.43) at p-value= 0.053.   
Characteristics and practice type  
 More than 93% of pharmacists have a good practice in antimicrobial use and resistance. 
According to the chi-square test, it shows that there is no significant difference between practice 
type and demographics as p-value >0.05. The results are shown in table 29. 
Demographics 
Practice type 
Poor (n) Good (n) 
p-value 
25 347 
Gender 
Male (n=112) 
Female (n=260) 
6 
19 
106 
241 
0.515 
Age 
lower than 30 yrs. (n=145) 
30-40 yrs.  (n=185) 
over than 40 yrs. (n=42) 
6 
16 
3 
139 
169 
39 
0.263 
Pharmacy Degree 
B Pharm (n=287) 
PharmD (n=85) 
21 
4 
266 
81 
0.471 
Postgraduate degree 
None (n=276) 
PG degree (n=96) 
18 
7 
258 
89 
0.814 
Experience 
less than 5 yrs. (n=180) 
5-10 yrs. (n=152) 
more than 10yrs. (n=40) 
10 
10 
5 
170 
142 
35 
0.310 
Location 
BKK (n=258) 
CHON (n=114) 
17 
8 
241 
106 
1.000 
Type    
Chain (n=139) 
Individual (n=233) 
6 
19 
133 
214 
0.200 
Table 29: Relationship of practice types and demographic data. 
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CHAPTER 6 
DISCUSSION AND CONCLUSION 
Antimicrobial resistance is a major threat to public health. Community pharmacists, among 
other healthcare professionals are expected to provide antimicrobials appropriately and take apart 
in antimicrobial stewardship initiatives. This study aims to assess community pharmacists’ 
knowledge, attitudes, and practice regarding non-prescription antimicrobial use and resistance in 
Thailand, where antimicrobial resistance levels are high, and evidence of antimicrobial stewardship 
practices are scarce. This research was conducted using a self-administrated online questionnaire 
to community pharmacists in Bangkok and Chonburi province. This research is the first study of 
antimicrobial stewardship in community pharmacists since the launch of the national strategy to 
combat antimicrobial resistance and its implementation in this sector. The main findings indicate 
that community pharmacists have a good knowledge, attitude, and practice regarding antimicrobial 
use and resistance. Although antimicrobial agents can legally be dispensed without a prescription 
in Thailand, almost all participating pharmacists reported can providing antimicrobials appropriately. 
Pharmacists further stated that the main reason for providing antimicrobials without prescription is 
due to pharmacists’ confidence in their competence. Furthermore, encountered infectious disease 
and commonly dispensed antimicrobials in pharmacies are important surveillance data of resistant 
pathogens in the country. This study demonstrates that community pharmacists are essential in 
initiatives to combat antimicrobial resistance. They are competent to provide quality service to 
patient as well as other healthcare professionals, however, antimicrobial stewardship in community 
pharmacy requires improvement.   
This chapter will discuss and provide evidence to support the findings of this research.  
Pharmacists’ knowledge, attitude and practice regarding antimicrobial use and resistance will be 
examined firstly. Then, a discussion of pharmacist attitude in antimicrobial resistance will be 
presented. Circumstances in community pharmacy to dispense antimicrobials without prescription 
will be discussed as well as pharmacists’ stewardship practices. Suggestions and implications of 
this research will also be discussed, and the study limitations will be highlighted.   
.   
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Current situation of antimicrobial provision in community pharmacy 
Encountered infections and dispensed antimicrobials in community pharmacy  
This research indicates that most encountered infectious case is respiratory infections, skin 
and soft tissue infection included wounds, and urinary infection. It seems that the pharmacists report 
bacterial infections as common and occasionally reported in viral or fungal infections. Associated 
with results of dispended antimicrobial, the most antimicrobial that dispensed in pharmacy is 
antibiotics while less than 2% of pharmacists replied to antivirals and antifungals. It is clear that 
pharmacists familiar with bacterial infections than other infections. It might be a reason of uncertain 
in in terms of “Superbugs”. The results in knowledge section show that more than 50% of 
pharmacists were not sure that resistant microorganisms could include bacteria, fungal, viral and 
parasite (WHO, 2015b; WHO, 2016). This is consistent with existing evidence support that 
community pharmacy reports being mostly faced with bacterial infections (Morgan et.al, 2011; 
Roque et.al, 2015; Yakimova, 2015).  
However, knowledge of fungal, parasite and viral infections needs to be improved. Malaria, 
HIV and TB infections have a serious prevalence of resistance to their medicine (WHO, 2016) 
though it not commonly presented in community pharmacy. Also, resistance in Influenza can exist 
in community pharmacy which appears as common cold or flu case. Hence, awareness of 
community pharmacists to antimicrobial resistance needs to span beyond bacterial infections. Other 
resistant diseases such HIV, TB, malaria, and influenzas can be prevented through stewardship 
practices of community pharmacists. They could educate patients who are at risk, or refer patients 
to suitable healthcare service. 
Antimicrobial consumption in pharmacies 
The results of dispensed antimicrobials in community pharmacies show that 
aminopenicillin, fluoroquinolone, and penicillinase resistance penicillin are generally provided in 
Thailand. The results are similar to information on database of CDDEP and national surveillance 
data (CDDEP, 2016; NARST, 2016). However, the database shows that cephalosporin is usual use 
in Thailand, but this study shows it was dispensed only 0.7%. Penicillin and cephalosporin are 
similar in structure and indication and have cross interaction of roughly 10% (Campagna et.al, 
2012). Most pharmacists aware this problem as shown in the knowledge section of the 
questionnaire. This might be a reason why pharmacists are no longer dispensing it.  
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Reason of dispense non-prescription antimicrobials 
This research investigates reasons of dispensing antimicrobials without prescription and 
show that medication law in country is one of reasons to affect them to practice. Furthermore, the 
community pharmacists responded that they have competency to treat common infection and their 
pharmacy is convenience to access healthcare service. It is not amazements in Thailand where 
have no prescription law and pharmacists can dispense medications by legal). The main role of 
community pharmacist is dispensing medications to patients both prescription and non-prescription 
and pharmacist perform triage and provide medication to patients. (Saramunee et. al, 2011; 
Chiyakunapruck, et.al, 2016).  
Business pressures may influence pharmacists’ provision of antimicrobials without a 
prescription (Khan et.al, 2016). 1.4% of participants replied that they dispense antimicrobials 
because of business benefit. However, the Good Pharmacy Practice (GPP) law has strictly 
controlled community pharmacy since 2014 in Thailand (Wuttipanich & Kitisopee, 2015). The law 
and professional ethics obligate appropriate practice.  Furthermore, this study finds that more than 
90% of pharmacists have good knowledge, attitude, and practice in relation to antimicrobial 
resistance and use.  
Community pharmacists’ knowledge, attitude, and practice to combat antimicrobial 
resistance. 
Knowledge and practice of community pharmacists towards antimicrobial use and 
resistance 
Community pharmacists in this study have a good knowledge, attitude, and practice to 
combat antimicrobial resistance and provision. These results concur with other studies that exist in 
many countries which indicates community pharmacists have proper knowledge, positive attitude, 
and appropriate practice in antimicrobial use and resistance (Saengchareon et.al,2008; Roque 
et.al, 2015; Khan et.al,2016). Nevertheless, these results are different from earlier findings in 
Thailand which used similar scenarios to evaluate community pharmacist’s knowledge and practice 
(Apisarnthanarak et.al, 2008; (Saengchareon et.al, 2010). A study of Apisarnthanarak and 
colleagues about antibiotic use in Thai pharmacies was conducted in 2008. The study results show 
that most pharmacies provided inappropriate antibiotics to patien ts. Also, around 24% of 
pharmacists were identified as having inadequate knowledge (Apisarnthanarak et.al, 2008). 
Similarly, a study of childhood diarrhoea management in pharmacies in Thailand indicates that 
practice and attitude of pharmacy workers were inappropriate (Saengchareon et.al, 2010).   
However, the research discussed that pharmacies where performed by pharmacist had better 
management and service than others. History taking and low adherence with local guideline have 
been highlighted as major problems in the previous study. In contrast with the prior studies, nearly 
all pharmacists in this research show that they take patient’s history and explore clinical information 
before dispensing antimicrobials as well as follow local antimicrobials guideline. Also, the 
pharmacists could identify appropriate use of antimicrobials in non-bacterial respiratory infections, 
wound treatment, and diarrhoea.  Appropriate antimicrobial use campaigns in Thailand have been 
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overwhelming for several years. Community pharmacists can access many resources to improve 
their knowledge on antimicrobial resistance and use. The pharmacists can access continuing 
education through conferences, workshops as well as online education. In this study, the 
participants replied that they do not lack education in this area.  Moreover, a campaign to improve 
antibiotic use in community pharmacy has been launched since 2012 (CPA, 2012). Although the 
campaign is only a pilot project, many resources such as literature, leaflets, and guidelines have 
been widely available. It can support pharmacists to improve their knowledge and practice. 
Attitude and practice of community pharmacists towards antimicrobial use and resistance 
The pharmacists agree that resistance affects public health, and antimicrobial use in human 
and animals can increase the risk of resistance which is similar to findings by Roque et al., 2015.  
However, they do not believe that new antimicrobial agents will solve the resistance issue. The 
pharmacists do not expect developing new drugs because Thailand cannot generate new medicine 
given lack of resources and skills. Also, new antimicrobials might also face resistance once used in 
the country. Here, developing new antimicrobials might not be a priority for the pharmacists to 
combat antimicrobial resistance.  
Although the pharmacists agree that dispensing antimicrobials without prescription is 
significant issue, most of them accept to prescribe it in practice. Most participants agree with 
negative attitude statements that antimicrobials sometime could dispense to patient because 
patients have neither time nor money to meet physician and medical service is difficult to obtain. It 
similar as pharmacists in previous study in Portugal to dispense antibiotic without prescription to 
patient because of these problems (Rogue et.al, 2015).  However, in practice assessment, the 
pharmacists present their good practice in both antimicrobial stewardship and provision. The results 
of these can show that community pharmacist in Thailand perform appropriated use and awareness 
in resistance of antimicrobials in practical although have no prescription system in Thailand. It 
follows a statement of International Pharmaceutical Federation (FIP) regarding antimicrobial 
stewardship in community pharmacy (FIP, 2015) 
Interdisciplinary collaboration could to improve antimicrobials combating 
In term of healthcare collaboration, over than 50% of participants reported that they have 
no chance collaborate with other health professional for antimicrobial stewardship. It is difference 
with study in Malaysian pharmacists in previous study (Khan et.al, 2016). It would be an outcome 
of prescription system do not imply in Thailand while Malaysia more strictly control.   As result, the 
pharmacists refer that physician dose not send prescription to pharmacies and influence them to 
dispense antimicrobials without prescription. This situation can reduce relationship between 
pharmacist and physician. It might affect to quality of service and patients’ safety. However, there 
are some activities can increase collaboration between community pharmacists and other 
healthcare profession. Model of community pharmacy in health promotion and disease prevention 
can use to increase collaboration with other healthcare providers (Tunpichart et.al, 2012; 
Chiyakunapruck et.al, 2016).  Community pharmacists could have collaborated with physician to 
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discuss patients’ problems and referral. Moreover, participating with public health campaign to 
combat antimicrobial resistance can induce opportunity to work with other healthcare providers. 
Relationship of community pharmacists’’ knowledge, attitude and practice in antimicrobial 
use and resistance.  
The correlation results show that knowledge score and attitude score of the pharmacists do not 
correlate and there is a weak relationship between attitude and practice scores. This is consistent 
with a previous study in pharmacy students which showed none and/ or a slight   relationship 
between the three dimensions (Khan et.al, 2014).  However, other influencing factors outside the 
KAP model could affect to pharmacists’ practice, including medication regulations, health system 
and patients’ pressure. Although, the KAP model dose not explain pharmacists’ behaviour, it is a 
useful tool to measure pharmacists practice (Vandamme, 2009).  
Relationship between characteristic and Knowledge, attitude, and practice of 
community pharmacists on antimicrobial use and resistance. 
Pharmacy degree associate with antimicrobial use and resistance 
This study finds that pharmacy qualification influences of knowledge, attitude, and practice 
score increasing in the pharmacists, but it is significant in type of positive attitude only. According 
to socio-economic data of community pharmacists in this research, the increase in the new 
generation of pharmacists (PharmD) is a result of pharmacy education programme reforms in 
Thailand, changing from a 5 years programme, bachelor’s degree to 6 years programme in a doctor 
of pharmacy programme. They are expected to be professionally “more” competent in clinical 
practice (Pongcharoensuk & Prakongpan, 2012; Chanakit et.al, 2015).  A prior study in Thailand 
shows that changing of pharmacy curriculum does not affect to pharmacists practice in antimicrobial 
use for diarrhoea treatment. (Saengchareon et.al,2010). However, the curriculum revision in the 
previous research was a five-year programme (BPharm) curriculum but this research considers 
between BPharm and PharmD programme which comes with enhanced clinical practicing in final 
year of study. These results are similar to previous research comparing BPharm and PharmD 
students in India. The research indicates that PharmD students have a more positive attitude 
towards antibiotic use compared to non-PharmD students (Ahmad et.al, 2015).  Nevertheless, the 
results show that PharmD and BPharm degree pharmacists do not differ in type of knowledge and 
practice in antimicrobial use and provision. They both could provide antimicrobials appropriately to 
their patients.  
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Pharmacy ownership associate with antimicrobial use and resistance 
Type of pharmacy ownership associated with knowledge, and attitude. The results show 
that pharmacists who in chain store have more knowledge and attitude scores than others. It seems 
similar with pharmacy degree because newly graduated pharmacists who mostly hold a PharmD 
degree are more likely to practice in a chain-store. Proportion of pharmacy workforces in chain and 
independent stores has changed for over the years. It is the outcome of chain-store pharmacies 
growth particularly in urban areas.  Chain store pharmacies made up around 3% all pharmacies in 
2011 (Saramunee et.al,2011), and this has increased to10% in 2015 (Kasikorn Research Center, 
2015). However, urban areas such as Bangkok would have a higher proportion of chain pharmacies 
compared to other cities. This research indicates that 29.8% of pharmacists work in chain-stores in 
Bangkok compared to 7.5 % in Chonburi. This may be attributed to lack of experience and lack of 
financial budgets to support opening their independent pharmacies.  
Although there are other factors can influence attitude and practice score but it not 
significant in practical. Extensive experience of participants shows better attitude and practice score 
than others, and male group shows significant practice score than female. Yet, they are not 
significantly when classified type into good or poor attitude and/or practice. So, pharmacists who 
extensive experience and male pharmacists could provide proper practice in antimicrobial 
provision.  
Implications 
 The results of this research confirm that although community pharmacists provide 
antimicrobials without a prescription, they are competent to ensure appropriate use of antimicrobials 
and reduce resistance. However, there are issues that need to be considered in future studies in 
relation to inter-professional collaboration and adherence to antimicrobial stewardship guideline. 
The results would be advantageous at many levels including individual, organisation and policy 
levels.  
 Individual level: Although this study shows that most community pharmacists have good 
knowledge, attitude, and practice, they still need to be evaluated to ensure up-to-date knowledge, 
sustain competence in practice, and ensure a positive attitude towards appropriate antimicrobial 
use and resistance. Findings of this study recommends that community pharmacist.  
• Improve their understanding of antimicrobial use and resistance issues through training, 
multi-professional workshops, continuing education, and online resources 
• Update surveillance data and resistance issues in country 
• Adhere to local antimicrobial guidelines 
• Educate and motivate patients to increase awareness of appropriate antimicrobial use and 
resistance 
• Participate in local and national campaigns regarding antimicrobial resistance 
• Collaborate with other healthcare providers to improve services such as referral and clinical 
consultations.  
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Organisation level: Pharmacy association is an important player, with the responsibility to 
improve, support and motivate their pharmacy members to engage in antimicrobial resistance 
combatting. The association could generate activities to support members through:    
• Providing training, workshops, continuing education in appropriate antimicrobial use and 
resistance, and antimicrobial stewardship programmes for pharmacists.  
• Support research in antimicrobial use and resistance in community pharmacy through 
funding, databases access, and research training.  
• Support resources such as booklets, e-resources and campaign literature to promote 
appropriate antimicrobial use and resistance. 
• Reward pharmacist(s) who act as role models to improve antimicrobial use and resistance 
in community pharmacy.   
• Produce professional guidelines in antimicrobial stewardship for community pharmacy that 
take into account the role of pharmacists and pharmacy workers.  
• Promote campaigns to improve public awareness in antimicrobial resistance and support 
antimicrobial provision in community pharmacy.  
• Collaborate with other healthcare professional associations and public communities to 
improve healthcare service and management in term of infection control and the issue of 
antimicrobial resistance.  
National level: National strategies and policies directly affect community pharmacy 
practice. Government and policy makers could support pharmacists’ role to ensure appropriate use 
of antimicrobials and combat resistance through: 
• Providing national strategies and an action plan to combat antimicrobial resistance that is 
relevant and accessible to the public and healthcare professionals  
• Supporting national research grants and funding to explore and follow up the situation of 
antimicrobials use and resistance.  
• Supporting and maintaining currency of national surveillance programme and 
antimicrobial use databases.  
• Communicating with healthcare professionals including community pharmacists to 
develop or improve strategies regarding antimicrobial use and resistance and set up plans 
to move these efforts forward.  
• Debating the non-prescription use of antimicrobial use and amend current regulations to 
reduce inappropriate use of antimicrobials and reduce the spread of resistance in the 
country.  
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Strengths and Limitations 
 The strength of this research is that it fulfils understanding of antimicrobial stewardship in 
community pharmacy in Thailand. It can be baseline evidence for future research which will be 
conducted after the implementation of the national strategic plan on antimicrobial resistance from 
2017 to 2021 (MOPH & MOAC, 2017).  
This study employed multiple choices questions to explore current knowledge, attitude, and 
practice of pharmacists combined with open-ended questions to explore the current situation in 
community pharmacies. It would beneficial to examine causes and effects of knowledge, attitude, 
and practice of participants. Moreover, relationship within knowledge, attitude, and practice (KAP) 
model were calculated to assure theory of the model.  
 There may be other factors that could influence pharmacists’ actual practice besides their 
knowledge and attitude which is captured through the KAP model. Regulations and policies could 
affect pharmacists practice in antimicrobial provision. Further, accessing educational resource 
might affect their knowledge, attitude, and practice. This could be explored in future studies to 
understand the impact of training and pharmacists KAP.  
  Although Bangkok and Chonburi province cover around 30% of pharmacies in country, it 
may not represent the current situation in other provinces especially in rural areas. The rural areas 
could be different in terms of the encountered infections, the dispensed antimicrobials, and the 
reasons to dispense antimicrobials without a prescription. They would have other reasons in relation 
to affordability of medicines that need to consider.  However, all community pharmacists are 
expected by law to have a good knowledge, a good positive attitude, and appropriate practice in 
antimicrobial use and resistance. The expectations are not specific to geography/ location, or 
practice area, thus, the two provinces could represent an overview of community pharmacists in 
Thailand in relation to this issue.  
This study recruited participants through online communities, email and social media. 
Some of the potential participants might not have been invited to participate if they cannot access 
online platforms, particular the older participants.  
Further, this study does not assess antimicrobials dispensing such as appropriateness of 
dosage regimens and patient counselling in pharmacy practice. This may need to be measured in 
future studies. 
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Conclusion 
 Antimicrobial resistance is increasing worldwide especially that antimicrobials consumption 
continues to escalate. This problem can damage public health and increase economic burden. 
(WHO,2016).  It is estimated that around 700,000 people a year die as a result of infections and 
this might rise to 10 million people in 2050, and a loss of $60 to $100 trillion (O’Nell et.al,2014). In 
Thailand, antimicrobial resistance infections cause 3.24 million additional hospitalisation days and 
38,481 deaths annually (Pumart et.al, 2012).  
Community pharmacists are expected to ensure appropriate use of medicines and health 
information for patients, carers and the general public (FIP,2015). They are very important to push 
forward antimicrobial resistance containment and reduce antimicrobial resistance emergence in 
primary care (FIP,2015). Previous studies indicate that community pharmacists had inadequate 
knowledge, poor attitude, and malpractice in antimicrobial use and resistance (Apisanthanarak et.al 
2008; Saengcharoen & Lerkiatbundit, 2010; Puspitasari et.al, 2011). However, these studies were 
conducted several years ago before policies, professional standards, and education in community 
pharmacy transformed; these recent changes include changing the pharmacy education system, 
introducing the good pharmacy practice law, and various national strategies to combat antimicrobial 
resistance.  Further, prior research in Thailand discussed the need for pharmacists’ knowledge to 
improve without actually assessing their knowledge.   
This research aimed to assess knowledge, attitude and practice of community pharmacists 
in Thailand regarding non-prescription antimicrobial use and resistance through the knowledge, 
attitude and practice model. This research is a cross-sectional descriptive study using a self-
administered questionnaire. The population in this study is community pharmacists working in 
Bangkok and Chonburi province in Thailand which have 5082 pharmacies and cover 33% of 
pharmacies in Thailand. The sample size calculation required a minimum of 358 participants. This 
research was granted ethical approval by the University of Hertfordshire under protocol number: 
LMS/PGR/UH/02811 
The self- administrative questionnaire was developed from a literature review and 
constructed using the knowledge, attitudes and practice model.  The questionnaire was divided into 
4 sections; demographic data, knowledge, attitude and practice which included open-end questions 
about the current situation of antimicrobial provision in community pharmacy. It was validated by 
three experts in antimicrobial stewardship and community pharmacy services. Also, its reliability 
was assessed in relation to consistency and reproducibility in a pilot test with 15 community 
pharmacists. The results of validation and reliability testing show that the questionnaire can be an 
appropriate measurement tool. The final questionnaire contains 35 items.   
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The Statistic Package for the Social Science (SPSS) software version 24 was used for 
analysis. Descriptive statistical analysis was done through the mean, standard diviation (SD), 
median, inter quartile (IQR). Mann-Whitney U Test and Kruskal-Wallis H test were applied for 
comparison of knowledge, attitude, and practice score with characteristics. Chi-square test was 
used to compare factors. Relationship of the three dimensions of the KAP model was analysed 
through Spearman rho correlation coefficient analysis. The open-end questions were analysed 
using coding technique and were presented as percentages.  
521 community pharmacists were invited to access an online questionnaire between 9 May 
2017 and 7 July 2017 (60 days). 372 pharmacists completed the questionnaire and met the 
inclusion criteria, achieving 71% response rate. The age average of participants was 32.02 (± 5.81) 
years and the experience average was 5.46 (± 4.31) years. The majority of participants were female 
(69.9%), graduated with a Bachelor of pharmacy (77.2%), and 62.6% of them worked in an 
individual/ independent pharmacy.  
The results of the study show that respiratory infections are the most commonly 
encountered infections while Aminopenicillin is the most commonly dispensed antimicrobial in 
community pharmacy.  Pharmacist provided competence, patient’s convenience, and legality of 
practice as the main reasons for dispensing antimicrobials without a prescription. 
More than 90% of community pharmacists were judged as having good knowledge, attitude, and 
practice in antimicrobial use and resistance. Moreover, the results indicate that Doctor of Pharmacy 
qualification, working in a chain store pharmacy, extensive experience can positively influence 
pharmacists’ knowledge, attitude, and practice score. However, these factors are not relevant when 
classifying KAP as either good or bad, especially in relation to practice. This research confirms that 
Thai community pharmacists have good knowledge, attitude and practice in antimicrobial use and 
resistance.  
This research examined the current situation in community pharmacy practice in relation to 
antimicrobial provision. Moreover, this study is an initial assessment of community pharmacists 
regarding antimicrobial use and resistance immediately following the launch of Thailand’s national 
strategy on AMR in early 2017. This research can be useful to develop future intervention for 
community pharmacist such as continuing professional development (CPD) courses and 
antimicrobial stewardship training.  Future interventions could take into account the current 
knowledge, attitude and practice of pharmacists, and aim to enhance pharmacists’ role in ensuring 
appropriate antimicrobial use and reducing/ containing antimicrobial resistance.  
In terms of the relationship between knowledge, attitude and practice in the KAP model, 
there is a weak correlation between attitude and practice scores and no relationship between 
knowledge and attitude scores, and knowledge and practice scores. However, other influencing 
factors such as regulations and policies could also affect pharmacists’ knowledge, attitude, and 
practice, and these need to be explored in future studies.  
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These findings confirm that most pharmacists in Thailand provide antimicrobials without a 
prescription, but this practice is supported by good knowledge, positive attitude and appropriate 
practice. However, antimicrobial stewardship in community pharmacy needs to improve. 
Antimicrobial stewardship strategy and guideline need to be produced, and interdisciplinary 
collaboration between sectors of healthcare is urgently required. Although pharmacists routinely 
undertake continuing education programmes regarding antimicrobials use, further education and 
CPD training is necessary. Future research could employ various behaviour models to investigate 
pharmacists and patients’ behaviour in relation to antimicrobial use and resistance. The next step 
would be to design and evaluate a suitable intervention in community pharmacy to improve patients’ 
antimicrobials use and awareness of resistance. 
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ETHICS APPROVAL NOTIFICATION 
 
TO: Budh Siltrakool 
 
CC: Dr Ilhem Berrou 
 
FROM: Dr Simon Trainis,Health,Sciences,Enginering &Technology ECDA Chair 
 
DATE: 04/05/2017  
 
 
 
Protocol number: LMS/PGR/UH/02811 
 
Title of study: Assessment of community pharmacists' knowledge,attitudes and practices 
regarding non-prescription antimicrobial use and resistance in Thailand 
 
Your application for ethics approval has been accepted and approved by the ECDA for your 
School and includes work undertaken for this study by the named additional workers below: 
 
 
This approval is valid: 
 
From: 04/05/2017 
 
To: 30/06/2018 
 
Additional workers: no additional workers named. 
 
Please note: 
 
If your research involves invasive procedures you are required to complete and 
submit an EC7 Protocol Monitoring Form, and your completed consent paperwork to 
this ECDA once your study is complete. 
 
Approval applies specifically to the research study/methodology and timings as detailed 
in your Form EC1. Should you amend any aspect of your research, or wish to apply for 
an extension to your study, you will need your supervisor’s approval and must complete 
and submit form EC2. In cases where the amendments to the original study are deemed 
to be substantial, a new Form EC1 may need to be completed prior to the study being 
undertaken. 
 
Should adverse circumstances arise during this study such as physical reaction/harm, 
mental/emotional harm, intrusion of privacy or breach of confidentiality this must be 
reported to the approving Committee immediately. Failure to report adverse 
circumstance/s would be considered misconduct. 
 
Ensure you quote the UH protocol number and the name of the approving Committee on 
all paperwork, including recruitment advertisements/online requests, for this study. 
 
Students must include this Approval Notification with their submission. 
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UNIVERSITY OF HERTFORDSHIRE 
 
ETHICS COMMITTEE FOR STUDIES INVOLVING THE USE OF HUMAN 
PARTICIPANTS (‘ETHICS COMMITTEE’) 
 
 
FORM EC6: PARTICIPANT INFORMATION SHEET 
 
1 Title of study 
 
Assessment of community pharmacists’ knowledge, attitude and practice regarding 
non-prescription antimicrobial use and resistance in Thailand. 
 
2 Introduction 
You are being invited to take part in a study. Before you decide whether to do so, it 
is important that you understand the research that is being done and what your 
involvement will include. Please take the time to read the following information 
carefully and discuss it with others if you wish. Do not hesitate to ask us anything 
that is not clear or for any further information you would like to help you make your 
decision. Please do take your time to decide whether or not you wish to take part.  
The University’s regulations governing the conduct of studies involving human 
participants can be accessed via this link: 
 
http://sitem.herts.ac.uk/secreg/upr/RE01.htm 
Thank you for reading this. 
 
3 What is the purpose of this study? 
 
This study aims to assessment community pharmacists’ attitudes, knowledge and 
practices regarding non-prescription antimicrobials prescribing and antimicrobial 
resistance 
 
4 Do I have to take part? 
 
It is completely up to you whether or not you decide to take part in this study. If you 
do decide to take part you will be given this information sheet to keep and be asked 
to sign a consent form. Agreeing to join the study does not mean that you have to 
complete it. You are free to withdraw at any stage without giving a reason. A 
decision to withdraw at any time, or a decision not to take part at all, will not affect 
any treatment/care that you may receive (should this be relevant). 
 
5 Are there any age or other restrictions that may prevent me from participating? 
 
You are not be eligible participate if you are age under 18 years old and 
not be a registered pharmacists by the pharmacy council of Thailand. 
 
6 How long will my part in the study take? 
 
If you decide to take part in this study, you will be involved in it for answering the 
questionnaire around 10 minutes. 
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7 What will happen to me if I take part? 
 
The first thing to happen the researcher will be provide a questionnaire to you. The 
questionnaire is divided into four sections. The first section ask your personal 
background and general topic in your community pharmacy working. The second 
section is a self-assessment of your know ledged in antimicrobial use and resistance. 
The third section will provide statements in antimicrobial use and resistance issue 
then you will give agreement to them. Last section is self-assessment about your 
activities to provide antimicrobial medicine in real practice. You will carefully read 
instruction of each part and answer the questions as possible as you can. 
 
8 What are the possible disadvantages, risks or side effects of taking part? 
 
In case you feel inconvenience to answers in some questions, you can skip the 
questions. Also, you are free to answer as little or a much as you want to in order to 
avoid you feeling uncomfortable and to withdraw yourself at any time. 
 
9 What are the possible benefits of taking part? 
 
The researcher expected that you may benefit from contributing this research. The 
research propose to understand current community pharmacists’ knowledge, attitude 
and practice regarding non-prescription antimicrobial use and resistance in Thailand. 
It will be useful for our pharmacy professional and health services improvement in the 
future. 
 
10 How will my taking part in this study be kept confidential? 
 
You will be asked about personal background in the first part or the questionnaire. 
However, it not ask any details or identification data. All responded questionnaire will 
be recorded in coding system. They will be stored separately to the consent form to 
protect your anonymity. It will be kept with secure conditions. It can be accessed only 
the researcher and their supervisors. 
 
11 Audio-visual material 
 
This research will NOT record any audio-visual material. 
 
12 What will happen to the data collected within this study? 
 
All responded questionnaire will be recorded in code system. They will be stored 
separately to the consent form to protect your anonymity. It will be kept with secure 
conditions. It can be accessed only the researcher and their supervisors. Storage and 
usage of personal information will be undertaken in accordance with the Data 
Protection Act 1998 and the EU Directive 95/46 on Data Protection. 
 
12.1   The data collected will be stored electronically, in a password-protected environment, 
for 36 months, after this study completed it will be destroyed under secure conditions. 
 
12.2 The data will be anonymised prior to storage. 
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13 Will the data be required for use in further studies? 
 
For dissemination through publication in peer-reviewed journals, posters or oral 
presentations at conferences, this data will be used in future studies. 
 
13.1 You are consenting to the re-use or further analysis of the data collected in a future 
ethically-approved study; 
 
13.2   The data collected will be stored electronically, in a password-protected environment, 
for 36 months, after this study completed it will be destroyed under secure conditions; 
 
 
14 Who has reviewed this study? 
 
This study has been reviewed by:  
The University of Hertfordshire Health and Human Sciences Ethics Committee with 
Delegated Authority 
 
The UH protocol number is LMS/PGR/UH/02811 
 
15 Factors that might put others at risk 
 
Please note that if, during the study, any medical conditions or non-medical 
circumstances such as unlawful activity become apparent that might or had put 
others at risk, the University may refer the matter to the appropriate authorities. 
 
16 Who can I contact if I have any questions? 
 
If you would like further information or would like to discuss any details personally, 
please get in touch with me, in writing, by phone or by email: 
 
Mr.Budh Siltrakool 
+4475-3590-7099, budh.sil@gmail.com 
 
Although we hope it is not the case, if you have any complaints or concerns about 
any aspect of the way you have been approached or treated during the course of 
this study, please write to the University’s Secretary and Registrar. 
 
Thank you very much for reading this information and giving consideration to taking 
part in this study. 
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Appendix 4: Statistical analysis data 
Chi square test - Demographic data 
1. Age * Gender 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Point 
Probability 
Pearson Chi-Square .716a 2 .699 .730   
Likelihood Ratio .696 2 .706 .730   
Fisher's Exact Test .776   .702   
Linear-by-Linear 
Association 
.271b 1 .603 .605 .331 .060 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 12.65. 
b. The standardized statistic is -.521. 
 
2. Age * Postgraduate degree 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Point 
Probability 
Pearson Chi-Square 20.106a 2 .000 .000   
Likelihood Ratio 19.843 2 .000 .000   
Fisher's Exact Test 19.808   .000   
Linear-by-Linear 
Association 
19.858b 1 .000 .000 .000 .000 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 10.84. 
b. The standardized statistic is 4.456. 
 
3. Age * Pharmacy degree 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Point 
Probability 
Pearson Chi-Square 63.590a 2 .000 .000   
Likelihood Ratio 69.943 2 .000 .000   
Fisher's Exact Test 65.887   .000   
Linear-by-Linear 
Association 
58.452b 1 .000 .000 .000 .000 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 9.60. 
b. The standardized statistic is -7.645. 
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4. Age* Location 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Point 
Probability 
Pearson Chi-Square 2.323a 2 .313 .308   
Likelihood Ratio 2.343 2 .310 .305   
Fisher's Exact Test 2.384   .296   
Linear-by-Linear 
Association 
2.172b 1 .141 .144 .083 .023 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 12.87. 
b. The standardized statistic is 1.474. 
 
5. Age* Pharmacy type 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
 (2-sided) 
Exact Sig.  
(1-sided) 
Point 
Probability 
Pearson Chi-Square 26.775a 2 .000 .000   
Likelihood Ratio 28.548 2 .000 .000   
Fisher's Exact Test 27.775   .000   
Linear-by-Linear 
Association 
26.703b 1 .000 .000 .000 .000 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 15.69. 
b. The standardized statistic is 5.167. 
 
6. Age * Experiences 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Point 
Probability 
Pearson Chi-Square 238.570a 4 .000 .000   
Likelihood Ratio 189.614 4 .000 .000   
Fisher's Exact Test 183.498   .000   
Linear-by-Linear 
Association 
149.120b 1 .000 .000 .000 .000 
N of Valid Cases 372      
a. 1 cells (11.1%) have expected count less than 5. The minimum expected count is 4.52. 
b. The standardized statistic is 12.211. 
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7. Experience * Gender 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Point 
Probability 
Pearson Chi-Square .148a 2 .929 .947   
Likelihood Ratio .147 2 .929 .947   
Fisher's Exact Test .199   .908   
Linear-by-Linear 
Association 
.131b 1 .717 .737 .389 .062 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 12.04. 
b. The standardized statistic is -.362. 
 
 
8. Experience * Postgraduate degree 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
 (2-sided) 
Exact Sig.  
(1-sided) 
Point 
Probability 
Pearson Chi-Square 16.142a 2 .000 .000   
Likelihood Ratio 14.821 2 .001 .001   
Fisher's Exact Test 14.935   .001   
Linear-by-Linear 
Association 
13.899b 1 .000 .000 .000 .000 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 10.32. 
b. The standardized statistic is 3.728. 
 
 
9. Experience * Pharmacy degree 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
 (2-sided) 
Exact Sig.  
(1-sided) 
Point 
Probability 
Pearson Chi-Square 56.006a 2 .000 .000   
Likelihood Ratio 64.969 2 .000 .000   
Fisher's Exact Test 60.749   .000   
Linear-by-Linear 
Association 
51.459b 1 .000 .000 .000 .000 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 9.14. 
b. The standardized statistic is -7.173. 
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10. Experience * Location 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Point 
Probability 
Pearson Chi-Square 4.687a 2 .096 .097   
Likelihood Ratio 4.655 2 .098 .096   
Fisher's Exact Test 4.561   .104   
Linear-by-Linear 
Association 
.674b 1 .412 .451 .230 .047 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 12.26. 
b. The standardized statistic is .821. 
 
 
11. Experience * Pharmacy type 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Point 
Probability 
Pearson Chi-Square 12.808a 2 .002 .002   
Likelihood Ratio 13.991 2 .001 .001   
Fisher's Exact Test 13.441   .001   
Linear-by-Linear 
Association 
11.980b 1 .001 .001 .000 .000 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 14.95. 
b. The standardized statistic is 3.461. 
 
 
12. Pharmacy degree * Gender 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig. 
 (1-sided) 
Point 
Probability 
Pearson Chi-Square 3.977a 1 .046 .059 .033  
Continuity Correctionb 3.459 1 .063    
Likelihood Ratio 3.853 1 .050 .059 .033  
Fisher's Exact Test    .059 .033  
Linear-by-Linear 
Association 
3.967c 1 .046 .059 .033 .015 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 25.59. 
b. Computed only for a 2x2 table 
c. The standardized statistic is -1.992. 
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13. Pharmacy degree * Location 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
 (2-sided) 
Exact Sig. 
 (1-sided) 
Point 
Probability 
Pearson Chi-Square 5.874a 1 .015 .016 .010  
Continuity Correctionb 5.243 1 .022    
Likelihood Ratio 6.229 1 .013 .016 .010  
Fisher's Exact Test    .016 .010  
Linear-by-Linear 
Association 
5.858c 1 .016 .016 .010 .005 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 26.05. 
b. Computed only for a 2x2 table 
c. The standardized statistic is -2.420. 
 
14. Pharmacy degree * Pharmacy type 
 
Chi-Square Tests 
 
 Value df 
Asymptotic 
Significance (2-
sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Point 
Probability 
Pearson Chi-Square 11.420a 1 .001 .001 .001  
Continuity Correctionb 10.574 1 .001    
Likelihood Ratio 11.144 1 .001 .001 .001  
Fisher's Exact Test    .001 .001  
Linear-by-Linear 
Association 
11.390c 1 .001 .001 .001 .000 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 31.76. 
b. Computed only for a 2x2 table 
c. The standardized statistic is -3.375. 
 
 
15. Postgraduate degree * Gender 
 
Chi-Square Tests 
 
 Value df 
Asymptotic 
Significance (2-
sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Point 
Probability 
Pearson Chi-Square .080a 1 .777 .797 .436  
Continuity Correctionb .024 1 .877    
Likelihood Ratio .080 1 .777 .797 .436  
Fisher's Exact Test    .797 .436  
Linear-by-Linear 
Association 
.080c 1 .777 .797 .436 .098 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 28.90. 
b. Computed only for a 2x2 table 
c. The standardized statistic is -.283. 
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16. Postgraduate degree * Location 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Point 
Probability 
Pearson Chi-Square .012a 1 .914 1.000 .511  
Continuity Correctionb .000 1 1.000    
Likelihood Ratio .012 1 .914 1.000 .511  
Fisher's Exact Test    1.000 .511  
Linear-by-Linear 
Association 
.012c 1 .914 1.000 .511 .102 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 29.42. 
b. Computed only for a 2x2 table 
c. The standardized statistic is -.108. 
 
 
17. Postgraduate degree * Pharmacy type 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig. 
(1-sided) 
Point 
Probability 
Pearson Chi-Square 3.716a 1 .054 .066 .034  
Continuity Correctionb 3.259 1 .071    
Likelihood Ratio 3.807 1 .051 .066 .034  
Fisher's Exact Test    .066 .034  
Linear-by-Linear 
Association 
3.707c 1 .054 .066 .034 .015 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 35.87. 
b. Computed only for a 2x2 table 
c. The standardized statistic is 1.925. 
 
 
18. Pharmacy degree * Postgraduate degree 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Point 
Probability 
Pearson Chi-Square 22.842a 1 .000 .000 .000  
Continuity Correctionb 21.514 1 .000    
Likelihood Ratio 28.263 1 .000 .000 .000  
Fisher's Exact Test    .000 .000  
Linear-by-Linear 
Association 
22.781c 1 .000 .000 .000 .000 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 21.94. 
b. Computed only for a 2x2 table 
c. The standardized statistic is -4.773. 
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19. Pharmacy type * Gender 
Chi-Square Tests 
 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Point 
Probability 
Pearson Chi-Square .039a 1 .843 .907 .469  
Continuity Correctionb .007 1 .935    
Likelihood Ratio .039 1 .843 .907 .469  
Fisher's Exact Test    .907 .469  
Linear-by-Linear 
Association 
.039c 1 .843 .907 .469 .091 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 41.85. 
b. Computed only for a 2x2 table 
c. The standardized statistic is -.198. 
 
 
20. Pharmacy type * Location 
 
Chi-Square Tests 
 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
 (2-sided) 
Exact Sig.  
(1-sided) 
Point 
Probability 
Pearson Chi-Square 11.515a 1 .001 .001 .000  
Continuity Correctionb 10.739 1 .001    
Likelihood Ratio 11.963 1 .001 .001 .000  
Fisher's Exact Test    .001 .000  
Linear-by-Linear 
Association 
11.484c 1 .001 .001 .000 .000 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 42.60. 
b. Computed only for a 2x2 table 
c. The standardized statistic is 3.389. 
 
 
21. Location * Gender  
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Point 
Probability 
Pearson Chi-Square .105a 1 .746 .807 .423  
Continuity Correctionb .041 1 .840    
Likelihood Ratio .106 1 .745 .807 .423  
Fisher's Exact Test    .807 .423  
Linear-by-Linear 
Association 
.105c 1 .746 .807 .423 .093 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 34.32. 
b. Computed only for a 2x2 table 
c. The standardized statistic is .324. 
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Mann Whitney Test 
 
1. Gender: Male and Female 
 
Ranks 
 Gender N Mean Rank Sum of Ranks 
Knowledge total score (K1-K9) Male 112 197.49 22118.50 
Female 260 181.77 47259.50 
Total 372   
Attitude total score (A1-A8) Male 112 185.50 20775.50 
Female 260 186.93 48602.50 
Total 372   
Practice total score (P1-P10) Male 112 204.97 22957.00 
Female 260 178.54 46421.00 
Total 372   
Test Statistics 
 
Knowledge total score 
(K1-K9) 
Attitude total score 
(A1-A8) 
Practice total score  
(P1-P10) 
Mann-Whitney U 13329.500 14447.500 12491.000 
Asymp. Sig. (2-tailed) .183 .905 .029 
 
2 Age:  
2.1 Lower than 30 and 30-40yrs.  
 
Ranks 
 Age by range N Mean Rank Sum of Ranks 
Knowledge total score (K1-K9) lower than 30 145 173.51 25159.50 
30-40 yrs. 185 159.22 29455.50 
Total 330   
Attitude total score (A1-A8) lower than 30 145 172.89 25069.00 
30-40 yrs. 185 159.71 29546.00 
Total 330   
Practice total score (P1-P10X lower than 30 145 165.97 24065.00 
30-40 yrs. 185 165.14 30550.00 
Total 330   
Test Statistics 
 
Knowledge total score 
(K1-K9) 
Attitude total score (A1-
A8) 
Practice total score  
(P1-P10) 
Mann-Whitney U 12250.500 12341.000 13345.000 
Asymp. Sig. (2-tailed) .165 .211 .937 
 
2.2 Age: lower than 30 yrs. and over than 40yrs. 
 
Ranks 
 Age by range N Mean Rank Sum of Ranks 
Knowledge total score (K1-K9) lower than 30 145 95.67 13871.50 
over than 40 42 88.25 3706.50 
Total 187   
Attitude total score (A1-A8) lower than 30 145 93.00 13485.00 
over than 40 42 97.45 4093.00 
Total 187   
Practice total score (P1-P10X lower than 30 145 96.63 14011.00 
over than 40 42 84.93 3567.00 
Total 187   
Test Statistics 
 
Knowledge total score 
(K1-K9) 
Attitude total score 
(A1-A8) 
Practice total score 
(P1-P10) 
Mann-Whitney U 2803.500 2900.000 2664.000 
Asymp. Sig. (2-tailed) .421 .637 .216 
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2.3 Age: 30-40 yrs. and over than 40yrs.  
 
Ranks 
 Age by range N Mean Rank Sum of Ranks 
Knowledge total score (K1-K9) 30-40 yrs. 185 113.74 21041.50 
over than 40 42 115.15 4836.50 
Total 227   
Attitude total score (A1-A8) 30-40 yrs. 185 111.92 20705.00 
over than 40 42 123.17 5173.00 
Total 227   
Practice total score (P1-P10X 30-40 yrs. 185 116.53 21558.00 
over than 40 42 102.86 4320.00 
Total 227   
Test Statistics 
 
Knowledge total 
score (K1-K9) 
Attitude total score 
(A1-A8) 
Practice total score 
(P1-P10) 
Mann-Whitney U 3836.500 3500.000 3417.000 
Asymp. Sig. (2-tailed) .896 .314 .222 
 
3. Pharmacy degree: BPharm and PharmD.  
 
Ranks 
 Phamacy degree N Mean Rank Sum of Ranks 
Knowledge total score (K1-K9) BPharm 287 180.95 51934.00 
PharmD 85 205.22 17444.00 
Total 372   
Attitude total score (A1-A8) BPharm 287 177.77 51019.00 
PharmD 85 215.99 18359.00 
Total 372   
Practice total score (P1-P10) BPharm 287 180.86 51906.00 
PharmD 85 205.55 17472.00 
Total 372   
Test Statistics 
 
Knowledge total score 
(K1-K9) 
Attitude total score 
(A1-A8) 
Practice total score 
(P1-P10) 
Mann-Whitney U 10606.000 9691.000 10578.000 
Asymp. Sig. (2-tailed) .060 .004 .062 
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4. Postgraduate degree: None and Postgraduate degree 
 
Ranks 
 Posgraduated degree N Mean Rank Sum of Ranks 
Knowledge total score (K1-
K9) 
None 276 190.06 52457.00 
Postgraduated degree 96 176.26 16921.00 
Total 372   
Attitude total score (A1-A8) None 276 187.12 51646.00 
Postgraduated degree 96 184.71 17732.00 
Total 372   
Practice total score (P1-P10X None 276 188.41 52001.50 
Postgraduated degree 96 181.01 17376.50 
Total 
372   
Test Statistics 
 
Knowledge total score 
(K1-K9) 
Attitude total score 
(A1-A8) 
Practice total score 
(P1-P10) 
Mann-Whitney U 12265.000 13076.000 12720.500 
Asymp. Sig. (2-tailed) .265 .849 .560 
 
 5. Experience 
 
5.1 lower than 5yrs. and 5-10 years 
 
Ranks 
 Experience by range N Mean Rank Sum of Ranks 
Knowledge total score (K1-K9) lower than 5 180 163.69 29465.00 
5-10 yrs. 152 169.82 25813.00 
Total 332   
Attitude total score (A1-A8) lower than 5 180 168.38 30308.00 
5-10 yrs. 152 164.28 24970.00 
Total 332   
Practice total score (P1-P10) lower than 5 180 175.85 31652.50 
5-10 yrs. 152 155.43 23625.50 
Total 332   
 
Test Statistics 
 
Knowledge total score 
(K1-K9) 
Attitude total score (A1-
A8) 
Practice total score 
(P1-P10) 
Mann-Whitney U 13175.000 13342.000 11997.500 
Asymp. Sig. (2-tailed) .551 .697 .053 
 
  
 111 
 
5.2 lower than 5yrs. and over than 10 years. 
 
Ranks 
 Experience by range N Mean Rank Sum of Ranks 
Knowledge total score (K1-K9) lower than 5 180 110.05 19808.50 
over than 10 40 112.54 4501.50 
Total 220   
Attitude total score (A1-A8) lower than 5 180 105.03 18904.50 
over than 10 40 135.14 5405.50 
Total 220   
Practice total score (P1-P10) lower than 5 180 113.58 20444.50 
over than 10 40 96.64 3865.50 
Total 220   
Test Statistics 
 
Knowledge total score 
(K1-K9) 
Attitude total score (A1-
A8) 
Practice total score 
(P1-P10) 
Mann-Whitney U 3518.500 2614.500 3045.500 
Asymp. Sig. (2-tailed) .818 .007 .127 
 
5.3 5-10 yrs. and over than 10 years. 
 
Ranks 
 Experience by range N Mean Rank Sum of Ranks 
Knowledge total score (K1-K9) 5-10 yrs. 152 96.60 14683.50 
over than 10 40 96.11 3844.50 
Total 192   
Attitude total score (A1-A8) 5-10 yrs. 152 91.18 13860.00 
over than 10 40 116.70 4668.00 
Total 192   
Practice total score (P1-P10) 5-10 yrs. 152 97.25 14782.50 
over than 10 40 93.64 3745.50 
Total 192   
Test Statistics 
 
Knowledge total score 
(K1-K9) 
Attitude total score (A1-
A8) 
Practice total score 
(P1-P10) 
Mann-Whitney U 3024.500 2232.000 2925.500 
Asymp. Sig. (2-tailed) .959 .010 .714 
 
6. Location: Bangkok and Chonburi 
 
Ranks 
 Location N Mean Rank Sum of Ranks 
Knowledge total score (K1-K9) Bangkok 258 189.10 48788.50 
Chonburi 114 180.61 20589.50 
Total 372   
Attitude total score (A1-A8) Bangkok 258 188.84 48720.50 
Chonburi 114 181.21 20657.50 
Total 372   
Practice total score (P1-P10) Bangkok 258 189.04 48772.00 
Chonburi 114 180.75 20606.00 
Total 372   
Test Statistics 
 
Knowledge total score 
(K1-K9) 
Attitude total score (A1-
A8) 
Practice total score 
(P1-P10) 
Mann-Whitney U 14034.500 14102.500 14051.000 
Asymp. Sig. (2-tailed) .470 .526 .492 
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7. Type of pharmacy: Chain store and Individual store 
 
Ranks 
 Type of pharmacies N Mean Rank Sum of Ranks 
Knowledge total score (K1-K9) Chain store 139 199.18 27685.50 
Individual store 233 178.94 41692.50 
Total 372   
Attitude total score (A1-A8) Chain store 139 206.16 28656.50 
Individual store 233 174.77 40721.50 
Total 372   
Practice total score (P1-P10) Chain store 139 180.36 25070.00 
Individual store 233 190.16 44308.00 
Total 372   
Test Statistics 
 
Knowledge total score 
(K1-K9) 
Attitude total score (A1-
A8) 
Practice total score 
(P1-P10) 
Mann-Whitney U 14431.500 13460.500 15340.000 
Asymp. Sig. (2-tailed) .071 .006 .394 
 
Kruskal-Wallis Test 
 
1. Age 
Ranks 
 Age by range N Mean Rank 
Knowledge total score (K1-K9) lower than 30 145 196.18 
30-40 yrs. 185 179.96 
over than 40 42 181.90 
Total 372  
Attitude total score (A1-A8) lower than 30 145 192.89 
30-40 yrs. 185 178.63 
over than 40 42 199.12 
Total 372  
Practice total score (P1-P10) lower than 30 145 189.59 
30-40 yrs. 185 188.66 
over than 40 42 166.29 
Total 372  
Test Statistics 
 
Knowledge total score 
(K1-K9) 
Attitude total score  
(A1-A8) 
Practice total score  
(P1-P10) 
Chi-Square 
2.053 2.100 1.687 
df 
2 2 2 
Asymp. Sig. 
.358 .350 .430 
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2. Experience 
 
Ranks 
 Experience by range N Mean Rank 
Knowledge total score (K1-K9) lower than 5 180 183.24 
5-10 yrs. 152 189.92 
over than 10 40 188.15 
Total 372  
Attitude total score (A1-A8) lower than 5 180 182.90 
5-10 yrs. 152 178.96 
over than 10 40 231.34 
Total 372  
Practice total score (P1-P10X lower than 5 180 198.93 
5-10 yrs. 152 176.18 
over than 10 40 169.78 
Total 372  
Test Statistics 
 
Knowledge total score 
(K1-K9) 
Attitude total score (A1-
A8) 
Practice total score (P1-
P10X 
Chi-Square .349 7.970 4.792 
df 2 2 2 
Asymp. Sig. .840 .019 .091 
 
 
Chi-square test, Knowledge types and demographics 
 
Knowledge type * Gender 
 
Crosstab 
Count   
 
Gender 
Total Male Female 
Knowledge type Poor 6 16 22 
Good 106 244 350 
Total 112 260 372 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Point 
Proba
bility 
Pearson Chi-Square .089a 1 .765 .817 .488  
Continuity Correctionb .004 1 .953    
Likelihood Ratio .091 1 .763 .817 .488  
Fisher's Exact Test    1.000 .488  
Linear-by-Linear 
Association 
.089c 1 .765 .817 .488 .185 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 6.62. 
b. Computed only for a 2x2 table 
c. The standardized statistic is -.298. 
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Knowledge type * Age by range 
Crosstab 
Count   
 
Age by range 
Total lower than 30 30-40 yrs. over than 40 
Knowledge type Poor 12 7 3 22 
Good 
133 178 39 350 
Total 145 185 42 372 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Point 
Probability 
Pearson Chi-Square 3.076a 2 .215 .238   
Likelihood Ratio 3.127 2 .209 .219   
Fisher's Exact Test 3.275   .191   
Linear-by-Linear 
Association 
.957b 1 .328 .401 .210 .085 
N of Valid Cases 372      
a. 1 cells (16.7%) have expected count less than 5. The minimum expected count is 2.48. 
b. The standardized statistic is .978. 
 
Knowledge type * Pharmacy degree 
Crosstab 
Count   
 
Phamacy degree 
Total BPharm PharmD 
Knowledge type Poor 16 6 22 
Good 
271 79 350 
Total 287 85 372 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Point 
Probability 
Pearson Chi-Square .260a 1 .610 .794 .387  
Continuity Correctionb .061 1 .804    
Likelihood Ratio .250 1 .617 .794 .387  
Fisher's Exact Test    .604 .387  
Linear-by-Linear 
Association 
.259c 1 .611 .794 .387 .172 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 5.03. 
b. Computed only for a 2x2 table 
c. The standardized statistic is -.509. 
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Knowledge type * Postgraduate degree 
Crosstab 
Count   
 
Posgraduated degree 
Total None Postgraduated degree 
Knowledge type Poor 18 4 22 
Good 258 92 350 
Total 276 96 372 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Point 
Probability 
Pearson Chi-Square .710a 1 .399 .464 .286  
Continuity Correctionb .350 1 .554    
Likelihood Ratio .762 1 .383 .464 .286  
Fisher's Exact Test    .615 .286  
Linear-by-Linear 
Association 
.708c 1 .400 .464 .286 .151 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 5.68. 
b. Computed only for a 2x2 table 
c. The standardized statistic is .841. 
 
Knowledge type * Experience by range 
 
Crosstab 
Count   
 
Experience by range 
Total lower than 5 5-10 yrs. over than 10 
Knowledge type Poor 13 6 3 22 
Good 167 146 37 350 
Total 180 152 40 372 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Point 
Probability 
Pearson Chi-Square 1.791a 2 .408 .412   
Likelihood Ratio 1.876 2 .391 .390   
Fisher's Exact Test 1.988   .349   
Linear-by-Linear 
Association 
.317b 1 .573 .628 .351 .114 
N of Valid Cases 372      
a. 1 cells (16.7%) have expected count less than 5. The minimum expected count is 2.37. 
b. The standardized statistic is .563. 
 
Knowledge type * Location  
Crosstab 
Count   
 
Location 
Total Bangkok Chonburi 
Knowledge type Poor 17 5 22 
Good 241 109 350 
Total 258 114 372 
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Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Point 
Probability 
Pearson Chi-Square .690a 1 .406 .482 .284  
Continuity Correctionb .351 1 .554    
Likelihood Ratio .727 1 .394 .482 .284  
Fisher's Exact Test    .482 .284  
Linear-by-Linear 
Association 
.688c 1 .407 .482 .284 .142 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 6.74. 
b. Computed only for a 2x2 table 
c. The standardized statistic is .829. 
 
Knowledge type * Type of pharmacies 
 
Crosstab 
Count   
 
Type of pharmacies 
Total Chain store Individual store 
Knowledge type Poor 6 16 22 
Good 133 217 350 
Total 139 233 372 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Point 
Probability 
Pearson Chi-Square 1.018a 1 .313 .370 .220  
Continuity Correctionb .611 1 .434    
Likelihood Ratio 1.063 1 .303 .370 .220  
Fisher's Exact Test    .370 .220  
Linear-by-Linear 
Association 
1.015c 1 .314 .370 .220 .114 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 8.22. 
b. Computed only for a 2x2 table 
c. The standardized statistic is -1.007. 
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Chi-square test, Attitude types and demographics 
 
Attitude type * Gender 
 
Crosstab 
Count   
 
Gender 
Total Male Female 
Attitude type Negative Attitude 9 16 25 
Positive Attitude 103 244 347 
Total 112 260 372 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significanc
e (2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Point 
Probability 
Pearson Chi-Square .442a 1 .506 .653 .323  
Continuity 
Correctionb 
.193 1 .660    
Likelihood Ratio .429 1 .513 .653 .323  
Fisher's Exact Test    .504 .323  
Linear-by-Linear 
Association 
.441c 1 .507 .653 .323 .138 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 7.53. 
b. Computed only for a 2x2 table 
c. The standardized statistic is .664. 
 
Attitude type * Age by range 
Crosstab 
Count   
 
Age by range 
Total lower than 30 30-40 yrs. over than 40 
Attitude type Negative Attitude 5 13 7 25 
Positive Attitude 140 172 35 347 
Total 145 185 42 372 
Chi-Square Tests 
 Value df 
Asymptotic 
Significanc
e (2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Point 
Probability 
Pearson Chi-Square 9.132a 2 .010 .011   
Likelihood Ratio 7.831 2 .020 .022   
Fisher's Exact Test 8.099   .013   
Linear-by-Linear 
Association 
7.991b 1 .005 .007 .004 .003 
N of Valid Cases 372      
a. 1 cells (16.7%) have expected count less than 5. The minimum expected count is 2.82. 
b. The standardized statistic is -2.827. 
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Attitude type * Pharmacy degree 
Crosstab 
Count   
 
Pharmacy degree 
Total BPharm PharmD 
Attitude type Negative Attitude 24 1 25 
Positive Attitude 263 84 347 
Total 287 85 372 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Point 
Probability 
Pearson Chi-Square 5.402a 1 .020 .023 .011  
Continuity 
Correctionb 
4.316 1 .038    
Likelihood Ratio 7.365 1 .007 .014 .011  
Fisher's Exact Test    .023 .011  
Linear-by-Linear 
Association 
5.387c 1 .020 .023 .011 .010 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 5.71. 
b. Computed only for a 2x2 table 
c. The standardized statistic is 2.321. 
 
Attitude type * Postgraduate degree 
Crosstab 
Count   
 
Posgraduated degree 
Total None 
Postgraduated 
degree 
Attitude type Negative Attitude 15 10 25 
Positive Attitude 261 86 347 
Total 276 96 372 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significanc
e (2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Point 
Probability 
Pearson Chi-
Square 
2.820a 1 .093 .101 .078  
Continuity 
Correctionb 
2.081 1 .149    
Likelihood Ratio 2.586 1 .108 .153 .078  
Fisher's Exact Test    .101 .078  
Linear-by-Linear 
Association 
2.812c 1 .094 .101 .078 .046 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 6.45. 
b. Computed only for a 2x2 table 
c. The standardized statistic is -1.677. 
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Attitude type * Experience by range 
Crosstab 
Count   
 
Experience by range 
Total lower than 5 5-10 yrs. over than 10 
Attitude type Negative Attitude 9 12 4 25 
Positive Attitude 171 140 36 347 
Total 180 152 40 372 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Point 
Probability 
Pearson Chi-Square 1.871a 2 .392 .413   
Likelihood Ratio 1.848 2 .397 .413   
Fisher's Exact Test 2.148   .355   
Linear-by-Linear 
Association 
1.848b 1 .174 .217 .115 .048 
N of Valid Cases 372      
a. 1 cells (16.7%) have expected count less than 5. The minimum expected count is 2.69. 
b. The standardized statistic is -1.359. 
 
Attitude type * Location  
Crosstab 
Count   
 
Location 
Total Bangkok Chonburi 
Attitude type Negative Attitude 13 12 25 
Positive Attitude 245 102 347 
Total 258 114 372 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Point 
Probability 
Pearson Chi-Square 3.798a 1 .051 .070 .046  
Continuity 
Correctionb 
2.973 1 .085    
Likelihood Ratio 3.539 1 .060 .070 .046  
Fisher's Exact Test    .070 .046  
Linear-by-Linear 
Association 
3.788c 1 .052 .070 .046 .028 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 7.66. 
b. Computed only for a 2x2 table 
c. The standardized statistic is -1.946. 
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Attitude type * Type of pharmacies 
 
Crosstab 
Count   
 
Type of pharmacies 
Total Chain store Individual store 
Attitude type Negative Attitude 5 20 25 
Positive Attitude 134 213 347 
Total 139 233 372 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significanc
e (2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Point 
Probability 
Pearson Chi-Square 3.453a 1 .063 .085 .046  
Continuity 
Correctionb 
2.704 1 .100    
Likelihood Ratio 3.769 1 .052 .085 .046  
Fisher's Exact Test    .085 .046  
Linear-by-Linear 
Association 
3.444c 1 .063 .085 .046 .031 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 9.34. 
b. Computed only for a 2x2 table 
c. The standardized statistic is -1.856. 
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Chi-square test, Practice types and demographics 
 
Practice type * Gender 
 
Crosstab 
Count   
 
Gender 
Total Male Female 
Practice type Inappropriate Practice 6 19 25 
Appropriate Practice 106 241 347 
Total 112 260 372 
 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Point 
Probability 
Pearson Chi-Square .475a 1 .491 .515 .330  
Continuity 
Correctionb 
.215 1 .643    
Likelihood Ratio .495 1 .482 .515 .330  
Fisher's Exact Test    .653 .330  
Linear-by-Linear 
Association 
.474c 1 .491 .515 .330 .148 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 7.53. 
b. Computed only for a 2x2 table 
c. The standardized statistic is -.688. 
 
Practice type * Age by range 
 
Crosstab 
Count   
 
Age by range 
Total lower than 30 30-40 yrs. over than 40 
Practice type Inappropriate Practice 6 16 3 25 
Appropriate Practice 139 169 39 347 
Total 145 185 42 372 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Point 
Probability 
Pearson Chi-Square 2.652a 2 .266 .263   
Likelihood Ratio 2.796 2 .247 .257   
Fisher's Exact Test 2.714   .259   
Linear-by-Linear 
Association 
1.544b 1 .214 .267 .139 .058 
N of Valid Cases 372      
a. 1 cells (16.7%) have expected count less than 5. The minimum expected count is 2.82. 
b. The standardized statistic is -1.243. 
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Practice type * Pharmacy degree 
Crosstab 
Count   
 
Pharmacy degree 
Total BPharm PharmD 
Practice type Inappropriate Practice 21 4 25 
Appropriate Practice 266 81 347 
Total 287 85 372 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Point 
Probability 
Pearson Chi-Square .713a 1 .398 .471 .284  
Continuity 
Correctionb 
.358 1 .550    
Likelihood Ratio .769 1 .380 .471 .284  
Fisher's Exact Test    .471 .284  
Linear-by-Linear 
Association 
.711c 1 .399 .471 .284 .149 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 5.71. 
b. Computed only for a 2x2 table 
c. The standardized statistic is .843. 
 
Practice type * Postgraduate degree 
Crosstab 
Count   
 
Postgraduate degree 
Total None 
Postgraduate 
degree 
Practice type Inappropriate Practice 18 7 25 
Appropriate Practice 258 89 347 
Total 276 96 372 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Point 
Probability 
Pearson Chi-Square .067a 1 .795 .814 .477  
Continuity 
Correctionb 
.001 1 .982    
Likelihood Ratio .066 1 .797 .814 .477  
Fisher's Exact Test    .814 .477  
Linear-by-Linear 
Association 
.067c 1 .796 .814 .477 .176 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 6.45. 
b. Computed only for a 2x2 table 
c. The standardized statistic is -.259. 
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Practice type * Experience by range 
Crosstab 
Count   
 
Experience by range 
Total lower than 5 5-10 yrs. over than 10 
Practice type Inappropriate Practice 10 10 5 25 
Appropriate Practice 170 142 35 347 
Total 180 152 40 372 
 
Chi-Square Tests 
 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Point 
Probability 
Pearson Chi-Square 2.526a 2 .283 .310   
Likelihood Ratio 2.146 2 .342 .351   
Fisher's Exact Test 2.565   .268   
Linear-by-Linear 
Association 
1.848b 1 .174 .217 .115 .048 
N of Valid Cases 372      
a. 1 cells (16.7%) have expected count less than 5. The minimum expected count is 2.69. 
b. The standardized statistic is -1.359. 
Practice type * Location  
Crosstab 
Count   
 
Location 
Total Bangkok Chonburi 
Practice type Inappropriate Practice 17 8 25 
Appropriate Practice 241 106 347 
Total 258 114 372 
 
Chi-Square Tests 
 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Point 
Probability 
Pearson Chi-Square .023a 1 .879 1.000 .519  
Continuity 
Correctionb 
.000 1 1.000    
Likelihood Ratio .023 1 .880 1.000 .519  
Fisher's Exact Test    .827 .519  
Linear-by-Linear 
Association 
.023c 1 .879 1.000 .519 .173 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 7.66. 
b. Computed only for a 2x2 table 
c. The standardized statistic is -.152. 
 
 
 124 
 
Practice type * Type of pharmacies 
Crosstab 
Count   
 
Type of pharmacies 
Total Chain store Individual store 
Practice type Inappropriate Practice 6 19 25 
Appropriate Practice 133 214 347 
Total 139 233 372 
 
Chi-Square Tests 
 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Point 
Probability 
Pearson Chi-Square 2.046a 1 .153 .200 .110  
Continuity 
Correctionb 
1.479 1 .224    
Likelihood Ratio 2.175 1 .140 .200 .110  
Fisher's Exact Test    .200 .110  
Linear-by-Linear 
Association 
2.040c 1 .153 .200 .110 .064 
N of Valid Cases 372      
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 9.34. 
b. Computed only for a 2x2 table 
c. The standardized statistic is -1.428. 
 
 
 
 
